| 1 |
Wang S, Chen L, Shi X, Wang Y, Xu S. Polystyrene microplastics-induced macrophage extracellular traps contributes to liver fibrotic injury by activating ROS/TGF-β/Smad2/3 signaling axis. Environ Pollut 2023;324:121388. [PMID: 36871749 DOI: 10.1016/j.envpol.2023.121388] [Reference Citation Analysis]
|
| 2 |
Aoyama S, Kido Y, Kanamoto M, Naito M, Nakanishi M, Kanna M, Yamamotoya T, Asano T, Nakatsu Y. Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex. Exp Cell Res 2023;425:113544. [PMID: 36906101 DOI: 10.1016/j.yexcr.2023.113544] [Reference Citation Analysis]
|
| 3 |
Guo M, Wang Z, Dai J, Fan H, Yuan N, Gao L, Peng H, Cheng X. Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway. Phytomedicine 2023;112:154587. [PMID: 36805480 DOI: 10.1016/j.phymed.2022.154587] [Reference Citation Analysis]
|
| 4 |
Guo Y, Tian G, Chen X, Hou Y, Zhang X, Xue X, Zhao L, Wu Y. GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway. Exp Cell Res 2023;425:113521. [PMID: 36841325 DOI: 10.1016/j.yexcr.2023.113521] [Reference Citation Analysis]
|
| 5 |
Xie C, Li X, Qu W, Ji R, Wang J, Song H. Numerical prediction of portal hypertension by a hydrodynamic blood flow model combing with the fractal theory. J Biomech 2023;150:111504. [PMID: 36871430 DOI: 10.1016/j.jbiomech.2023.111504] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Bastos MS, Saalfeld RM, Costa BP, Garcia MC, Antunes KH, Rodrigues KF, Melo D, Santarém ER, de Oliveira JR. Moquiniastrum polymorphum subsp. polymorphum extract inhibits the proliferation of an activated hepatic stellate cell line (GRX) by regulating the p27 pathway to generate cell cycle arrest. J Ethnopharmacol 2023;303:116056. [PMID: 36535332 DOI: 10.1016/j.jep.2022.116056] [Reference Citation Analysis]
|
| 7 |
Li S, Zhou B, Xue M, Zhu J, Tong G, Fan J, Zhu K, Hu Z, Chen R, Dong Y, Chen Y, Lee KY, Li X, Jin L, Cong W. Macrophage-specific FGF12 promotes liver fibrosis progression in mice. Hepatology 2023;77:816-33. [PMID: 35753047 DOI: 10.1002/hep.32640] [Reference Citation Analysis]
|
| 8 |
Salgüero S, Brochado-Kith Ó, Verdices AV, Berenguer J, González-García J, Martínez I, Díez C, Hontañón V, Pérez-Latorre L, Fernández-Rodríguez A, Jiménez-Sousa MÁ, Resino S. PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study. Biomed Pharmacother 2023;159:114220. [PMID: 36628818 DOI: 10.1016/j.biopha.2023.114220] [Reference Citation Analysis]
|
| 9 |
Lønsmann I, Steen Pedersen J, Krag A, Hansen T, Karsdal M, Julie Leeming D, Juul Nielsen M, Bendtsen F. Biomarkers reflecting pericellular fibrosis improve together with liver histology after bariatric surgery in early non-alcoholic fatty liver disease. Clin Biochem 2023;113:29-35. [PMID: 36574896 DOI: 10.1016/j.clinbiochem.2022.12.012] [Reference Citation Analysis]
|
| 10 |
Liu N, Liu M, Jiang M, Li Z, Chen W, Wang W, Fu X, Qi M, Ali MH, Zou N, Liu Q, Tang H, Chu S. Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2. Biomed Pharmacother 2023;159:114173. [PMID: 36680814 DOI: 10.1016/j.biopha.2022.114173] [Reference Citation Analysis]
|
| 11 |
Chen L, Wei X, Gu D, Xu Y, Zhou H. Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy. Cancer Lett 2023;555:216048. [PMID: 36603689 DOI: 10.1016/j.canlet.2022.216048] [Reference Citation Analysis]
|
| 12 |
Wang WQ, Xu GY, Li J, Liang BY, Li J, Lin ML, Chen XP, Zhang EL, Huang ZY. HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma. Cancer Med 2023. [PMID: 36847156 DOI: 10.1002/cam4.5740] [Reference Citation Analysis]
|
| 13 |
Wang R, Liu F, Chen P, Li S, Gu Y, Wang L, Chen C, Yuan Y. Gomisin D alleviates liver fibrosis through targeting PDGFRβ in hepatic stellate cells. Int J Biol Macromol 2023;235:123639. [PMID: 36822287 DOI: 10.1016/j.ijbiomac.2023.123639] [Reference Citation Analysis]
|
| 14 |
Zhang C, Shao Q, Liu M, Wang X, Loor JJ, Jiang Q, Cuan S, Li X, Wang J, Li Y, He L, Huang Y, Liu G, Lei L. Liver fibrosis is a common pathological change in the liver of dairy cows with fatty liver. J Dairy Sci 2023:S0022-0302(23)00064-4. [PMID: 36823013 DOI: 10.3168/jds.2022-22021] [Reference Citation Analysis]
|
| 15 |
van Son KC, Verschuren L, Hanemaaijer R, Reeves H, Takkenberg RB, Drenth JPH, Tushuizen ME, Holleboom AG. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Cancers (Basel) 2023;15. [PMID: 36831649 DOI: 10.3390/cancers15041308] [Reference Citation Analysis]
|
| 16 |
Luo S, Yang Y, Zhao T, Zhang R, Fang C, Li Y, Zhang Z, Gong T. Albumin-Based Silibinin Nanocrystals Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy. ACS Appl Mater Interfaces 2023;15:7747-58. [PMID: 36719351 DOI: 10.1021/acsami.2c19269] [Reference Citation Analysis]
|
| 17 |
Li X, Fan Y, Zha Z, Gong D, Yu J, Li Q, Li R, Wang H, Wang F. Cordycepin‐Loaded Macrophage Vesicles for Targeted Nonalcoholic Steatohepatitis Attenuation. Adv Funct Materials 2023. [DOI: 10.1002/adfm.202214059] [Reference Citation Analysis]
|
| 18 |
Kim DH, Kim MJ, Kwak SY, Jeong J, Choi D, Choi SW, Ryu J, Kang KS. Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation. Nat Commun 2023;14:801. [PMID: 36781854 DOI: 10.1038/s41467-023-35941-2] [Reference Citation Analysis]
|
| 19 |
Qiu L, Kong B, Kong T, Wang H. Recent advances in liver‐on‐chips: Design, fabrication, and applications. Smart Medicine 2023. [DOI: 10.1002/smmd.20220010] [Reference Citation Analysis]
|
| 20 |
Wu KJ, Qian QF, Zhou JR, Sun DL, Duan YF, Zhu X, Sartorius K, Lu YJ. Regulatory T cells (Tregs) in liver fibrosis. Cell Death Discov 2023;9:53. [PMID: 36759593 DOI: 10.1038/s41420-023-01347-8] [Reference Citation Analysis]
|
| 21 |
Qiu L, Chao W, Zhong S, Ren AJ. Eukaryotic Ribosomal Protein S5 of the 40S Subunit: Structure and Function. Int J Mol Sci 2023;24. [PMID: 36834797 DOI: 10.3390/ijms24043386] [Reference Citation Analysis]
|
| 22 |
Jangjoo S, Emami N, Sahranavard M, Shah NZ, Alidadi M, Baratzadeh F, Sathyapalan T, Eid AH, Jangjoo A, Jamialahmadi T, Sahebkar A. Diagnostic Value of Non-invasive Liver Function Tests in Liver Fibrosis and Changes in These Parameters Post-metabolic Surgery. Obes Surg 2023;33:548-54. [PMID: 36538211 DOI: 10.1007/s11695-022-06416-y] [Reference Citation Analysis]
|
| 23 |
Darwish OI, Gharib AM, Jeljeli S, Metwalli NS, Feeley J, Rotman Y, Brown RJ, Ouwerkerk R, Kleiner DE, Stäb D, Speier P, Sinkus R, Neji R. Single Breath-Hold 3-Dimensional Magnetic Resonance Elastography Depicts Liver Fibrosis and Inflammation in Obese Patients. Invest Radiol 2023. [PMID: 36719974 DOI: 10.1097/RLI.0000000000000952] [Reference Citation Analysis]
|
| 24 |
Nokkeaw A, Thamjamrassri P, Tangkijvanich P, Ariyachet C. Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis. Cells 2023;12. [PMID: 36766720 DOI: 10.3390/cells12030378] [Reference Citation Analysis]
|
| 25 |
Smirnova OA, Ivanova ON, Fedyakina IT, Yusubalieva GM, Baklaushev VP, Yanvarev DV, Kechko OI, Mitkevich VA, Vorobyev PO, Fedorov VS, Bartosch B, Valuev-Elliston VT, Lipatova AL, Ivanov AV. SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines. Cancers (Basel) 2023;15. [PMID: 36765590 DOI: 10.3390/cancers15030632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Zheng H, Huang N, Lin JQ, Yan LY, Jiang QG, Yang WZ. Effect and mechanism of pirfenidone combined with 2-methoxy-estradiol perfusion through portal vein on hepatic artery hypoxia-induced hepatic fibrosis. Adv Med Sci 2023;68:46-53. [PMID: 36610261 DOI: 10.1016/j.advms.2022.12.001] [Reference Citation Analysis]
|
| 27 |
Jia H, Liu J, Fang T, Zhou Z, Li R, Yin W, Qian Y, Wang Q, Zhou W, Liu C, Sun D, Chen X, Ouyang Z, Dong J, Wang Y, Yue S. The role of altered lipid composition and distribution in liver fibrosis revealed by multimodal nonlinear optical microscopy. Sci Adv 2023;9:eabq2937. [PMID: 36638165 DOI: 10.1126/sciadv.abq2937] [Reference Citation Analysis]
|
| 28 |
Zhang N, Yao H, Zhang Z, Li Z, Chen X, Zhao Y, Ju R, He J, Pan H, Liu X, Lv Y. Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment. Front Immunol 2023;14:1131588. [PMID: 36875101 DOI: 10.3389/fimmu.2023.1131588] [Reference Citation Analysis]
|
| 29 |
Yuan Z, Wang J, Zhang H, Chai Y, Xu Y, Miao Y, Yuan Z, Zhang L, Jiang Z, Yu Q. Glycocholic acid aggravates liver fibrosis by promoting the up-regulation of connective tissue growth factor in hepatocytes. Cell Signal 2023;101:110508. [PMID: 36341984 DOI: 10.1016/j.cellsig.2022.110508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Godugu C, Khurana A, Saifi MA. Rare earth cerium oxide nanoparticles attenuated liver fibrosis in bile duct ligation mice model. J Trace Elem Med Biol 2023;75:127102. [PMID: 36423438 DOI: 10.1016/j.jtemb.2022.127102] [Reference Citation Analysis]
|
| 31 |
He X, Wu J, Hou W, Li J, Xu H. Association of hydroxysteroid 11-beta dehydrogenase 1 polymorphisms with chronic liver fibrosis and the occurrence of hepatocellular carcinoma in a Han Chinese population. All Life 2022;15:951-959. [DOI: 10.1080/26895293.2021.2000893] [Reference Citation Analysis]
|
| 32 |
Guller A, Igrunkova A. Engineered Microenvironments for 3D Cell Culture and Regenerative Medicine: Challenges, Advances, and Trends. Bioengineering (Basel) 2022;10. [PMID: 36671589 DOI: 10.3390/bioengineering10010017] [Reference Citation Analysis]
|
| 33 |
Gao H, Wang X, Ma H, Lin S, Zhang D, Wu W, Liao Z, Chen M, Ye H, Li Q, Lin M, Li D. LncRNA CCAT2, involving miR-34a/TGF-β1/Smad4 signaling, regulate hepatic stellate cells proliferation. Sci Rep 2022;12:21199. [PMID: 36482069 DOI: 10.1038/s41598-022-25738-6] [Reference Citation Analysis]
|
| 34 |
Mohammad Omar J, Hai Y, Jin S. Hypoxia-induced factor and its role in liver fibrosis. PeerJ 2022;10:e14299. [PMID: 36523459 DOI: 10.7717/peerj.14299] [Reference Citation Analysis]
|
| 35 |
Kim TH, Kim YR, Jeong CW, Kim HJ, Kim JW, Lee YH, Yoon KH. Regional Analysis of Liver Surface Nodularity in a Single Axial MR Image for Staging Liver Fibrosis. J Magn Reson Imaging 2022;56:1781-91. [PMID: 35543163 DOI: 10.1002/jmri.28208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Qu B, Liu X, Liang Y, Zheng K, Zhang C, Lu L. Salidroside in the Treatment of NAFLD/NASH. Chem Biodivers 2022;19:e202200401. [PMID: 36210339 DOI: 10.1002/cbdv.202200401] [Reference Citation Analysis]
|
| 37 |
Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei S, Liu M, Wang P, Qiu J, Zhang L, Wu C, Shen H, Wang X, Cheng F, Lu L. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut 2022;71:2539-50. [PMID: 35140065 DOI: 10.1136/gutjnl-2021-325150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 38 |
Li K, Zheng J, Liu H, Gao Q, Yang M, Tang J, Wang H, Li S, Sun Y, Chang X. Whole-transcriptome sequencing revealed differentially expressed mRNAs and non-coding RNAs played crucial roles in NiONPs-induced liver fibrosis. Ecotoxicology and Environmental Safety 2022;248:114308. [DOI: 10.1016/j.ecoenv.2022.114308] [Reference Citation Analysis]
|
| 39 |
Ren H, Li W, Liu X, Zhao N. γδ T cells: The potential role in liver disease and implications for cancer immunotherapy. J Leukoc Biol 2022;112:1663-8. [PMID: 36098208 DOI: 10.1002/JLB.5MR0822-733RRR] [Reference Citation Analysis]
|
| 40 |
Liu Q, Lei X, Cao Z, Zhang J, Yan L, Fu J, Tong Q, Qin W, Shao Y, Liu C, Liu Z, Wang Z, Chu Y, Xu G, Liu S, Wen X, Yamamoto H, Mori M, Liang XM, Xu X. TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling. Cell Biosci 2022;12:58. [DOI: 10.1186/s13578-022-00789-4] [Reference Citation Analysis]
|
| 41 |
Peng X, Yang H, Tao L, Xiao J, Zeng Y, Shen Y, Yu X, Qin J. Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway.. [DOI: 10.21203/rs.3.rs-2251158/v1] [Reference Citation Analysis]
|
| 42 |
Yan L, Zhang T, Wang K, Chen Z, Yang Y, Shan B, Sun Q, Zhang M, Zhang Y, Zhong Y, Liu N, Gu J, Xu D. SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation. Nat Commun 2022;13:7153. [PMID: 36414671 DOI: 10.1038/s41467-022-34993-0] [Reference Citation Analysis]
|
| 43 |
Cho SS, Yang JH, Lee JH, Baek JS, Ku SK, Cho IJ, Kim KM, Ki SH. Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis. Free Radic Biol Med 2022;193:620-37. [PMID: 36370962 DOI: 10.1016/j.freeradbiomed.2022.11.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 44 |
Li B, Zhou J, Luo Y, Tao K, Zhang L, Zhao Y, Lin Y, Zeng X, Yu H. Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p/Col1a1 axis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1050093] [Reference Citation Analysis]
|
| 45 |
Liu Y, Kong X, You Y, Xiang L, Zhang Y, Wu R, Zhou L, Duan L. S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression. Cells 2022;11. [PMID: 36429008 DOI: 10.3390/cells11223579] [Reference Citation Analysis]
|
| 46 |
Williams J, Ferreira MAR, Ji T. BICOSS: Bayesian iterative conditional stochastic search for GWAS. BMC Bioinformatics 2022;23:475. [DOI: 10.1186/s12859-022-05030-0] [Reference Citation Analysis]
|
| 47 |
Zhao J, Li R, Li J, Chen Z, Lin Z, Zhang B, Deng L, Chen G, Wang Y. CAFs-derived SCUBE1 promotes malignancy and stemness through the Shh/Gli1 pathway in hepatocellular carcinoma. J Transl Med 2022;20:520. [DOI: 10.1186/s12967-022-03689-w] [Reference Citation Analysis]
|
| 48 |
Panzarini E, Leporatti S, Tenuzzo BA, Quarta A, Hanafy NAN, Giannelli G, Moliterni C, Vardanyan D, Sbarigia C, Fidaleo M, Tacconi S, Dini L. Therapeutic Effect of Polymeric Nanomicelles Formulation of LY2157299-Galunisertib on CCl(4)-Induced Liver Fibrosis in Rats. J Pers Med 2022;12. [PMID: 36579532 DOI: 10.3390/jpm12111812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 49 |
Yu S, Ji G, Zhang L. The role of p53 in liver fibrosis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1057829] [Reference Citation Analysis]
|
| 50 |
del Río C, Ruiz-pino F, Prados ME, Fiebich BL, Tena-sempere M, Muñoz E. Cannabidiol markedly alleviates skin and liver fibrosis. Front Pharmacol 2022;13:981817. [DOI: 10.3389/fphar.2022.981817] [Reference Citation Analysis]
|
| 51 |
Flores Molina M, Abdelnabi MN, Mazouz S, Villafranca-baughman D, Trinh VQ, Muhammad S, Bédard N, Osorio Laverde D, Hassan GS, Di Polo A, Shoukry NH. Distinct spatial distribution and roles of Kupffer cells and monocyte-derived macrophages in mouse acute liver injury. Front Immunol 2022;13:994480. [DOI: 10.3389/fimmu.2022.994480] [Reference Citation Analysis]
|
| 52 |
Zhang B, Wu F, Li P, Li H. ARRDC3 inhibits liver fibrosis and epithelial-to-mesenchymal transition via the ITGB4/PI3K/Akt signaling pathway. Immunopharmacol Immunotoxicol 2022;:1-15. [PMID: 36154540 DOI: 10.1080/08923973.2022.2128369] [Reference Citation Analysis]
|
| 53 |
Sun TT, Liu XL, Yang GY, Zhang W, Tao L, Ma WT, Wu L, Li Q, Liu C. Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis. Biochem Biophys Res Commun 2022;630:167-74. [PMID: 36155063 DOI: 10.1016/j.bbrc.2022.09.025] [Reference Citation Analysis]
|
| 54 |
Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity 2022;55:1515-29. [PMID: 36103850 DOI: 10.1016/j.immuni.2022.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 55 |
Duizendstra AA, De Knegt RJ, Nagtzaam NMA, Betjes MGH, Dik WA, Litjens NHR, Kwekkeboom J. Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation. Transplant Proc 2022:S0041-1345(22)00423-7. [PMID: 36100485 DOI: 10.1016/j.transproceed.2022.04.023] [Reference Citation Analysis]
|
| 56 |
Shan S, Liu Z, Liu Z, Zhang C, Song F. MitoQ alleviates carbon tetrachloride-induced liver fibrosis in mice through regulating JNK/YAP pathway. Toxicology Research 2022. [DOI: 10.1093/toxres/tfac062] [Reference Citation Analysis]
|
| 57 |
Li C, Ru YJ, Lin QY, Gao GC, Yang YD, Zhang XQ, Gao JL, Liu SH, Zheng CW, Wang L, Zheng YX, Wu JM. Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study. Fitoterapia 2022;:105290. [PMID: 36064152 DOI: 10.1016/j.fitote.2022.105290] [Reference Citation Analysis]
|
| 58 |
Karmacharya MB, Hada B, Park SR, Kim KH, Choi BH. Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. PLoS ONE 2022;17:e0274126. [DOI: 10.1371/journal.pone.0274126] [Reference Citation Analysis]
|
| 59 |
Luo Q, Ling Y, Li Y, Qu X, Shi Q, Zheng S, Li Y, Huang Y, Zhou X. Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway. Front Pharmacol 2022;13:964829. [DOI: 10.3389/fphar.2022.964829] [Reference Citation Analysis]
|
| 60 |
Li H, Liu T, Yang Y, Cho WC, Flynn RJ, Harandi MF, Song H, Luo X, Zheng Y. Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.08.013] [Reference Citation Analysis]
|
| 61 |
Zanelatto ACO, Lacerda GS, Accardo CM, Rosário NFD, Silva AAD, Motta G, Tersariol ILDS, Xavier AR. Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection. Microorganisms 2022;10. [PMID: 36144371 DOI: 10.3390/microorganisms10091769] [Reference Citation Analysis]
|
| 62 |
Yue L, Xue T, Su X, Liu Z, Liu H, Tan Z, Gan C, Xie Y, Ye T. Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents. Eur J Med Chem 2022;242:114685. [PMID: 36037790 DOI: 10.1016/j.ejmech.2022.114685] [Reference Citation Analysis]
|
| 63 |
Abdelnabi MN, Flores Molina M, Soucy G, Quoc-Huy Trinh V, Bédard N, Mazouz S, Jouvet N, Dion J, Tran S, Bilodeau M, Estall JL, Shoukry NH. Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis. Cell Mol Gastroenterol Hepatol 2022;14:1269-94. [PMID: 35970323 DOI: 10.1016/j.jcmgh.2022.08.001] [Reference Citation Analysis]
|
| 64 |
Mahdinloo S, Hemmati S, Valizadeh H, Mahmoudian M, Mahmoudi J, Roshangar L, Sarfraz M, Zakeri-Milani P. Synthesis and preparation of vitamin A coupled butein-loaded solid lipid nanoparticles for liver fibrosis therapy in rats. Int J Pharm 2022;625:122063. [PMID: 35964827 DOI: 10.1016/j.ijpharm.2022.122063] [Reference Citation Analysis]
|
| 65 |
Al Mahtab M, Ghosh J, Bhatia S, Nagral A, Bangar M, Menezes S, Butt N, Manchanayake JH, Singh SP. Gender Differences in Nonalcoholic Fatty Liver Disease. Euroasian Journal of Hepato-Gastroenterology 2022;12:S19-S25. [DOI: 10.5005/jp-journals-10018-1370] [Reference Citation Analysis]
|
| 66 |
Guo X, Li Y, Wang W, Wang L, Hu S, Xiao X, Hu C, Dai Y, Zhang Y, Li Z, Li J, Ma X, Zeng J. The construction of preclinical evidence for the treatment of liver fibrosis with quercetin: A systematic review and meta-analysis. Phytother Res 2022. [PMID: 35918855 DOI: 10.1002/ptr.7569] [Reference Citation Analysis]
|
| 67 |
Su SB, Tao L, Liang XL, Chen W. Long noncoding RNA GAS5 inhibits LX-2 cells activation by suppressing NF-κB signalling through regulation of the miR-433-3p/TLR10 axis. Dig Liver Dis 2022;54:1066-75. [PMID: 34903500 DOI: 10.1016/j.dld.2021.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 68 |
Dooling LJ, Saini K, Anlaş AA, Discher DE. Tissue mechanics coevolves with fibrillar matrisomes in healthy and fibrotic tissues. Matrix Biol 2022;111:153-88. [PMID: 35764212 DOI: 10.1016/j.matbio.2022.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 69 |
Liu P, Mao Y, Xie Y, Wei J, Yao J. Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential. Stem Cell Res Ther 2022;13:356. [PMID: 35883127 DOI: 10.1186/s13287-022-03041-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Jang E. Hyperoside as a Potential Natural Product Targeting Oxidative Stress in Liver Diseases. Antioxidants 2022;11:1437. [DOI: 10.3390/antiox11081437] [Reference Citation Analysis]
|
| 71 |
Song X, Shi J, Liu J, Liu Y, Yu Y, Qiu Y, Cao Z, Pan Y, Yuan X, Chu Y, Wu D. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway. Mol Med 2022;28:80. [PMID: 35842576 DOI: 10.1186/s10020-022-00508-2] [Reference Citation Analysis]
|
| 72 |
Chen X, Zhu S, Chen SY, Wang JN, Sun LJ, Tao SM, Li XF, Li HD, Sun YY, Xu CH, Suo XG, Ji ML, Huang C, Meng XM, Li J. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β. Int Immunopharmacol 2022;110:109034. [PMID: 35834952 DOI: 10.1016/j.intimp.2022.109034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 73 |
Yang L, Zhang B. Protective Mechanism of Nostoc sphaeroides Kütz. Polysaccharide on Liver Fibrosis by HFD-Induced Liver Fat Synthesis and Oxidative Stress. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-11. [DOI: 10.1155/2022/1745244] [Reference Citation Analysis]
|
| 74 |
Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, Guo L, Zhang X, Zhou X, Xu X, Yan X, Wang Y, Zhang J, Xu A, Tse HF, Lian Q. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis 2022;13:580. [PMID: 35787632 DOI: 10.1038/s41419-022-05034-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 75 |
Zhao Y, Li H. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease. Scand J Gastroenterol 2022;57:872-7. [PMID: 35189786 DOI: 10.1080/00365521.2022.2041085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Sheng R, Zhang Y, Sun W, Ji Y, Zeng M, Yao X, Dai Y. Staging Chronic Hepatitis B Related Liver Fibrosis with a Fractional Order Calculus Diffusion Model. Acad Radiol 2022;29:951-63. [PMID: 34429260 DOI: 10.1016/j.acra.2021.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 77 |
Luan S, Yang Y, Ye M, Liu H, Rao Q, Kong J, Wu F. ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p/BTG1 pathway. International Journal of Biological Macromolecules 2022;211:128-139. [DOI: 10.1016/j.ijbiomac.2022.05.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 78 |
Sun R, Xiang Z, Wu B. T cells and liver fibrosis. Portal Hypertension & Cirrhosis. [DOI: 10.1002/poh2.11] [Reference Citation Analysis]
|
| 79 |
Du Z, Huang D, Shi P, Dong Z, Wang X, Li M, Chen W, Zhang F, Sun L. Integrated Chemical Interpretation and Network Pharmacology Analysis to Reveal the Anti-Liver Fibrosis Effect of Penthorum chinense. Front Pharmacol 2022;13:788388. [PMID: 35721129 DOI: 10.3389/fphar.2022.788388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 80 |
Bai L, Wang YL, Chen YL, Li HX, Zhu SW, Liu Y, Song ZC, Duan SZ. The combination of experimental periodontitis and oral microbiota from periodontitis patients aggravates liver fibrosis in mice. J Clin Periodontol 2022. [PMID: 35713233 DOI: 10.1111/jcpe.13682] [Reference Citation Analysis]
|
| 81 |
Somade OT, Adeyi OE, Ajayi BO, Asunde OO, Iloh PD, Adesanya AA, Babalola OI, Folorunsho OT, Olakunle DA, Lawal OF. Syringic and ascorbic acids prevent NDMA-induced pulmonary fibrogenesis, inflammation, apoptosis, and oxidative stress through the regulation of PI3K-Akt/PKB-mTOR-PTEN signaling pathway. Metabolism Open 2022;14:100179. [DOI: 10.1016/j.metop.2022.100179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 82 |
Zhang K, Lin L, Zhu Y, Zhang N, Zhou M, Li Y. Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway. Front Pharmacol 2022;13:894981. [DOI: 10.3389/fphar.2022.894981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 83 |
Shan S, Liu Z, Wang S, Liu Z, Huang Z, Yang Y, Zhang C, Song F. Drp1-mediated mitochondrial fission promotes carbon tetrachloride-induced hepatic fibrogenesis in mice. Toxicology Research 2022. [DOI: 10.1093/toxres/tfac027] [Reference Citation Analysis]
|
| 84 |
Safran M, Masoud R, Sultan M, Tachlytski I, Chai Gadot C, Pery R, Balint-Lahat N, Pappo O, Buzaglo N, Ben-Ari Z. Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells. Cells 2022;11. [PMID: 35626751 DOI: 10.3390/cells11101715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 85 |
Manzoor R, Ahmed W, Afify N, Memon M, Yasin M, Memon H, Rustom M, Al Akeel M, Alhajri N. Trust Your Gut: The Association of Gut Microbiota and Liver Disease. Microorganisms 2022;10:1045. [DOI: 10.3390/microorganisms10051045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 86 |
Wu J, Zhang D, Zhu B, Wang S, Xu Y, Zhang C, Yang H, Wang S, Liu P, Qin L, Liu W. Rubus chingii Hu. unripe fruits extract ameliorates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance. Chin Med 2022;17:56. [PMID: 35549741 DOI: 10.1186/s13020-022-00607-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Shu G, Dai C, Yusuf A, Sun H, Deng X. Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl4-induced liver fibrosis in mice via upregulating Smad7 and subsequent suppression of TGF-β/Smad cascade. J Nutr Biochem 2022;:109039. [PMID: 35533902 DOI: 10.1016/j.jnutbio.2022.109039] [Reference Citation Analysis]
|
| 88 |
Miao X, Sha T, Zhang W, Zhou H, Qiu C, Deng H, You Y, Ren J, Zhang X, Zheng R, Yin T. Liver Fibrosis Assessment by Viewing Sinusoidal Capillarization: US Molecular Imaging versus Two-dimensional Shear-Wave Elastography in Rats. Radiology 2022;:212325. [PMID: 35503015 DOI: 10.1148/radiol.212325] [Reference Citation Analysis]
|
| 89 |
Fu R, Zu S, Liu Y, Li J, Dang W, Liao L, Liu L, Chen P, Huang H, Wu K, Zhou B, Pan Q, Luo C, Zhang Y, Li G. Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis. Bioengineered 2022;13:10914-30. [DOI: 10.1080/21655979.2022.2066756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 90 |
Song N, Xu H, Liu J, Zhao Q, Chen H, Yan Z, Yang R, Luo Z, Liu Q, Ouyang J, Wu S, Luo S, Ye S, Lin R, Sun X, Xie J, Lan T, Wu Z, Wang R, Jiang X. Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis. Acta Pharm Sin B 2022;12:2443-61. [PMID: 35646543 DOI: 10.1016/j.apsb.2021.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 91 |
Al Danaf L, Hussein Kamareddine M, Fayad E, Hussain A, Farhat S. Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis. World J Hepatol 2022;14:744-53. [PMID: 35646268 DOI: 10.4254/wjh.v14.i4.744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 92 |
Miao H, Ouyang H, Guo Q, Wei M, Lu B, Kai G, Ji L. Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism. J Nutr Biochem 2022;:109020. [PMID: 35472433 DOI: 10.1016/j.jnutbio.2022.109020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 93 |
Su S, Wang Q, Wei F, Zheng G. Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth. Evid Based Complement Alternat Med 2022;2022:5063088. [PMID: 35449813 DOI: 10.1155/2022/5063088] [Reference Citation Analysis]
|
| 94 |
Liu J, Yao Q, Xie X, Cui Q, Jiang T, Zhao Z, Du X, Lai B, Xiao L, Wang N. Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism. Nutrients 2022;14:1756. [DOI: 10.3390/nu14091756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 95 |
Lee C, Han J, Jung Y. Pathological Contribution of Extracellular Vesicles and Their MicroRNAs to Progression of Chronic Liver Disease. Biology 2022;11:637. [DOI: 10.3390/biology11050637] [Reference Citation Analysis]
|
| 96 |
Jiang YC, Han X, Dou JY, Yuan MH, Zhou MJ, Cui ZY, Lian LH, Nan JX, Zhang X, Wu YL. Protective role of Siberian onions against toxin-induced liver dysfunction: an insight into health-promoting effects. Food Funct 2022;13:4678-90. [PMID: 35377371 DOI: 10.1039/d1fo04404d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 97 |
Kaplow IM, Schäffer DE, Wirthlin ME, Lawler AJ, Brown AR, Kleyman M, Pfenning AR. Inferring mammalian tissue-specific regulatory conservation by predicting tissue-specific differences in open chromatin. BMC Genomics 2022;23:291. [PMID: 35410163 DOI: 10.1186/s12864-022-08450-7] [Reference Citation Analysis]
|
| 98 |
Gu Y, Wang R, Chen P, Li S, Chai X, Chen C, Liu Y, Cao Y, Lv D, Hong Z, Zhu Z, Chai Y, Yuan Y, Chen X. In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.04.010] [Reference Citation Analysis]
|
| 99 |
Chen ZW, Xiao HM, Ye X, Liu K, Rios RS, Zheng KI, Jin Y, Targher G, Byrne CD, Shi J, Yan Z, Chi XL, Zheng MH. A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study. Hepatobiliary Surg Nutr 2022;11:212-26. [PMID: 35464279 DOI: 10.21037/hbsn-21-23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 100 |
Lucantoni F, Benedicto AM, Gruevska A, Moragrega ÁB, Fuster-martínez I, Esplugues JV, Blas-garcía A, Apostolova N. Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less. Cell Death Dis 2022;13:385. [DOI: 10.1038/s41419-022-04789-7] [Reference Citation Analysis]
|
| 101 |
Lachowski D, Matellan C, Gopal S, Cortes E, Robinson BK, Saiani A, Miller AF, Stevens MM, Del Río Hernández AE. Substrate Stiffness-Driven Membrane Tension Modulates Vesicular Trafficking via Caveolin-1. ACS Nano 2022;16:4322-37. [PMID: 35255206 DOI: 10.1021/acsnano.1c10534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 102 |
Lyu H, Tang H, Liang Y, Huang S, Wang Y, Huang W, Zhou Y. Alcohol Consumption and Risk of Liver Fibrosis in People Living With HIV: A Systematic Review and Meta-Analysis. Front Immunol 2022;13:841314. [DOI: 10.3389/fimmu.2022.841314] [Reference Citation Analysis]
|
| 103 |
Li N, Shan S, Li XQ, Chen TT, Qi M, Zhang SN, Wang ZY, Zhang LL, Wei W, Sun WY. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases. Front Immunol 2021;12:822345. [PMID: 35111168 DOI: 10.3389/fimmu.2021.822345] [Reference Citation Analysis]
|
| 104 |
Ji J, Feng M, Huang Y, Niu X. Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitro. Bioengineered 2022;13:5091-102. [PMID: 35164657 DOI: 10.1080/21655979.2022.2036902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 105 |
Venkatesh SK, Torbenson MS. Liver fibrosis quantification. Abdom Radiol (NY) 2022;47:1032-52. [PMID: 35022806 DOI: 10.1007/s00261-021-03396-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 106 |
Königshofer P, Hofer BS, Brusilovskaya K, Simbrunner B, Petrenko O, Wöran K, Herac M, Stift J, Lampichler K, Timelthaler G, Bauer D, Hartl L, Robl B, Sibila M, Podesser BK, Oberhuber G, Schwabl P, Mandorfer M, Trauner M, Reiberger T. Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies. Hepatology 2022;75:610-22. [PMID: 34716927 DOI: 10.1002/hep.32220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 107 |
Xin X, Xu H, Jian J, Lv W, Zhao Y, Li Y, Zhao X, Hu C. A method of three-dimensional branching geometry to differentiate the intrahepatic vascular type in early-stage liver fibrosis using X-ray phase-contrast CT. European Journal of Radiology 2022;148:110178. [DOI: 10.1016/j.ejrad.2022.110178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 108 |
Zhu T, Zhang L, Li C, Tan X, Liu J, Huiqin Li, Fan Q, Zhang Z, Zhan M, Fu L, Luo J, Geng J, Wu Y, Zou X, Liang B. The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling. J Genet Genomics 2022:S1673-8527(22)00064-9. [PMID: 35240304 DOI: 10.1016/j.jgg.2022.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 109 |
Taniki N, Nakamoto N, Chu PS, Ichikawa M, Teratani T, Kanai T. Th17 cells in the liver: balancing autoimmunity and pathogen defense. Semin Immunopathol 2022. [PMID: 35211777 DOI: 10.1007/s00281-022-00917-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 110 |
Yu X, Elfimova N, Müller M, Bachurski D, Koitzsch U, Drebber U, Mahabir E, Hansen HP, Friedman SL, Klein S, Dienes HP, Hösel M, Buettner R, Trebicka J, Kondylis V, Mannaerts I, Odenthal M. Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular Secretion. Cell Mol Gastroenterol Hepatol 2022;13:1701-16. [PMID: 35219894 DOI: 10.1016/j.jcmgh.2022.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 111 |
Bae M, Kim M, Lee J. Astaxanthin Attenuates the Changes in the Expression of MicroRNAs Involved in the Activation of Hepatic Stellate Cells. Nutrients 2022;14:962. [DOI: 10.3390/nu14050962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 112 |
Zhong H, Gui X, Hou L, Lv R, Jin Y. From Inflammation to Fibrosis: Novel Insights into the Roles of High Mobility Group Protein Box 1 in Schistosome-Induced Liver Damage. Pathogens 2022;11:289. [DOI: 10.3390/pathogens11030289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 113 |
Zhang Z, Tang R, Chen X, Waller L, Kau A, Fung AA, Gutierrez B, An C, Cho SH, Shi L, Lo YH. A high-throughput technique to map cell images to cell positions using a 3D imaging flow cytometer. Proc Natl Acad Sci U S A 2022;119:e2118068119. [PMID: 35173045 DOI: 10.1073/pnas.2118068119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 114 |
Xing Y, Ye Y, Zuo H, Li Y. Progress on the Function and Application of Thymosin β4. Front Endocrinol (Lausanne) 2021;12:767785. [PMID: 34992578 DOI: 10.3389/fendo.2021.767785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 115 |
Song YR, Jang MH, Jang B, Bae SJ, Bak SB, Lee SM, Yun U, Lee JH, Park SM, Jung DH, Sa BS, Song JK, Lee EH, Kim KY, Park K, Kim YW, Kim SC. Jageum-Jung, the herbal pharmaceuticals, inhibits the hepatic fibrogenesis as mediated with TGF-β1/smad signaling. Mol Cell Toxicol . [DOI: 10.1007/s13273-021-00196-9] [Reference Citation Analysis]
|
| 116 |
Singh Rawat B, Venkataraman R, Budhwar R, Tailor P. Methionine- and Choline-Deficient Diet Identifies an Essential Role for DNA Methylation in Plasmacytoid Dendritic Cell Biology. J I 2022;208:881-897. [DOI: 10.4049/jimmunol.2100763] [Reference Citation Analysis]
|
| 117 |
Wang F, Zhou J, Chen E. Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis. Front Pharmacol 2022;13:787748. [DOI: 10.3389/fphar.2022.787748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 118 |
Chen N, Liu S, Qin D, Guan D, Chen Y, Hou C, Zheng S, Wang L, Chen X, Zhang L. Fate tracing reveals differences between Reelin+ HSCs and Desmin+ HSCs in activation, migration, and proliferation activities.. [DOI: 10.1101/2022.02.06.479312] [Reference Citation Analysis]
|
| 119 |
Dana J, Venkatasamy A, Saviano A, Lupberger J, Hoshida Y, Vilgrain V, Nahon P, Reinhold C, Gallix B, Baumert TF. Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease. Hepatol Int 2022. [PMID: 35138551 DOI: 10.1007/s12072-022-10303-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 120 |
Mastoridou EM, Goussia AC, Glantzounis GK, Kanavaros P, Charchanti AV. Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis. Front Physiol 2022;12:801340. [DOI: 10.3389/fphys.2021.801340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 121 |
Li Q, Chen T, Shi N, Ye W, Yuan M, Shi Y. Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B. Abdom Radiol (NY) 2022;47:684-92. [PMID: 34825269 DOI: 10.1007/s00261-021-03300-8] [Reference Citation Analysis]
|
| 122 |
Melayah S, Kallala O, Ben Ahmed M, Fodha I, Yacoub Jemni S, Ghedira I, Mankaï A. IgA anti-beta-2 glycoprotein I antibodies in chronic hepatitis C. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2021.12.003] [Reference Citation Analysis]
|
| 123 |
Ullah H, Khan A, Bibi T, Ahmad S, Shehzad O, Ali H, Seo EK, Khan S. Comprehensive in vivo and in silico approaches to explore the hepatoprotective activity of poncirin against paracetamol toxicity. Naunyn Schmiedebergs Arch Pharmacol 2022;395:195-215. [PMID: 34994820 DOI: 10.1007/s00210-021-02192-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 124 |
Wang A, Bu FT, Li JJ, Zhang YF, Jia PC, You HM, Wu S, Wu YY, Zhu S, Huang C, Li J. MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression. Toxicol Lett 2022;355:88-99. [PMID: 34838997 DOI: 10.1016/j.toxlet.2021.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 125 |
Xiong Y, Wen S, Li Y, Wei Y, Fang B, Li C, Huang Q, Lin X. Comprehensive analysis of transcriptomics and metabolomics to illustrate the underlying mechanism of helenalin against hepatic fibrosis. Eur J Pharmacol 2022;:174770. [PMID: 35120860 DOI: 10.1016/j.ejphar.2022.174770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 126 |
Guedes PLR, Carvalho CPF, Carbonel AAF, Simões MJ, Icimoto MY, Aguiar JAK, Kouyoumdjian M, Gazarini ML, Nagaoka MR. Chondroitin Sulfate Protects the Liver in an Experimental Model of Extra-Hepatic Cholestasis Induced by Common Bile Duct Ligation. Molecules 2022;27:654. [PMID: 35163920 DOI: 10.3390/molecules27030654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 127 |
Brougham-Cook A, Jain I, Kukla DA, Masood F, Kimmel H, Ryoo H, Khetani SR, Underhill GH. High throughput interrogation of human liver stellate cells reveals microenvironmental regulation of phenotype. Acta Biomater 2022;138:240-53. [PMID: 34800715 DOI: 10.1016/j.actbio.2021.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 128 |
Nie Y, Liu Q, Zhang W, Wan Y, Huang C, Zhu X. Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis. Gut Microbes 2021;13:1972746. [PMID: 34530693 DOI: 10.1080/19490976.2021.1972746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 129 |
Huang T, Li YQX, Zhou MY, Hu RH, Zou GL, Li JC, Feng S, Liu YM, Xin CQ, Zhao XK. Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis via the FAK/Ras/c-myc/ENO1 pathway. World J Gastroenterol 2022; 28(1): 123-139 [DOI: 10.3748/wjg.v28.i1.123] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 130 |
Wan C, Gu T, Ling J, Qin Y, Luo J, Sun L, Hua L, Zhao J, Jiang S. Perfluorooctane sulfonate aggravates CCl4-induced hepatic fibrosis via HMGB1/TLR4/Smad signaling. Environ Toxicol 2022. [PMID: 34990082 DOI: 10.1002/tox.23458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 131 |
Zhong Y, Zhang X, Chong W. Interleukin-24 Immunobiology and Its Roles in Inflammatory Diseases. Int J Mol Sci 2022;23:627. [PMID: 35054813 DOI: 10.3390/ijms23020627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 132 |
Saylan Y, Akgönüllü S, Özgür E, Denizli A. Nanosensors for smartphone-enabled sensing devices. Nanotechnology-Based Smart Remote Sensing Networks for Disaster Prevention 2022. [DOI: 10.1016/b978-0-323-91166-5.00003-3] [Reference Citation Analysis]
|
| 133 |
Zhou Z, Kong C, Sun J, Qu X, Sun J, Sun A. Fisetin Ameliorates Alcohol-Induced Liver Injury through Regulating SIRT1 and SphK1 Pathway. Am J Chin Med 2022;50:2171-2184. [DOI: 10.1142/s0192415x22500938] [Reference Citation Analysis]
|
| 134 |
Li W, Chen JY, Sun C, Sparks RP, Pantano L, Rahman RU, Moran SP, Pondick JV, Kirchner R, Wrobel D, Bieler M, Sauer A, Ho Sui SJ, Doerner JF, Rippmann JF, Mullen AC. Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells. Elife 2022;11. [PMID: 35617485 DOI: 10.7554/eLife.74513] [Reference Citation Analysis]
|
| 135 |
Albhaisi S, Sanyal AJ. Pharmacology of NASH. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00121-3] [Reference Citation Analysis]
|
| 136 |
Huang J, Cheng D. MRI-Visible Nanocarrier for Synergistic MicroRNA Therapy in Liver Fibrotic Rat. Biomaterial Engineering 2022. [DOI: 10.1007/978-981-16-5419-0_14] [Reference Citation Analysis]
|
| 137 |
Muriel P. The healthy and diseased extracellular matrix of the liver. Hepatic Fibrosis 2022. [DOI: 10.1016/b978-0-323-99764-5.00009-3] [Reference Citation Analysis]
|
| 138 |
He H, Peng S, Song X, Jia R, Zou Y, Li L, Yin Z. Protective effect of isoflavones and triterpenoid saponins from pueraria lobata on liver diseases: A review. Food Sci Nutr 2022;10:272-85. [PMID: 35035928 DOI: 10.1002/fsn3.2668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 139 |
Hossen MJ, Matin MA, Sikder MH, Ahmed MS, Rahman M. Kupffer cells and liver. Recent Advancements in Microbial Diversity 2022. [DOI: 10.1016/b978-0-12-822368-0.00016-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 140 |
Lee SH, Oh MH, Shin M, Lee JH, Roh S. Effect of <italic>Sosiho-tang</italic> on a Thioacetamide-induced Liver Fibrosis Mouse Model. J Int Korean Med 2021;42:1223-1236. [DOI: 10.22246/jikm.2021.42.6.1223] [Reference Citation Analysis]
|
| 141 |
Pessoa J, Teixeira J. Cytoskeleton alterations in non-alcoholic fatty liver disease. Metabolism 2021;128:155115. [PMID: 34974078 DOI: 10.1016/j.metabol.2021.155115] [Reference Citation Analysis]
|
| 142 |
Yang L, Liu Y, Sun Y, Huang C, Li J, Wang Y. New advances of DNA/RNA methylation modification in liver fibrosis. Cell Signal 2021;:110224. [PMID: 34954394 DOI: 10.1016/j.cellsig.2021.110224] [Reference Citation Analysis]
|
| 143 |
Yano M, Nasti A, Seki A, Ishida K, Yamato M, Inui H, Ogawa N, Inagaki S, Ho TTB, Kawaguchi K, Yamashita T, Arai K, Yamashita T, Mizukoshi E, Inoue O, Takashima S, Usui S, Takamura M, Honda M, Wada T, Kaneko S, Sakai Y. Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair. Regen Ther 2021;18:497-507. [PMID: 34926735 DOI: 10.1016/j.reth.2021.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 144 |
Ji K, Fan M, Huang D, Sun L, Li B, Xu R, Zhang J, Shao X, Chen Y. Clodronate-nintedanib-loaded exosome-liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity. Biomater Sci 2021. [PMID: 34927632 DOI: 10.1039/d1bm01663f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 145 |
Cardoso AC, A Villela-Nogueira C, de Figueiredo-Mendes C, Leão Filho H, Pinto Silva RA, Valle Tovo C, Perazzo H, Matteoni AC, de Carvalho-Filho RJ, Lisboa Bittencourt P. Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases. Ann Hepatol 2021;22:100341. [PMID: 33737252 DOI: 10.1016/j.aohep.2021.100341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 146 |
Braun LM, Zeiser R. Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease. Front Immunol 2021;12:760199. [PMID: 34868001 DOI: 10.3389/fimmu.2021.760199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 147 |
Wang C, Ma C, Gong L, Dai S, Li Y. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. Eur J Pharmacol 2021;912:174604. [PMID: 34743980 DOI: 10.1016/j.ejphar.2021.174604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 148 |
Li Y, Liu P, Wei F. Long non‑coding RNA MBI‑52 inhibits the development of liver fibrosis by regulating the microRNA‑466g/SMAD4 signaling pathway. Mol Med Rep 2022;25:33. [PMID: 34850963 DOI: 10.3892/mmr.2021.12549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 149 |
Chen X, Wang Z, Han S, Wang Z, Zhang Y, Li X, Xia N, Yu W, Jia C, Ni Y, Pu L. Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment. Cell Death Dis 2021;12:1123. [PMID: 34853322 DOI: 10.1038/s41419-021-04403-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 150 |
Zaghary WA, Elansary MM, Shouman DN, Abdelrahim AA, Abu-zied KM, Sakr TM. Can nanotechnology overcome challenges facing stem cell therapy? A review. Journal of Drug Delivery Science and Technology 2021;66:102883. [DOI: 10.1016/j.jddst.2021.102883] [Reference Citation Analysis]
|
| 151 |
El-Nahaas SM, Rady NH, Malek S, Serag K. Changes in serum interferon-γ-inducible protein-10 levels and liver stiffness among chronic hepatitis C Egyptian patients in response to directly acting antiviral agents. Eur J Gastroenterol Hepatol 2021;33:e335-40. [PMID: 33470694 DOI: 10.1097/MEG.0000000000002059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 152 |
Li Y, Kim M, Park Y, Lee J. Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells. Journal of Agriculture and Food Research 2021;6:100245. [DOI: 10.1016/j.jafr.2021.100245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 153 |
Landerer S, Kalthoff S, Strassburg CP. UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice. Hepatobiliary Surg Nutr 2021;10:766-81. [PMID: 35004944 DOI: 10.21037/hbsn-20-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 154 |
Wan J, Zhang Y, Yang D, Liang Y, Yang L, Hu S, Liu Z, Fang Q, Tian S, Ding Y. Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway. Hepatology 2021;74:3074-90. [PMID: 34297426 DOI: 10.1002/hep.32068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 155 |
Li T, Liu J, Wang Y, Zhou C, Shi Q, Huang S, Yang C, Chen Y, Bai Y, Xiong B. Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model. Sci Rep 2021;11:22846. [PMID: 34819565 DOI: 10.1038/s41598-021-02155-9] [Reference Citation Analysis]
|
| 156 |
Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 157 |
Li S, Han S, Jin K, Yu T, Chen H, Zhou X, Tan Z, Zhang G. SOCS2 Suppresses Inflammation and Apoptosis during NASH Progression through Limiting NF-κB Activation in Macrophages. Int J Biol Sci 2021;17:4165-75. [PMID: 34803490 DOI: 10.7150/ijbs.63889] [Reference Citation Analysis]
|
| 158 |
Jussila AR, Zhang B, Caves E, Kirti S, Steele M, Hamburg-Shields E, Lydon J, Ying Y, Lafyatis R, Rajagopalan S, Horsley V, Atit RP. Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4. J Invest Dermatol 2021:S0022-202X(21)02487-8. [PMID: 34808238 DOI: 10.1016/j.jid.2021.10.025] [Reference Citation Analysis]
|
| 159 |
Liu T, Hu J, Liu Y, Chen H, Guo D. Magnetic resonance quantification of non-Gaussian water diffusion in hepatic fibrosis staging: a pilot study of diffusion kurtosis imaging to identify reversible hepatic fibrosis. Ann Transl Med 2021;9:1569. [PMID: 34790775 DOI: 10.21037/atm-21-4884] [Reference Citation Analysis]
|
| 160 |
Su Q, Kim SY, Adewale F, Zhou Y, Aldler C, Ni M, Wei Y, Burczynski ME, Atwal GS, Sleeman MW, Murphy AJ, Xin Y, Cheng X. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience 2021;24:103233. [PMID: 34755088 DOI: 10.1016/j.isci.2021.103233] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 161 |
Hung WL, Hsiao YT, Chiou YS, Nagabhushanam K, Ho CT, Pan MH. Hepatoprotective effect of piceatannol against carbon tetrachloride-induced liver fibrosis in mice. Food Funct 2021;12:11229-40. [PMID: 34676843 DOI: 10.1039/d1fo02545g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 162 |
Goto RL, Tablas MB, Prata GB, Espírito Santo SG, Fernandes AAH, Cogliati B, Barbisan LF, Romualdo GR. Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis. J Steroid Biochem Mol Biol 2022;215:106022. [PMID: 34774723 DOI: 10.1016/j.jsbmb.2021.106022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 163 |
Pandita H, Mezey E, Ganapathy-Kanniappan S. Augmented Liver Uptake of the Membrane Voltage Sensor Tetraphenylphosphonium Distinguishes Early Fibrosis in a Mouse Model. Front Physiol 2021;12:676722. [PMID: 34759830 DOI: 10.3389/fphys.2021.676722] [Reference Citation Analysis]
|
| 164 |
Qin R, Huang W, Huang Y, Zhang Z, Su Y, Chen S, Wang H. lncRNA MEG3 modulates hepatic stellate cell activation by sponging miR‑145 to regulate PPARγ. Mol Med Rep 2022;25:3. [PMID: 34738631 DOI: 10.3892/mmr.2021.12519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 165 |
Deng Y, Li J, Zhou M, Liang Z, Zhao L. c-Myc affects hedgehog pathway via KCNQ1OT1/RAC1: A new mechanism for regulating HSC proliferation and epithelial-mesenchymal transition. Dig Liver Dis 2021;53:1458-67. [PMID: 33451909 DOI: 10.1016/j.dld.2020.11.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 166 |
Yang W, He H, Wang T, Su N, Zhang F, Jiang K, Zhu J, Zhang C, Niu K, Wang L, Yuan X, Liu N, Li L, Wei W, Hu J. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Hepatology 2021;74:2774-90. [PMID: 34089528 DOI: 10.1002/hep.31987] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 167 |
Quenum AJI, Shukla A, Rexhepi F, Cloutier M, Ghosh A, Kufer TA, Ramanathan S, Ilangumaran S. NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis. Front Immunol 2021;12:749646. [PMID: 34712238 DOI: 10.3389/fimmu.2021.749646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 168 |
Tian S, Chen M, Wang B, Han Y, Shang H, Chen J. Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling. Ann Hepatol 2021;20:100259. [PMID: 32980439 DOI: 10.1016/j.aohep.2020.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 169 |
Zhou MY, Cheng ML, Huang T, Hu RH, Zou GL, Li H, Zhang BF, Zhu JJ, Liu YM, Liu Y, Zhao XK. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells. World J Gastroenterol 2021; 27(40): 6908-6926 [PMID: 34790014 DOI: 10.3748/wjg.v27.i40.6908] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 170 |
Sarma MS, Seetharaman J. Pediatric non-cirrhotic portal hypertension: Endoscopic outcome and perspectives from developing nations. World J Hepatol 2021;13:1269-88. [PMID: 34786165 DOI: 10.4254/wjh.v13.i10.1269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 171 |
Chen L, Huang Y, Duan Z, Huang P, Yao H, Zhou Y, Ji Q, Liu X. Exosomal miR-500 Derived From Lipopolysaccharide-Treated Macrophage Accelerates Liver Fibrosis by Suppressing MFN2. Front Cell Dev Biol 2021;9:716209. [PMID: 34676206 DOI: 10.3389/fcell.2021.716209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 172 |
Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen SY, Wang J, Tan Y, Wu M, Chen X, Johansson PK, Osman I, Kunimoto K, Russo P, Heilshorn SC, Peltz G. A human multi-lineage hepatic organoid model for liver fibrosis. Nat Commun 2021;12:6138. [PMID: 34686668 DOI: 10.1038/s41467-021-26410-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 173 |
Gabbia D, Carpi S, Sarcognato S, Cannella L, Colognesi M, Scaffidi M, Polini B, Digiacomo M, Esposito Salsano J, Manera C, Macchia M, Nieri P, Carrara M, Russo FP, Guido M, De Martin S. The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver. Front Nutr 2021;8:715183. [PMID: 34671630 DOI: 10.3389/fnut.2021.715183] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 174 |
Tang XH, Melis M, Lu C, Rappa A, Zhang T, Jessurun J, Gross SS, Gudas LJ. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. J Biol Chem 2021;297:101331. [PMID: 34688661 DOI: 10.1016/j.jbc.2021.101331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 175 |
Shu Y, Xu Q, Xu Y, Tao Q, Shao M, Cao X, Chen Y, Wu Z, Chen M, Zhou Y, Zhou P, Shi Y, Bu H. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling. Cell Death Dis 2021;12:966. [PMID: 34667161 DOI: 10.1038/s41419-021-04263-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 176 |
Liang C, Li J, Tian B, Tian L, Liu Y, Li J, Xin L, Wang J, Fu C, Shi Z, Xia J, Liang Y, Wang K. Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. Biomed Pharmacother 2021;144:112298. [PMID: 34649219 DOI: 10.1016/j.biopha.2021.112298] [Reference Citation Analysis]
|
| 177 |
Dai C, Yusuf A, Sun H, Shu G, Deng X. A characterized saponin extract of Panax japonicus suppresses hepatocyte EMT and HSC activation in vitro and CCl4-provoked liver fibrosis in mice: Roles of its modulatory effects on the Akt/GSK3β/Nrf2 cascade. Phytomedicine 2021;93:153746. [PMID: 34634746 DOI: 10.1016/j.phymed.2021.153746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 178 |
Li W, Chen JY, Sun C, Sparks RP, Pantano L, Rahman R, Moran SP, Pondick JV, Kirchner R, Wrobel D, Bieler M, Ho Sui SJ, Doerner JF, Rippmann JF, Mullen AC. Nanchangmycin regulates FYN, FAK and ERK to control the fibrotic activity of hepatic stellate cells.. [DOI: 10.1101/2021.10.08.463221] [Reference Citation Analysis]
|
| 179 |
Zhu H, Zhao H, Xu S, Zhang Y, Ding Y, Li J, Huang C, Ma T. Sennoside A alleviates inflammatory responses by inhibiting the hypermethylation of SOCS1 in CCl4-induced liver fibrosis. Pharmacol Res 2021;174:105926. [PMID: 34619344 DOI: 10.1016/j.phrs.2021.105926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 180 |
Chen Y, Yuan S, Cao Y, Kong G, Jiang F, Li Y, Wang Q, Tang M, Zhang Q, Wang Q, Liu L. Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases. Oxid Med Cell Longev 2021;2021:3206982. [PMID: 34594474 DOI: 10.1155/2021/3206982] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 181 |
Cui Q, He F, Hu J, Li S, Guo D, Bie X, Liu W, Zhao Y. Evaluation of Rabbits Liver Fibrosis Using Gd-DTPA-BMA of Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Evid Based Complement Alternat Med 2021;2021:2791142. [PMID: 34567208 DOI: 10.1155/2021/2791142] [Reference Citation Analysis]
|
| 182 |
Choi JH, Park S, Kim GD, Kim JY, Jun JH, Bae SH, Baik SK, Hwang SG, Kim GJ. Increased Phosphatase of Regenerating Liver-1 by Placental Stem Cells Promotes Hepatic Regeneration in a Bile-Duct-Ligated Rat Model. Cells 2021;10:2530. [PMID: 34685509 DOI: 10.3390/cells10102530] [Reference Citation Analysis]
|
| 183 |
Jiao W, Bai M, Yin H, Liu J, Sun J, Su X, Zeng H, Wen J. Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway. Front Mol Biosci 2021;8:690170. [PMID: 34540892 DOI: 10.3389/fmolb.2021.690170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 184 |
Tayler IM, Stowers RS. Engineering hydrogels for personalized disease modeling and regenerative medicine. Acta Biomater 2021;132:4-22. [PMID: 33882354 DOI: 10.1016/j.actbio.2021.04.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 185 |
Shakerian E, Akbari R, Mohammad Taghvaei N, Mohammadi Gahrooie M, Afarin R. Quercetin Reduces Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3 Signaling Pathway in LX-2 Cell Line. Jundishapur J Nat Pharm Prod 2021;In Press. [DOI: 10.5812/jjnpp.113484] [Reference Citation Analysis]
|
| 186 |
Hui ST, Wang F, Stappenbeck F, French SW, Magyar CE, Parhami F, Lusis AJ. Oxy210, a novel inhibitor of hedgehog and TGF-β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice. Endocrinol Diabetes Metab 2021;4:e00296. [PMID: 34505423 DOI: 10.1002/edm2.296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 187 |
Zhan J, Hu T, Shen J, Yang G, Ho C, Li S. Pterostilbene is more efficacious than hydroxystilbenes in protecting liver fibrogenesis in a carbon tetracholride-induced rat model. Journal of Functional Foods 2021;84:104604. [DOI: 10.1016/j.jff.2021.104604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 188 |
Xiong Y, Huang J. Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment. Chin Med 2021;16:80. [PMID: 34407830 DOI: 10.1186/s13020-021-00489-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 189 |
Kaur J, Mohan G, Chandey M. To Compare Serum Vitamin D Levels with Severity of Liver Cirrhosis According to Child-Pugh Score in Amritsar, Punjab. jebmh 2021;8:3090-3096. [DOI: 10.18410/jebmh/2021/563] [Reference Citation Analysis]
|
| 190 |
Yan Y, Zeng J, Xing L, Li C. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021;9:1014. [PMID: 34440218 DOI: 10.3390/biomedicines9081014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 191 |
Ahrari A, Najafzadehvarzi H, Taravati A, Tohidi F. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression. Life Sci 2021;284:119884. [PMID: 34389401 DOI: 10.1016/j.lfs.2021.119884] [Reference Citation Analysis]
|
| 192 |
Zhou Y, Chen Y, Zhang X, Xu Q, Wu Z, Cao X, Shao M, Shu Y, Lv T, Lu C, Xie M, Wen T, Yang J, Shi Y, Bu H. Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion. Hepatology 2021;74:797-815. [PMID: 33650193 DOI: 10.1002/hep.31780] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 193 |
Cui E, Long W, Wu J, Li Q, Ma C, Lei Y, Lin F. Predicting the stages of liver fibrosis with multiphase CT radiomics based on volumetric features. Abdom Radiol (NY) 2021;46:3866-76. [PMID: 33751193 DOI: 10.1007/s00261-021-03051-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 194 |
Königshofer P, Brusilovskaya K, Petrenko O, Hofer BS, Schwabl P, Trauner M, Reiberger T. Nuclear Receptors in Liver Fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;:166235. [PMID: 34339839 DOI: 10.1016/j.bbadis.2021.166235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 195 |
Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, LeBleu VS, McAndrews KM, Kalluri R. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J 2021;35:e21557. [PMID: 33855751 DOI: 10.1096/fj.202002777RR] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 196 |
de Souza Basso B, Haute GV, Ortega-Ribera M, Luft C, Antunes GL, Bastos MS, Carlessi LP, Levorse VG, Cassel E, Donadio MVF, Santarém ER, Gracia-Sancho J, Rodrigues de Oliveira J. Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism. J Ethnopharmacol 2021;280:114433. [PMID: 34280502 DOI: 10.1016/j.jep.2021.114433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 197 |
Wu C, Cheng D, Peng Y, Li Y, Fu C, Wang Y, Fu L, Peng S, Ni X. Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity. Front Med (Lausanne) 2021;8:683506. [PMID: 34336890 DOI: 10.3389/fmed.2021.683506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 198 |
Kim D, Kim B, Sim H, Lee TK, Tae HJ, Lee JC, Park JH, Cho JH, Won MH, Park Y, Ahn JH. Hypothermic treatment reduces matrix metalloproteinase-9 expression and damage in the liver following asphyxial cardiac arrest in rats. Lab Anim Res 2021;37:16. [PMID: 34261545 DOI: 10.1186/s42826-021-00095-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 199 |
Sun X, Mei J, Lin W, Yang Z, Peng W, Chen J, Zhang Y, Xu L, Chen M. Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients. BMC Cancer 2021;21:775. [PMID: 34218801 DOI: 10.1186/s12885-021-08428-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 200 |
Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 201 |
Hou C, Lu S, Su Y, Ding D, Tao L, Wang M, Wang Y, Liu X. C/EBP-α induces autophagy by binding to Beclin1 through its own acetylation modification in activated hepatic stellate cells. Exp Cell Res 2021;405:112721. [PMID: 34217716 DOI: 10.1016/j.yexcr.2021.112721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 202 |
Ferdous MR, Song Y; Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Shandong, China, 1Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Shandong, China. Pharmacological potential of ferulic acid for the treatment of metabolic diseases and its mechanism of action: A review. Physiol Pharmacol 2021;0:0-0. [DOI: 10.52547/phypha.26.4.8] [Reference Citation Analysis]
|
| 203 |
Wang S, Tang C, Zhao H, Shen P, Lin C, Zhu Y, Han D. Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis. Front Pharmacol 2021;12:656115. [PMID: 34276360 DOI: 10.3389/fphar.2021.656115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 204 |
Zhou M, Zhao X, Huang T, Zou G, Hu R, Cheng M. PFKFB3 Promotes Liver Fibrosis by Regulating Aerobic Glycolysis of Hepatic Stellate Cells. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.113968] [Reference Citation Analysis]
|
| 205 |
Habibie H, Adhyatmika A, Schaafsma D, Melgert BN. The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases. Pharmacol Ther 2021;228:107941. [PMID: 34171336 DOI: 10.1016/j.pharmthera.2021.107941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 206 |
Charchanti A, Kanavaros P, Koniaris E, Kataki A, Glantzounis G, Agnantis NJ, Goussia AC. Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis. In Vivo 2021;35:333-9. [PMID: 33402482 DOI: 10.21873/invivo.12264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 207 |
Jantararussamee C, Rodniem S, Taweechotipatr M, Showpittapornchai U, Pradidarcheep W. Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats. Probiotics Antimicrob Proteins 2021;13:40-50. [PMID: 32468435 DOI: 10.1007/s12602-020-09663-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 208 |
Wang X, Copmans D, de Witte PAM. Using Zebrafish as a Disease Model to Study Fibrotic Disease. Int J Mol Sci 2021;22:6404. [PMID: 34203824 DOI: 10.3390/ijms22126404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 209 |
Lam HYP, Liang TR, Lan YC, Chang KC, Cheng PC, Peng SY. Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice. J Microbiol Immunol Infect 2021:S1684-1182(21)00086-4. [PMID: 34167886 DOI: 10.1016/j.jmii.2021.03.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 210 |
Yao J, Lin C, Jiang J, Zhang X, Li F, Liu T, Diao H. lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-β Expression in Long-Term Outcome of Chronic Hepatitis B. Front Immunol 2021;12:666370. [PMID: 34168644 DOI: 10.3389/fimmu.2021.666370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 211 |
Dat NQ, Thuy LTT, Hieu VN, Hai H, Hoang DV, Thi Thanh Hai N, Thuy TTV, Komiya T, Rombouts K, Dong MP, Hanh NV, Hoang TH, Sato-Matsubara M, Daikoku A, Kadono C, Oikawa D, Yoshizato K, Tokunaga F, Pinzani M, Kawada N. Hexa Histidine-Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species. Hepatology 2021;73:2527-45. [PMID: 33576020 DOI: 10.1002/hep.31752] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 212 |
Wang J, Li T, Huang X, Geng C, Shen C, Sun J, Xue D, Chen J. Synthesis and anti-fibrotic effects of santamarin derivatives as cytotoxic agents against hepatic stellate cell line LX2. Bioorganic & Medicinal Chemistry Letters 2021;41:127994. [DOI: 10.1016/j.bmcl.2021.127994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 213 |
Wang X, Han F, Shen Y, Chen Y, Ji Z. A20 Attenuates Lipopolysaccharide-Induced Inflammation Through MAPK/ERK/JNK Pathway in LX-2 Cells. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.114050] [Reference Citation Analysis]
|
| 214 |
Salunkhe SA, Chitkara D, Mahato RI, Mittal A. Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis. Adv Drug Deliv Rev 2021;173:394-415. [PMID: 33831474 DOI: 10.1016/j.addr.2021.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 215 |
Fleischmann D, Goepferich A. General sites of nanoparticle biodistribution as a novel opportunity for nanomedicine. Eur J Pharm Biopharm 2021;166:44-60. [PMID: 34087354 DOI: 10.1016/j.ejpb.2021.05.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 216 |
Yue Z, Jiang Z, Ruan B, Duan J, Song P, Liu J, Han H, Wang L. Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression. Int J Biol Sci 2021;17:2135-46. [PMID: 34239344 DOI: 10.7150/ijbs.60056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 217 |
Bao YL, Wang L, Pan HT, Zhang TR, Chen YH, Xu SJ, Mao XL, Li SW. Animal and Organoid Models of Liver Fibrosis. Front Physiol 2021;12:666138. [PMID: 34122138 DOI: 10.3389/fphys.2021.666138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 218 |
Shuai C, Xia GQ, Yuan F, Wang S, Lv XW. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease. Eur J Pharmacol 2021;905:174198. [PMID: 34033815 DOI: 10.1016/j.ejphar.2021.174198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 219 |
Jiang QQ, Liu BB, Xu KS. New insights into BMP9 signaling in liver diseases. Mol Cell Biochem 2021;476:3591-600. [PMID: 34019202 DOI: 10.1007/s11010-021-04182-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 220 |
Zhu X, Ye S, Yu D, Zhang Y, Li J, Zhang M, Leng Y, Yang T, Luo J, Chen X, Zhang H, Kong L. Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation. Br J Pharmacol 2021;178:3428-47. [PMID: 33864382 DOI: 10.1111/bph.15490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 221 |
Pascut D, Hoang M, Nguyen NNQ, Pratama MY, Tiribelli C. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers (Basel) 2021;13:2485. [PMID: 34069740 DOI: 10.3390/cancers13102485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 222 |
Qiu C, Sha T, Yin T, Zhang W, Chen X, Miao X, Zheng R, Shuai X, Ren J. VEGFR2-targeted ultrasound molecular imaging of angiogenesis to evaluate liver allograft fibrosis. Biomater Sci 2021;9:5802-11. [PMID: 34008615 DOI: 10.1039/d1bm00100k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 223 |
Zhan J, Cao H, Hu T, Shen J, Wang W, Wu P, Yang G, Ho CT, Li S. Efficient Preparation of Black Tea Extract (BTE) with the High Content of Theaflavin Mono- and Digallates and the Protective Effects of BTE on CCl4-Induced Rat Liver and Renal Injury. J Agric Food Chem 2021;69:5938-47. [PMID: 34003645 DOI: 10.1021/acs.jafc.1c01851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 224 |
Sun YM, Chen SY, You H. Regression of liver fibrosis: evidence and challenges. Chin Med J (Engl) 2020;133:1696-702. [PMID: 32568866 DOI: 10.1097/CM9.0000000000000835] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 225 |
Ye Q, Zhou Y, Zhao C, Xu L, Ping J. Salidroside Inhibits CCl4-Induced Liver Fibrosis in Mice by Reducing Activation and Migration of HSC Induced by Liver Sinusoidal Endothelial Cell-Derived Exosomal SphK1. Front Pharmacol 2021;12:677810. [PMID: 34054552 DOI: 10.3389/fphar.2021.677810] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 226 |
Su S, Xiang X, Lin L, Xiong Y, Ma H, Yuan G, Zhao J, Zhang Z, Liu S, Nie D, Tang G. Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer. Nucl Med Biol 2021;98-99:76-83. [PMID: 34062322 DOI: 10.1016/j.nucmedbio.2021.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 227 |
Shouman MM, Abdelsalam RM, Tawfick MM, Kenawy SA, El-Naa MM. Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway. Front Pharmacol 2021;12:676608. [PMID: 34045968 DOI: 10.3389/fphar.2021.676608] [Reference Citation Analysis]
|
| 228 |
Tabernilla A, Dos Santos Rodrigues B, Pieters A, Caufriez A, Leroy K, Van Campenhout R, Cooreman A, Gomes AR, Arnesdotter E, Gijbels E, Vinken M. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. Int J Mol Sci 2021;22:5038. [PMID: 34068678 DOI: 10.3390/ijms22095038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 229 |
Natarajan V, Moeun Y, Kidambi S. Exploring Interactions between Primary Hepatocytes and Non-Parenchymal Cells on Physiological and Pathological Liver Stiffness. Biology (Basel) 2021;10:408. [PMID: 34063016 DOI: 10.3390/biology10050408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 230 |
Xue F, Lu J, Buchl SC, Sun L, Shah VH, Malhi H, Maiers JL. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice. Am J Physiol Gastrointest Liver Physiol 2021;320:G864-79. [PMID: 33728997 DOI: 10.1152/ajpgi.00453.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 231 |
Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses? World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
|
| 232 |
Pan Y, Wang J, He L, Zhang F. MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-β1/smad Pathway. J Immunol Res 2021;2021:6890423. [PMID: 33977112 DOI: 10.1155/2021/6890423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 233 |
Yin J, Quan W, Kong X, Liu C, Lu B, Lin W. Utilizing a Solvatochromic Optical Agent to Monitor the Polarity Changes in Dynamic Liver Injury Progression. ACS Appl Bio Mater 2021;4:3630-8. [PMID: 35014449 DOI: 10.1021/acsabm.1c00130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 234 |
Vallverdú J, Martínez García de la Torre RA, Mannaerts I, Verhulst S, Smout A, Coll M, Ariño S, Rubio-Tomás T, Aguilar-Bravo B, Martínez-Sánchez C, Blaya D, Verfaillie CM, van Grunsven LA, Sancho-Bru P. Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells. Nat Protoc 2021;16:2542-63. [PMID: 33864055 DOI: 10.1038/s41596-021-00509-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 235 |
Liu Y, Li J, Liao L, Huang H, Fan S, Fu R, Huang J, Shi C, Yu L, Chen KX, Zhang YY, Luo C, Li GM. Cyclin-dependent kinase inhibitor roscovitine attenuates liver inflammation and fibrosis by influencing initiating steps of liver injury. Clin Sci (Lond) 2021;135:925-41. [PMID: 33786590 DOI: 10.1042/CS20201111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 236 |
Sufleţel RT, Melincovici CS, Gheban BA, Toader Z, Mihu CM. Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. Rom J Morphol Embryol 2020;61:615-42. [PMID: 33817704 DOI: 10.47162/RJME.61.3.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 237 |
Khurana A, Sayed N, Allawadhi P, Weiskirchen R. It's all about the spaces between cells: role of extracellular matrix in liver fibrosis. Ann Transl Med 2021;9:728. [PMID: 33987426 DOI: 10.21037/atm-20-2948] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 238 |
Zhao J, Jiang Y, Sun X, Liu X, Liu F, Song M, Zhang L. The mechanism and role of intracellular α-ketoglutarate reduction in hepatic stellate cell activation. Biosci Rep 2020;40:BSR20193385. [PMID: 32124915 DOI: 10.1042/BSR20193385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 239 |
Adhikari R, Shah R, Reyes-Gordillo K, Arellanes-Robledo J, Cheng Y, Ibrahim J, Tuma PL. Spermidine Prevents Ethanol and Lipopolysaccharide-Induced Hepatic Injury in Mice. Molecules 2021;26:1786. [PMID: 33810101 DOI: 10.3390/molecules26061786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 240 |
Tong M, Zheng Q, Liu M, Chen L, Lin YH, Tang SG, Zhu YM. 5-methoxytryptophan alleviates liver fibrosis by modulating FOXO3a/miR-21/ATG5 signaling pathway mediated autophagy. Cell Cycle 2021;20:676-88. [PMID: 33734029 DOI: 10.1080/15384101.2021.1897241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 241 |
Yan Q, Pan L, Qi S, Liu F, Wang Z, Qian C, Chen L, Du J. RNF2 Mediates Hepatic Stellate Cells Activation by Regulating ERK/p38 Signaling Pathway in LX-2 Cells. Front Cell Dev Biol 2021;9:634902. [PMID: 33816485 DOI: 10.3389/fcell.2021.634902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 242 |
Hsu E, Murray K. Cirrhosis and Chronic Liver Failure in Children. Liver Disease in Children 2021. [DOI: 10.1017/9781108918978.005] [Reference Citation Analysis]
|
| 243 |
Tang J, Yan Z, Feng Q, Yu L, Wang H. The Roles of Neutrophils in the Pathogenesis of Liver Diseases. Front Immunol 2021;12:625472. [PMID: 33763069 DOI: 10.3389/fimmu.2021.625472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 244 |
Armandi A, Rosso C, Caviglia GP, Bugianesi E. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites 2021;11:155. [PMID: 33800465 DOI: 10.3390/metabo11030155] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 245 |
Ballway JW, Song BJ. Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease. Antioxidants (Basel) 2021;10:384. [PMID: 33806556 DOI: 10.3390/antiox10030384] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 246 |
Xu A, Zhou J, Li Y, Qiao L, Jin C, Chen W, Sun L, Wu S, Li X, Zhou D, Jia S, Zhang B, Yao J, Zhang X, You H, Huang J. 14-kDa phosphohistidine phosphatase is a potential therapeutic target for liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G351-65. [PMID: 33406007 DOI: 10.1152/ajpgi.00334.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 247 |
Luan D, Zhao Z, Xia D, Zheng Q, Gao X, Xu K, Tang B. Hydrogen selenide, a vital metabolite of sodium selenite, uncouples the sulfilimine bond and promotes the reversal of liver fibrosis. Sci China Life Sci 2021;64:443-51. [PMID: 32880866 DOI: 10.1007/s11427-019-1761-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 248 |
Kang R, Tian W, Cao W, Sun Y, Zhang HN, Feng YD, Li C, Li ZZ, Li XQ. Ligustroflavone ameliorates CCl4-induced liver fibrosis through down-regulating the TGF-β/Smad signaling pathway. Chin J Nat Med 2021;19:170-80. [PMID: 33781450 DOI: 10.1016/S1875-5364(21)60018-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 249 |
Cai S, Wu L, Yuan S, Liu G, Wang Y, Fang L, Xu D. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway. Eur J Pharmacol 2021;898:173982. [PMID: 33647257 DOI: 10.1016/j.ejphar.2021.173982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 250 |
Shan C, Wang R, Wang S, Zhang Z, Xing C, Feng W, Zhao Z, Zhou S, Zhao AZ, Mu Y, Li F. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways. Exp Physiol 2021;106:983-93. [PMID: 33605486 DOI: 10.1113/EP089328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 251 |
Tariq S, Koloko BL, Malik A, Rehman S, Ijaz B, Shahid AA. Tectona grandis leaf extract ameliorates hepatic fibrosis: Modulation of TGF- β /Smad signaling pathway and upregulating MMP3/TIMP1 ratio. J Ethnopharmacol 2021;272:113938. [PMID: 33610708 DOI: 10.1016/j.jep.2021.113938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 252 |
Ciceu A, Balta C, Herman H, Gharbia S, Ignat SR, Dinescu S, Váradi J, Fenyvesi F, Gyöngyösi S, Hermenean A, Costache M. Complexation with Random Methyl-β-Cyclodextrin and (2-Hidroxypropyl)-β-Cyclodextrin Enhances In Vivo Anti-Fibrotic and Anti-Inflammatory Effects of Chrysin via the Inhibition of NF-κB and TGF-β1/Smad Signaling Pathways and Modulation of Hepatic Pro/Anti-Fibrotic miRNA. Int J Mol Sci 2021;22:1869. [PMID: 33668543 DOI: 10.3390/ijms22041869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 253 |
He C, Yang Y, Zheng K, Chen Y, Liu S, Li Y, Han Q, Zhao RC, Wang L, Zhang F. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Ther Adv Chronic Dis 2021;12:2040622321993442. [PMID: 33633826 DOI: 10.1177/2040622321993442] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 254 |
Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 255 |
Tao XM, Li D, Zhang C, Wen GH, Wu C, Xu YY, Kan Y, Lu WP, Ding HY, Yang Y. Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation. Exp Ther Med 2021;21:341. [PMID: 33732314 DOI: 10.3892/etm.2021.9772] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 256 |
Wong JSL, Kwok GGW, Tang V, Li BCW, Leung R, Chiu J, Ma KW, She WH, Tsang J, Lo CM, Cheung TT, Yau T. Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors. J Immunother Cancer 2021;9:e001945. [PMID: 33563773 DOI: 10.1136/jitc-2020-001945] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 257 |
Huang W, Ji R, Ge S, Zhou D, Liu Z, Sun Y, Huang W, Lu C. MicroRNA-92b-3p promotes the progression of liver fibrosis by targeting CREB3L2 through the JAK/STAT signaling pathway. Pathol Res Pract 2021;219:153367. [PMID: 33618248 DOI: 10.1016/j.prp.2021.153367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 258 |
Ma L, Liu J, Xiao E, Ning H, Li K, Shang J, Kang Y. MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells. Life Sci 2021;270:119144. [PMID: 33545201 DOI: 10.1016/j.lfs.2021.119144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 259 |
Zou LQ, Zhao F, Zhang H, Zhang K, Xing W. Staging liver fibrosis on multiparametric MRI in a rabbit model with elastography, susceptibility-weighted imaging and T1ρ imaging: a preliminary study. Acta Radiol 2021;62:155-63. [PMID: 32326722 DOI: 10.1177/0284185120917117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 260 |
Kim SJ, Kim KM, Yang JH, Cho SS, Jeong EH, Kim JH, Lee JH, Seo KH, Park EY, Ki SH. Transforming Growth Factor Beta-Induced Foxo3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells. Toxicol Sci 2021;179:241-50. [PMID: 33372984 DOI: 10.1093/toxsci/kfaa185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 261 |
Ji J, Yu Q, Dai W, Wu L, Feng J, Zheng Y, Li Y, Guo C. Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways. PPAR Res 2021;2021:6651839. [PMID: 33574836 DOI: 10.1155/2021/6651839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 262 |
Serag WM, Elsayed BE. Detection of liver fibrosis stages in patients with hepatitis C virus infection by non-invasive tool. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00076-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 263 |
Jussila A, Caves E, Zhang B, Kirti S, Steele M, Lei V, Hamburg-shields E, Lydon J, Ying Y, Lafyatis R, Rajagopalan S, Horsley V, Atit R. Adipocyte lipolysis abrogates skin fibrosis in a Wnt/DPP4-dependent manner.. [DOI: 10.1101/2021.01.21.427497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 264 |
Yu Q, Cheng P, Wu J, Guo C. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med 2021;25:1645-60. [PMID: 33438347 DOI: 10.1111/jcmm.16267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 265 |
Mukhtar S, Xiaoxiong Z, Qamer S, Saad M, Mubarik MS, Mahmoud AH, Mohammed OB. Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats. Saudi J Biol Sci 2021;28:717-23. [PMID: 33424359 DOI: 10.1016/j.sjbs.2020.10.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 266 |
Liang Z, Li J, Zhao L, Deng Y. miR‑375 affects the hedgehog signaling pathway by downregulating RAC1 to inhibit hepatic stellate cell viability and epithelial‑mesenchymal transition. Mol Med Rep 2021;23:182. [PMID: 33398380 DOI: 10.3892/mmr.2020.11821] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 267 |
Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 268 |
Aghbash PS, Hemmat N, Nahand JS, Shamekh A, Memar MY, Babaei A, Baghi HB. The role of Th17 cells in viral infections. Int Immunopharmacol 2021;91:107331. [PMID: 33418239 DOI: 10.1016/j.intimp.2020.107331] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 269 |
Osna NA, Ganesan M, Seth D, Wyatt TA, Kidambi S, Kharbanda KK. Second hits exacerbate alcohol-related organ damage: an update. Alcohol Alcohol 2021;56:8-16. [PMID: 32869059 DOI: 10.1093/alcalc/agaa085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 270 |
Chen ZW, Tang K, Zhao YF, Chen YZ, Tang LJ, Li G, Huang OY, Wang XD, Targher G, Byrne CD, Zheng XW, Zheng MH. Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study. Int J Med Sci 2021;18:3624-30. [PMID: 34790034 DOI: 10.7150/ijms.64458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 271 |
Condrat CE, Barbu MG, Thompson DC, Dănilă CA, Boboc AE, Suciu N, Crețoiu D, Voinea SC. Roles and distribution of telocytes in tissue organization in health and disease. Tissue Barriers in Disease, Injury and Regeneration 2021. [DOI: 10.1016/b978-0-12-818561-2.00001-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 272 |
Guragac Dereli FT, Guragac A, Belwal T. Introduction. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 2021. [DOI: 10.1016/b978-0-12-816488-4.00011-5] [Reference Citation Analysis]
|
| 273 |
The morphological specifics of the stromal and parenchymal liver components of 6-12-months old children from hiv-mono-infected mothers. Actual problems of modern medicine 2021. [DOI: 10.26565/2617-409x-2021-7-06] [Reference Citation Analysis]
|
| 274 |
Qiu C, Sha T, Yin T, Zhang W, Chen X, Miao X, Zheng R, Shuai X, Ren J. VEGFR2-Targeted Ultrasound Molecular Imaging of Angiogenesis to Evaluate Liver Allograft Fibrosis. SSRN Journal. [DOI: 10.2139/ssrn.3763765] [Reference Citation Analysis]
|
| 275 |
Yan Z, Wang D, An C, Xu H, Zhao Q, Shi Y, Song N, Deng B, Guo X, Rao J, Cheng L, Zhang B, Mou L, Yang W, Jiang X, Xie J. The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis. Acta Pharm Sin B 2021;11:100-11. [PMID: 33532183 DOI: 10.1016/j.apsb.2020.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 276 |
Zhou IY, Montesi SB, Akam EA, Caravan P. Molecular Imaging of Fibrosis. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00077-6] [Reference Citation Analysis]
|
| 277 |
Hall RA, Lammert F. Genetics of Polygenic Metabolic Liver Disease. Systems Medicine 2021. [DOI: 10.1016/b978-0-12-801238-3.11596-x] [Reference Citation Analysis]
|
| 278 |
Bove G, Mehnert A, Dao Thi VL. iPSCs for modeling hepatotropic pathogen infections. iPSCs for Studying Infectious Diseases 2021. [DOI: 10.1016/b978-0-12-823808-0.00013-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 279 |
Huang J, Cheng D. MRI-Visible Nanocarrier for Synergistic MicroRNA Therapy in Liver Fibrotic Rat. Biomaterial Engineering 2021. [DOI: 10.1007/978-981-33-6198-0_14-1] [Reference Citation Analysis]
|
| 280 |
Ortiz C, Schierwagen R, Schaefer L, Klein S, Trepat X, Trebicka J. Extracellular Matrix Remodeling in Chronic Liver Disease. Curr Tissue Microenviron Rep 2021;2:41-52. [PMID: 34337431 DOI: 10.1007/s43152-021-00030-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 281 |
Yang G, Zhan J, Yang Y, Yuan L, Wang P, Ho C, Li S. Inhibitory effects of oxyresveratrol on ERK and Smad1/2 phosphorylation and HSC activation in preventing carbon tetrachloride-induced rat liver fibrosis. Food Science and Human Wellness 2021;10:6-12. [DOI: 10.1016/j.fshw.2020.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 282 |
Payushina OV, Tsomartova DA, Chereshneva YV, Ivanova MY, Kuznetsov SL. Regulatory Effect of Mesenchymal Stromal Cells on the Development of Liver Fibrosis: Cellular and Molecular Mechanisms and Prospects for Clinical Application. Biol Bull Rev 2021;11:54-66. [DOI: 10.1134/s2079086421010059] [Reference Citation Analysis]
|
| 283 |
Gee L, Oakley F. 5-HT2B Receptors in Liver. 5-HT2B Receptors 2021. [DOI: 10.1007/978-3-030-55920-5_14] [Reference Citation Analysis]
|
| 284 |
Zong Z, Liu J, Wang N, Yang C, Wang Q, Zhang W, Chen Y, Liu X, Deng H. Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE(2) degradation. Free Radic Biol Med 2021;162:571-81. [PMID: 33220424 DOI: 10.1016/j.freeradbiomed.2020.11.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 285 |
Atanasova I, Sojoodi M, Leitão HS, Shuvaev S, Geraldes CFGC, Masia R, Guimaraes AS, Tanabe KK, Fuchs BC, Caravan P. Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation. Invest Radiol 2020;55:209-16. [PMID: 31895219 DOI: 10.1097/RLI.0000000000000631] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 286 |
Wang Z, Cheng ZX, Abrams ST, Lin ZQ, Yates E, Yu Q, Yu WP, Chen PS, Toh CH, Wang GZ. Extracellular histones stimulate collagen expression in vitro and promote liver fibrogenesis in a mouse model via the TLR4-MyD88 signaling pathway. World J Gastroenterol 2020; 26(47): 7513-7527 [PMID: 33384551 DOI: 10.3748/wjg.v26.i47.7513] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 287 |
Zhou S, Zhu Y, Li Z, Zhu Y, He Z, Zhang C. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway. J Cell Mol Med 2021;25:2262-73. [PMID: 33345447 DOI: 10.1111/jcmm.16219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 288 |
Zhang R, Chen J, Jiang Y, Wang J, Chen S. Prognostic nomogram for hepatocellular carcinoma with fibrosis of varying degrees: a retrospective cohort study. Ann Transl Med 2020;8:1429. [PMID: 33313174 DOI: 10.21037/atm-20-3267] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 289 |
Han X, Wu Y, Yang Q, Cao G. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther 2021;222:107791. [PMID: 33321113 DOI: 10.1016/j.pharmthera.2020.107791] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 290 |
Nathwani R, Mullish BH, Kockerling D, Forlano R, Manousou P, Dhar A. A Review of Liver Fibrosis and Emerging Therapies. EMJ 2020. [DOI: 10.33590/emj/10310892] [Reference Citation Analysis]
|
| 291 |
Emsen B, Sadi G, Bostanci A, Aslan A. In vitro evaluation of cytotoxic, oxidative, genotoxic, and apoptotic activities of physodic acid from Pseudevernia furfuracea in HepG2 and THLE2 cells. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. [DOI: 10.1080/11263504.2020.1852329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 292 |
Kaplow IM, Schäffer DE, Wirthlin ME, Lawler AJ, Brown AR, Kleyman M, Pfenning AR. Inferring mammalian tissue-specific regulatory conservation by predicting tissue-specific differences in open chromatin.. [DOI: 10.1101/2020.12.04.410795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 293 |
Liu J, Xie Y, Cui Z, Xia T, Wan L, Zhou H, Zhang P, Zhang Y, Guan F, Liu W, Shi C. Bnip3 interacts with vimentin, an intermediate filament protein, and regulates autophagy of hepatic stellate cells. Aging (Albany NY) 2020;13:957-72. [PMID: 33290258 DOI: 10.18632/aging.202211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 294 |
Mak M. Impact of crosslink heterogeneity on extracellular matrix mechanics and remodeling. Comput Struct Biotechnol J 2020;18:3969-76. [PMID: 33335693 DOI: 10.1016/j.csbj.2020.11.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 295 |
Donati C, Cencetti F, Bernacchioni C, Vannuzzi V, Bruni P. Role of sphingosine 1-phosphate signalling in tissue fibrosis. Cell Signal 2021;78:109861. [PMID: 33253915 DOI: 10.1016/j.cellsig.2020.109861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 296 |
Kaan D, Toprak G, Yay A, Başkol G, Ertekin T, Ülger H. Karaciğer Fibrozis Modellerinde Sık Kullanılan Kimyasal Ajanların Farklı Doz ve Zaman Dilimindeki Etkilerinin Belirlenmesi. Acta Medica Alanya 2020. [DOI: 10.30565/medalanya.775667] [Reference Citation Analysis]
|
| 297 |
Ünver Saraydin S, Saraydin D, Şahin İnan ZD. A digital image analysis study on the disintegration kinetics of reticular fibers in the ethylene glycol-induced rat liver tissue. Microsc Res Tech 2020;83:1585-93. [PMID: 33220018 DOI: 10.1002/jemt.23554] [Reference Citation Analysis]
|
| 298 |
Kabra H, Walimbe T, Stuart K, Indey C, Jalgaonkar S, Ikwa E, Skurnac T, Chen J, Woolley A, Snead NM, Bachtell N, Leeming DJ, Karsdal M, Prestwich G, Panitch A, Paderi J. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. Biomaterials 2021;269:120538. [PMID: 33246740 DOI: 10.1016/j.biomaterials.2020.120538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 299 |
Rothlin CV, Hille TD, Ghosh S. Determining the effector response to cell death. Nat Rev Immunol 2021;21:292-304. [PMID: 33188303 DOI: 10.1038/s41577-020-00456-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 300 |
Li X, Xing Y, Mao D, Ying L, Luan Y, Xu M, Wang H, Li C, Li Y, Zheng S, Li Z, Hu J, Li Z, Wang H, Luan Y. Codonopis bulleynana Forest ex Diels (cbFeD) effectively attenuates hepatic fibrosis in CCl4-induced fibrotic mice model. Biomed Pharmacother 2021;133:110960. [PMID: 33197763 DOI: 10.1016/j.biopha.2020.110960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 301 |
McQuitty CE, Williams R, Chokshi S, Urbani L. Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment. Front Immunol 2020;11:574276. [PMID: 33262757 DOI: 10.3389/fimmu.2020.574276] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 302 |
Song M, Zhang H, Chen Z, Yang J, Li J, Shao S, Liu J. Shikonin reduces hepatic fibrosis by inducing apoptosis and inhibiting autophagy via the platelet-activating factor-mitogen-activated protein kinase axis. Exp Ther Med 2021;21:28. [PMID: 33262814 DOI: 10.3892/etm.2020.9460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 303 |
Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 304 |
Huang H, Wang K, Liu Q, Ji F, Zhou H, Fang S, Zhu J. The Active Constituent From Gynostemma Pentaphyllum Prevents Liver Fibrosis Through Regulation of the TGF-β1/NDRG2/MAPK Axis. Front Genet 2020;11:594824. [PMID: 33329740 DOI: 10.3389/fgene.2020.594824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 305 |
Zhu X. Editorial for "Radiomics Approaches for Predicting Liver Fibrosis With Nonenhanced T1-Weighted Imaging: Comparison of Different Radiomics Models". J Magn Reson Imaging 2021;53:1090-1. [PMID: 33135268 DOI: 10.1002/jmri.27425] [Reference Citation Analysis]
|
| 306 |
Hai Y, Zhang Y, Liang Y, Ma X, Qi X, Xiao J, Xue W, Luo Y, Yue T. Advance on the absorption, metabolism, and efficacy exertion of quercetin and its important derivatives: Absorption, metabolism and function of quercetin. Food Frontiers 2020;1:420-34. [DOI: 10.1002/fft2.50] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 307 |
Zhou IY, Tanabe KK, Fuchs BC, Caravan P. Collagen-targeted molecular imaging in diffuse liver diseases. Abdom Radiol (NY) 2020;45:3545-56. [PMID: 32737546 DOI: 10.1007/s00261-020-02677-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 308 |
Kumar S, Verma AK, Rani R, Sharma A, Wang J, Shah SA, Behari J, Salazar Gonzalez R, Kohli R, Gandhi CR. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis. Hepatology 2020;72:1586-604. [PMID: 32031683 DOI: 10.1002/hep.31167] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 309 |
Sharma A, Verma AK, Kofron M, Kudira R, Miethke A, Wu T, Wang J, Gandhi CR. Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors. Hepatology 2020;72:1800-18. [PMID: 32064648 DOI: 10.1002/hep.31188] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 310 |
Zhang H, Yan X, Yang C, Zhan Q, Fu Y, Luo H, Luo H. Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen-activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection. J Viral Hepat 2020;27:1138-49. [PMID: 32559002 DOI: 10.1111/jvh.13352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 311 |
Zhou IY, Catalano OA, Caravan P. Advances in functional and molecular MRI technologies in chronic liver diseases. J Hepatol 2020;73:1241-54. [PMID: 32585160 DOI: 10.1016/j.jhep.2020.06.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 312 |
Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 313 |
Liao J, Zhang Z, Yuan Q, Liu Q, Kuang J, Fang Y, Hu X. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation. Toxicol Lett 2021;336:21-31. [PMID: 33069761 DOI: 10.1016/j.toxlet.2020.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 314 |
Ni M, Wang L, Yu H, Wen X, Yang Y, Liu G, Hu Y, Li Z. Radiomics Approaches for Predicting Liver Fibrosis With Nonenhanced T1 -Weighted Imaging: Comparison of Different Radiomics Models. J Magn Reson Imaging 2021;53:1080-9. [PMID: 33043991 DOI: 10.1002/jmri.27391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 315 |
Saidu NEB, Bonini C, Dickinson A, Grce M, Inngjerdingen M, Koehl U, Toubert A, Zeiser R, Galimberti S. New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions. Front Immunol 2020;11:578314. [PMID: 33162993 DOI: 10.3389/fimmu.2020.578314] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 316 |
Yuan T, Chen J, Shie R, Yeh Y, Chen Y, Chan C. Liver fibrosis associated with potential vinyl chloride and ethylene dichloride exposure from the petrochemical industry. Science of The Total Environment 2020;739:139920. [DOI: 10.1016/j.scitotenv.2020.139920] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 317 |
Bai X, Su G, Zhai S. Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis. Nanomaterials (Basel) 2020;10:E1945. [PMID: 33003520 DOI: 10.3390/nano10101945] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 318 |
Pesce A, Ciurleo R, Bramanti A, Armeli Iapichino EC, Petralia MC, Magro GG, Fagone P, Bramanti P, Nicoletti F, Mangano K. Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis. Molecules 2020;25. [PMID: 32962198 DOI: 10.3390/molecules25184310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 319 |
Wang Z, Cheng Z, Abrams ST, Lin Z, Yates E, Yu Q, Yu W, Chen P, Toh C, Wang G. Extracellular histones stimulate collagen expression and potentially promote liver fibrogenesis via TLR4-MyD88 signalling pathway.. [DOI: 10.1101/2020.09.17.302240] [Reference Citation Analysis]
|
| 320 |
Zhu H, He C, Zhao H, Jiang W, Xu S, Li J, Ma T, Huang C. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation. FASEB J 2020;34:14558-71. [PMID: 32946656 DOI: 10.1096/fj.202000494RR] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 321 |
Xu X, Zhu H, Li R, Lin H, Grimm R, Fu C, Yan F. Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD. Eur Radiol 2021;31:1748-59. [PMID: 32897416 DOI: 10.1007/s00330-020-07235-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 322 |
Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen S, Wang J, Tan Y, Wu M, Chen X, Johansson PK, Osman I, Kunimoto K, Russo P, Heilshorn SC, Peltz G. A Human Multi-Lineage Hepatic Organoid Model for Liver Fibrosis.. [DOI: 10.1101/2020.09.01.278473] [Reference Citation Analysis]
|
| 323 |
Liao Y, Wang Y, Liu C, Fang C, Hsu M, Suk F. 4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt Signaling Pathways. Applied Sciences 2020;10:5941. [DOI: 10.3390/app10175941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 324 |
Xie H, Xie D, Zhang J, Jin W, Li Y, Yao J, Pan Z, Xie D. ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis. Mol Ther Nucleic Acids 2020;22:114-23. [PMID: 32916597 DOI: 10.1016/j.omtn.2020.08.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 325 |
Gowifel AMH, Khalil MG, Nada SA, Kenawy SA, Ahmed KA, Salama MM, Safar MM. Combination of pomegranate extract and curcumin ameliorates thioacetamide-induced liver fibrosis in rats: impact on TGF-β/Smad3 and NF-κB signaling pathways. Toxicol Mech Methods 2020;30:620-33. [PMID: 32718261 DOI: 10.1080/15376516.2020.1801926] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 326 |
Lan T, Zhuang L, Li S, Yang G, Xuan Y, Guo J. Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1. Biomed Pharmacother 2020;130:110586. [PMID: 34321171 DOI: 10.1016/j.biopha.2020.110586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 327 |
Kuo CY, Chiu V, Hsieh PC, Huang CY, Huang SJ, Tzeng IS, Tsai FM, Chen ML, Liu CT, Chen YR. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis. J Pharmacol Sci 2020;144:172-82. [PMID: 32811746 DOI: 10.1016/j.jphs.2020.07.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 328 |
Yang YR, Bu FT, Yang Y, Li H, Huang C, Meng XM, Zhang L, Lv XW, Li J. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway. Mol Immunol 2020;126:31-9. [PMID: 32745796 DOI: 10.1016/j.molimm.2020.07.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 329 |
Liao X, Zhan W, Tian T, Yu L, Li R, Yang Q. MicroRNA-326 attenuates hepatic stellate cell activation and liver fibrosis by inhibiting TLR4 signaling. J Cell Biochem 2020;121:3794-803. [PMID: 31692098 DOI: 10.1002/jcb.29520] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 330 |
Ramachandran P, Matchett KP, Dobie R, Wilson-Kanamori JR, Henderson NC. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat Rev Gastroenterol Hepatol 2020;17:457-72. [PMID: 32483353 DOI: 10.1038/s41575-020-0304-x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 26.7] [Reference Citation Analysis]
|
| 331 |
Hu X, Zhou Y. Curcumin reduces methionine adenosyltransferase 2B expression by interrupting phosphorylation of p38 MAPK in hepatic stellate cells. Eur J Pharmacol 2020;886:173424. [PMID: 32738342 DOI: 10.1016/j.ejphar.2020.173424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 332 |
Shahramian I, Khalili M, Sargazi A, Dechal A, Bazi M, Jahantigh M, Delaramnasab M, Bazi A. Non-Invasive Markers of Liver Fibrosis in Children with Chronic Hepatic Disorders. Gene Cell Tissue 2020;7. [DOI: 10.5812/gct.101443] [Reference Citation Analysis]
|
| 333 |
Liu CJ, Chen PJ. Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead. Viruses 2020;12:E815. [PMID: 32731536 DOI: 10.3390/v12080815] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 334 |
Xiang D, Zou J, Zhu X, Chen X, Luo J, Kong L, Zhang H. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Phytomedicine 2020;78:153294. [PMID: 32771890 DOI: 10.1016/j.phymed.2020.153294] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 335 |
Su W, Tai Y, Tang SH, Ye YT, Zhao C, Gao JH, Tuo BG, Tang CW. Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats. World J Gastroenterol 2020; 26(28): 4094-4107 [PMID: 32821072 DOI: 10.3748/wjg.v26.i28.4094] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 336 |
Hoshikawa Y, Furukawa S, Irie K, Kimura M, Takeuchi K, Sugiyama A. Sequential histological changes in the liver of medaka exposed to methylazoxymethaol acetate. J Toxicol Pathol 2020;33:219-26. [PMID: 33239840 DOI: 10.1293/tox.2020-0033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 337 |
Choi B, Choi IY, Cha SH, Yeom SK, Chung HH, Lee SH, Cha J, Lee JH. Feasibility of computed tomography texture analysis of hepatic fibrosis using dual-energy spectral detector computed tomography. Jpn J Radiol 2020;38:1179-89. [PMID: 32666182 DOI: 10.1007/s11604-020-01020-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 338 |
Zhao P, Saltiel AR. From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases. J Biol Chem 2020;295:12279-89. [PMID: 32651233 DOI: 10.1074/jbc.REV120.011356] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 339 |
Wang Z, Zhao Y, Zhao H, Zhou J, Feng D, Tang F, Li Y, Lv L, Chen Z, Ma X, Tian X, Yao J. Inhibition of p66Shc Oxidative Signaling via CA-Induced Upregulation of miR-203a-3p Alleviates Liver Fibrosis Progression. Mol Ther Nucleic Acids 2020;21:751-63. [PMID: 32781430 DOI: 10.1016/j.omtn.2020.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 340 |
Zehra M, Curry JC, Pillai SS, Lakhani HV, Edwards CE, Sodhi K. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Int J Mol Sci 2020;21:E4737. [PMID: 32635162 DOI: 10.3390/ijms21134737] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 341 |
Aravalli RN, Steer CJ. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes (Basel) 2020;11:E729. [PMID: 32630053 DOI: 10.3390/genes11070729] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 342 |
Shao T, Josephson L, Liang SH. PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease. Mol Imaging 2019;18:1536012119871455. [PMID: 31478458 DOI: 10.1177/1536012119871455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 343 |
Chang Y, Xia L, Song M, Tang M, Patpur BK, Li J, Yang W, Yang C. The in vitro effects of phospholipase D1-mTOR axis in liver fibrogenesis. Life Sci 2020;251:117595. [PMID: 32240681 DOI: 10.1016/j.lfs.2020.117595] [Reference Citation Analysis]
|
| 344 |
Bae M, Lee Y, Pham TX, Hu S, Park YK, Lee JY. Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells. Life Sci 2020;256:117926. [PMID: 32535081 DOI: 10.1016/j.lfs.2020.117926] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 345 |
Rostom DM, Attia N, Khalifa HM, Abou Nazel MW, El Sabaawy EA. The Therapeutic Potential of Extracellular Vesicles Versus Mesenchymal Stem Cells in Liver Damage. Tissue Eng Regen Med. 2020;17:537-552. [PMID: 32506351 DOI: 10.1007/s13770-020-00267-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 346 |
Lishnevska AG, Sumy State University, Sumy, Ukraine, Chemych MD, Sumy State University, Sumy, Ukraine. CORRELATIONS BETWEEN CLINICAL, HEMATOLOGICAL, BIOCHEMICAL AND INTEGRATIVE INDICATORS AND THE DEGREE OF FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C. Hepatol Gastroenterol 2020;4:45-54. [DOI: 10.25298/2616-5546-2020-4-1-45-54] [Reference Citation Analysis]
|
| 347 |
Lee CY, Suk FM, Twu YC, Liao YJ. Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Librosis. Int J Environ Res Public Health 2020;17:E3802. [PMID: 32471116 DOI: 10.3390/ijerph17113802] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 348 |
Song J, Yu X, Song W, Guo D, Li C, Liu H, Zhang H, Zhou J, Liu Y. MRI ‐Based Radiomics Models Developed With Features of the Whole Liver and Right Liver Lobe: Assessment of Hepatic Inflammatory Activity in Chronic Hepatic Disease. J Magn Reson Imaging 2020;52:1668-78. [DOI: 10.1002/jmri.27197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 349 |
Qiu R, Murata S, Oshiro K, Hatada Y, Taniguchi H. Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model. Sci Rep 2020;10:8231. [PMID: 32427847 DOI: 10.1038/s41598-020-65069-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 350 |
Hübbers A, Hennings J, Lambertz D, Haas U, Trautwein C, Nevzorova YA, Sonntag R, Liedtke C. Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro. Int J Mol Sci 2020;21:E3267. [PMID: 32380742 DOI: 10.3390/ijms21093267] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 351 |
Huang W, Zheng Y, Feng H, Ni L, Ruan Y, Zou X, Ye M, Zou S. Total phenolic extract of Euscaphis konishii hayata Pericarp attenuates carbon tetrachloride (CCl4)-induced liver fibrosis in mice. Biomedicine & Pharmacotherapy 2020;125:109932. [DOI: 10.1016/j.biopha.2020.109932] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 352 |
Ma X, Zhou Y, Qiao B, Jiang S, Shen Q, Han Y, Liu A, Chen X, Wei L, Zhou L, Zhao J. Androgen aggravates liver fibrosis by activation of NLRP3 inflammasome in CCl(4)-induced liver injury mouse model. Am J Physiol Endocrinol Metab 2020;318:E817-29. [PMID: 32182125 DOI: 10.1152/ajpendo.00427.2019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 353 |
Dolgikh HV, Maslak HS, Didenko VI, Klenina IA, Abraimova OE. АКТИВНІСТЬ КАТЕПСИНІВ В, L, Н У ПЛАЗМІ КРОВІ ПАЦІЄНТІВ ІЗ ХРОНІЧНИМИ ДИФУЗНИМИ ЗАХВОРЮВАННЯМИ ПЕЧІНКИ. MCCh 2020. [DOI: 10.11603/mcch.2410-681x.2020.v.i1.11052] [Reference Citation Analysis]
|
| 354 |
Zhao P, Sun X, Chaggan C, Liao Z, In Wong K, He F, Singh S, Loomba R, Karin M, Witztum JL, Saltiel AR. An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science 2020;367:652-60. [PMID: 32029622 DOI: 10.1126/science.aay0542] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 29.0] [Reference Citation Analysis]
|
| 355 |
Gandhi CR. Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver. Front Med (Lausanne) 2020;7:130. [PMID: 32373617 DOI: 10.3389/fmed.2020.00130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 356 |
Stamataki Z, Swadling L. The liver as an immunological barrier redefined by single-cell analysis. Immunology 2020;160:157-70. [PMID: 32176810 DOI: 10.1111/imm.13193] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 357 |
Lin XH, Liu HH, Hsu SJ, Zhang R, Chen J, Chen J, Gao DM, Cui JF, Ren ZG, Chen RX. Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop. J Exp Clin Cancer Res 2020;39:64. [PMID: 32293507 DOI: 10.1186/s13046-020-01568-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 358 |
Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells 2020;9:E929. [PMID: 32290100 DOI: 10.3390/cells9040929] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 359 |
Jin K, Liu Y, Shi Y, Zhang H, Sun Y, Zhangyuan G, Wang F, Yu W, Wang J, Tao X, Chen X, Zhang W, Sun B. PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis. Theranostics 2020;10:5290-304. [DOI: 10.7150/thno.42658] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 360 |
Xu LM, Liu P; Hepatology Committee of Chinese Association of Integrative Medicine, China. Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition). J Integr Med 2020;18:203-13. [PMID: 32331978 DOI: 10.1016/j.joim.2020.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 361 |
Kennedy P, Taouli B. Collagen-targeted MRI contrast agent for liver fibrosis detection. Nat Rev Gastroenterol Hepatol 2020;17:201-2. [PMID: 31980755 DOI: 10.1038/s41575-020-0266-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 362 |
Yavuz BG, Pestana RC, Abugabal YI, Krishnan S, Chen J, Hassan MM, Wolff RA, Rashid A, Amin HM, Kaseb AO. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma. Oncotarget 2020;11:1186-201. [PMID: 32284794 DOI: 10.18632/oncotarget.27532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 363 |
Yavuz BG, Pestana RC, Abugabal YI, Krishnan S, Chen J, Hassan MM, Wolff RA, Rashid A, Amin HM, Kaseb AO. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma. Oncotarget 2020;11:1186-201. [PMID: 32284794 DOI: 10.18632/oncotarget.27532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 364 |
Liu D, Qin H, Yang B, Du B, Yun X. Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome. Drug Dev Res 2020;81:526-33. [PMID: 32219880 DOI: 10.1002/ddr.21649] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 365 |
Chen X, Li HD, Bu FT, Li XF, Chen Y, Zhu S, Wang JN, Chen SY, Sun YY, Pan XY, Yin NN, Xu JJ, Huang C, Li J. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics 2020;10:4851-70. [PMID: 32308754 DOI: 10.7150/thno.42423] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 366 |
Lv F, Li N, Kong M, Wu J, Fan Z, Miao D, Xu Y, Ye Q, Wang Y. CDKN2a/p16 Antagonizes Hepatic Stellate Cell Activation and Liver Fibrosis by Modulating ROS Levels. Front Cell Dev Biol 2020;8:176. [PMID: 32266258 DOI: 10.3389/fcell.2020.00176] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 367 |
Lee SW, Jung DJ, Jeong GS. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models. Tissue Eng Regen Med 2020;17:731-45. [PMID: 32207030 DOI: 10.1007/s13770-020-00245-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 368 |
Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 369 |
Zuo L, Tan T, Wei C, Wang H, Tan L, Hao Y, Qian J, Chen Y, Wu C. HOXB13 expression is correlated with hepatic inflammatory activity of patients with hepatic fibrosis. J Mol Histol 2020;51:183-9. [PMID: 32200464 DOI: 10.1007/s10735-020-09868-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 370 |
Yang L, Han B, Zhang M, Wang YH, Tao K, Zhu MX, He K, Zhang ZG, Hou S. Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways. Front Pharmacol 2020;11:165. [PMID: 32210801 DOI: 10.3389/fphar.2020.00165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 371 |
Kurtoğlu EL, Kayhan B, Gül M, Kayhan B, Akdoğan Kayhan M, Karaca ZM, Yeşilada E, Yılmaz S. A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes. Turk J Gastroenterol 2019;30:745-57. [PMID: 31418419 DOI: 10.5152/tjg.2019.18276] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 372 |
Chen C, Li X, Wang L. Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways. Dig Liver Dis 2020;52:324-30. [PMID: 31542221 DOI: 10.1016/j.dld.2019.08.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 373 |
Li X, Ge J, Zheng Q, Zhang J, Sun R, Liu R. Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases. Phytomedicine 2020;68:153180. [DOI: 10.1016/j.phymed.2020.153180] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 374 |
Cheng F, Su S, Zhu X, Jia X, Tian H, Zhai X, Guan W, Zhou Y. Leptin promotes methionine adenosyltransferase 2A expression in hepatic stellate cells by the downregulation of E2F-4 via the β-catenin pathway. FASEB J 2020;34:5578-89. [PMID: 32108965 DOI: 10.1096/fj.201903021RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 375 |
Lee DY, Yun SM, Song MY, Ji SD, Son JG, Kim EH. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats. Cells 2020;9:E568. [PMID: 32121064 DOI: 10.3390/cells9030568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 376 |
Tao HC, Chen KX, Wang X, Chen B, Zhao WO, Zheng Y, Yang YG. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism. Front Immunol 2020;11:148. [PMID: 32158445 DOI: 10.3389/fimmu.2020.00148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 377 |
Zhang B, Lai L, Tan Y, Liang Q, Bai F, Mai W, Huang Q, Ye Y. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways. J Ethnopharmacol 2020;254:112714. [PMID: 32105750 DOI: 10.1016/j.jep.2020.112714] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 378 |
Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacol Res 2020;155:104720. [PMID: 32092405 DOI: 10.1016/j.phrs.2020.104720] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 379 |
Chen L, Yao X, Yao H, Ji Q, Ding G, Liu X. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells. FASEB J. 2020;34:5178-5192. [PMID: 32061112 DOI: 10.1096/fj.201902307rrr] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 380 |
Li Y, Wang J, Song K, Liu S, Zhang H, Wang F, Ni C, Zhai W, Liang J, Qin Z, Zhang J. S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness. Oncoimmunology 2020;9:1725355. [PMID: 32117590 DOI: 10.1080/2162402X.2020.1725355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 381 |
Breuer DA, Pacheco MC, Washington MK, Montgomery SA, Hasty AH, Kennedy AJ. CD8(+) T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G211-24. [PMID: 31709830 DOI: 10.1152/ajpgi.00040.2019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 382 |
Miao Y, Wu Y, Jin Y, Lei M, Nan J, Wu X. Benzoquinone derivatives with antioxidant activity inhibit activated hepatic stellate cells and attenuate liver fibrosis in TAA-induced mice. Chemico-Biological Interactions 2020;317:108945. [DOI: 10.1016/j.cbi.2020.108945] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 383 |
Yang D, Li D, Li J, Yang Z, Wang Z. Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging. Eur J Radiol 2020;125:108857. [PMID: 32113153 DOI: 10.1016/j.ejrad.2020.108857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 384 |
Shan L, Jiang T, Ci L, Liu Z, Lv X, Li J. Purine signaling regulating HSCs inflammatory cytokines secretion, activation, and proliferation plays a critical role in alcoholic liver disease. Mol Cell Biochem 2020;466:91-102. [PMID: 31989367 DOI: 10.1007/s11010-020-03691-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 385 |
Li X, Chen R, Kemper S, Brigstock DR. Dynamic Changes in Function and Proteomic Composition of Extracellular Vesicles from Hepatic Stellate Cells during Cellular Activation. Cells 2020;9:E290. [PMID: 31991791 DOI: 10.3390/cells9020290] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 386 |
Han HS, Lee H, You D, Nguyen VQ, Song DG, Oh BH, Shin S, Choi JS, Kim JD, Pan CH, Jo DG, Cho YW, Choi KY, Park JH. Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis. J Control Release 2020;320:328-36. [PMID: 31981658 DOI: 10.1016/j.jconrel.2020.01.042] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 387 |
Ocker M. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma. World J Gastroenterol 2020; 26(3): 279-290 [PMID: 31988589 DOI: 10.3748/wjg.v26.i3.279] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 388 |
Wang S, Li M, Zhao X, Wang H, Zhu J, Wang C, Zhou M, Dong H, Zhou R. Upregulation of KSRP by miR-27b attenuates schistosomiasis-induced hepatic fibrosis by targeting TGF-β1. FASEB J 2020;34:4120-33. [PMID: 31953889 DOI: 10.1096/fj.201902438R] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 389 |
Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J Gastroenterol 2020; 26(2): 109-133 [PMID: 31969775 DOI: 10.3748/wjg.v26.i2.109] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 66] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 390 |
Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood) 2020;245:96-108. [PMID: 31924111 DOI: 10.1177/1535370219898141] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 391 |
Soydemir S, Comella O, Abdelmottaleb D, Pritchett J. Does Mechanocrine Signaling by Liver Sinusoidal Endothelial Cells Offer New Opportunities for the Development of Anti-fibrotics? Front Med (Lausanne) 2019;6:312. [PMID: 31998732 DOI: 10.3389/fmed.2019.00312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 392 |
Sun X, Seidman JS, Zhao P, Troutman TD, Spann NJ, Que X, Zhou F, Liao Z, Pasillas M, Yang X, Magida JA, Kisseleva T, Brenner DA, Downes M, Evans RM, Saltiel AR, Tsimikas S, Glass CK, Witztum JL. Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. Cell Metab 2020;31:189-206.e8. [PMID: 31761566 DOI: 10.1016/j.cmet.2019.10.014] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 28.3] [Reference Citation Analysis]
|
| 393 |
Kadota T, Kosaka N, Fujita Y, Araya J, Kuwano K, Ochiya T. Extracellular vesicles in fibrotic diseases: New applications for fibrosis diagnosis and treatment. Exosomes 2020. [DOI: 10.1016/b978-0-12-816053-4.00013-4] [Reference Citation Analysis]
|
| 394 |
Shiha G, Mousa N. Noninvasive Biomarkers for Liver Fibrosis. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_36] [Reference Citation Analysis]
|
| 395 |
Kidambi S. Stiffness and Hepatocytes Function In Vitro. Liver Elastography 2020. [DOI: 10.1007/978-3-030-40542-7_55] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 396 |
Karsdal MA, Detlefsen S, Daniels SJ, Nielsen MJ, Krag A, Schuppan D. Is the Total Amount as Important as Localization and Type of Collagen in Liver Fibrosis Attributable to Steatohepatitis? Hepatology 2020;71:346-51. [PMID: 31553813 DOI: 10.1002/hep.30969] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 397 |
Pastore M, Gentilini A, Marra F. Mechanisms of Fibrogenesis in NASH. Non-Alcoholic Fatty Liver Disease 2020. [DOI: 10.1007/978-3-319-95828-6_6] [Reference Citation Analysis]
|
| 398 |
Bhattacharyya S. Inflammation During Virus Infection: Swings and Roundabouts. Dynamics of Immune Activation in Viral Diseases 2020. [DOI: 10.1007/978-981-15-1045-8_3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 399 |
Yu L, Li Y, Grisé A, Wang H. CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis. Adv Exp Med Biol 2020;1276:197-222. [PMID: 32705602 DOI: 10.1007/978-981-15-6082-8_13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 400 |
Zhou J, Lan Q, Li W, Yang L, You J, Zhang YM, Ni W. Tripartite motif protein 52 (TRIM52) promoted fibrosis in LX-2 cells through PPM1A-mediated Smad2/3 pathway. Cell Biol Int 2020;44:108-16. [PMID: 31329338 DOI: 10.1002/cbin.11206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 401 |
Datsko VА, Fedoniuk LY, Ivankiv YI, Kurylo KI, Volska АS, Malanchuk SL, Oleshchuk ОМ. EXPERIMENTAL CIRRHOSIS: LIVER MORPHOLOGY AND FUNCTION. Wiad Lek 2020;73:947-52. [DOI: 10.36740/wlek202005120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 402 |
Witzigmann D, Kulkarni JA, Leung J, Chen S, Cullis PR, van der Meel R. Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv Drug Deliv Rev 2020;159:344-63. [PMID: 32622021 DOI: 10.1016/j.addr.2020.06.026] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 40.3] [Reference Citation Analysis]
|
| 403 |
Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, Liu X, Zhang R, Wang Y. Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol 2019;176:4666-80. [PMID: 31412137 DOI: 10.1111/bph.14831] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 404 |
Winkler I, Bitter C, Winkler S, Weichenhan D, Thavamani A, Hengstler JG, Borkham-Kamphorst E, Kohlbacher O, Plass C, Geffers R, Weiskirchen R, Nordheim A. Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment. Proc Natl Acad Sci U S A 2020;117:454-63. [PMID: 31871210 DOI: 10.1073/pnas.1909145117] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 405 |
Ge MX, Liu HT, Zhang N, Niu WX, Lu ZN, Bao YY, Huang R, Yu DK, Shao RG, He HW. Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation. Br J Pharmacol 2020;177:372-87. [PMID: 31621893 DOI: 10.1111/bph.14873] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 406 |
Giambartolomei GH, Delpino MV. Immunopathogenesis of Hepatic Brucellosis. Front Cell Infect Microbiol 2019;9:423. [PMID: 31956605 DOI: 10.3389/fcimb.2019.00423] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 407 |
Chen A, Xu C, Luo Y, Liu L, Song K, Deng G, Yang M, Cao J, Yuan L, Li X. Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1. Acta Biochim Biophys Sin (Shanghai) 2019;51:1267-75. [PMID: 31750892 DOI: 10.1093/abbs/gmz129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 408 |
Phaosri M, Jantrapirom S, Takuathung MN, Soonthornchareonnon N, Sireeratawong S, Buacheen P, Pitchakarn P, Nimlamool W, Potikanond S. Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells Through the Inhibition of the TGF-β1-Induced SMAD2/3 Signaling Pathway. Int J Mol Sci 2019;20:E6314. [PMID: 31847284 DOI: 10.3390/ijms20246314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 409 |
Rao C, Ni YR, Zhao YM, Zhang YQ, Zhou RT, Liu CB, Han L, Wu JF. Class C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cells. Mol Med Rep 2020;21:667-74. [PMID: 31974596 DOI: 10.3892/mmr.2019.10881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 410 |
Fan QQ, Zhang CL, Qiao JB, Cui PF, Xing L, Oh YK, Jiang HL. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials 2020;230:119616. [PMID: 31837823 DOI: 10.1016/j.biomaterials.2019.119616] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 411 |
El-maadawy W, Hammam O, Seif el-Din S, El-lakkany N. α-Lipoic acid modulates liver fibrosis: A cross talk between TGF-β1, autophagy, and apoptosis. Hum Exp Toxicol 2020;39:440-50. [DOI: 10.1177/0960327119891212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 412 |
Tsai MC, Yen YH, Chang KC, Hung CH, Chen CH, Lin MT, Hu TH. Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection. BMC Cancer 2019;19:1169. [PMID: 31791275 DOI: 10.1186/s12885-019-6397-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 413 |
Ghallab A, Myllys M, Holland CH, Zaza A, Murad W, Hassan R, Ahmed YA, Abbas T, Abdelrahim EA, Schneider KM, Matz-Soja M, Reinders J, Gebhardt R, Berres ML, Hatting M, Drasdo D, Saez-Rodriguez J, Trautwein C, Hengstler JG. Influence of Liver Fibrosis on Lobular Zonation. Cells 2019;8:E1556. [PMID: 31810365 DOI: 10.3390/cells8121556] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 414 |
Zhang T, Yang Y, Wang B, Zheng X, Wang L, Feng X, Li G, Shi J, Cao N. Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e18458. [PMID: 31861022 DOI: 10.1097/MD.0000000000018458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 415 |
Ni HM, Chao X, Yang H, Deng F, Wang S, Bai Q, Qian H, Cui Y, Cui W, Shi Y, Zong WX, Wang Z, Yang L, Ding WX. Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy-Defective Mouse Liver. Hepatology 2019;70:2142-55. [PMID: 31095752 DOI: 10.1002/hep.30770] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 416 |
Sun X, Nkennor B, Mastikhina O, Soon K, Nunes SS. Endothelium-mediated contributions to fibrosis. Semin Cell Dev Biol. 2020;101:78-86. [PMID: 31791693 DOI: 10.1016/j.semcdb.2019.10.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 417 |
Hintermann E, Christen U. The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis. Cells 2019;8:E1503. [PMID: 31771248 DOI: 10.3390/cells8121503] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 418 |
He L, Ye X, Gao M, Yang J, Ma J, Xiao F, Wei H. Down-regulation of GLT25D1 inhibited collagen secretion and involved in liver fibrogenesis. Gene 2020;729:144233. [PMID: 31759980 DOI: 10.1016/j.gene.2019.144233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 419 |
Elfeky MG, Mantawy EM, Gad AM, Fawzy HM, El-Demerdash E. Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways. Life Sci 2020;240:117096. [PMID: 31760097 DOI: 10.1016/j.lfs.2019.117096] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 420 |
Lee H, Yu D, Um MJ, Yoon SY, Kim K, Kwon YJ, Lee S, Bahn M, Koo S, Jung KH, Lee J, Ko Y. Hepatocytic Prominin-1 protects against liver fibrosis by stabilizing the SMAD7 protein.. [DOI: 10.1101/846493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 421 |
Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells 2019;8:E1419. [PMID: 31718044 DOI: 10.3390/cells8111419] [Cited by in Crossref: 214] [Cited by in F6Publishing: 239] [Article Influence: 53.5] [Reference Citation Analysis]
|
| 422 |
Tee JK, Yip LX, Tan ES, Santitewagun S, Prasath A, Ke PC, Ho HK, Leong DT. Nanoparticles' interactions with vasculature in diseases. Chem Soc Rev 2019;48:5381-407. [PMID: 31495856 DOI: 10.1039/c9cs00309f] [Cited by in Crossref: 160] [Cited by in F6Publishing: 167] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 423 |
Khalifa YH, Mourad GM, Stephanos WM, Omar SA, Mehanna RA. Bone Marrow-Derived Mesenchymal Stem Cell Potential Regression of Dysplasia Associating Experimental Liver Fibrosis in Albino Rats. Biomed Res Int 2019;2019:5376165. [PMID: 31781620 DOI: 10.1155/2019/5376165] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 424 |
Nithyananthan S, Thirunavukkarasu C. Chemotherapeutic doses of arsenic trioxide delays hepatic regeneration by oxidative stress and hepatocyte apoptosis in partial hepatectomy rat. Toxicology and Applied Pharmacology 2019;382:114760. [DOI: 10.1016/j.taap.2019.114760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 425 |
Moran-Salvador E, Garcia-Macia M, Sivaharan A, Sabater L, Zaki MYW, Oakley F, Knox A, Page A, Luli S, Mann J, Mann DA. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells. Gastroenterology 2019;157:1398-1412.e9. [PMID: 31352003 DOI: 10.1053/j.gastro.2019.07.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 426 |
Chen CH, Chang CL, Chen KH, Cheng BC, Chen HH, Chiang JY, Sung PH, Yip HK. Level and Value of T Cell-derived Circulating Microparticles in Liver Cirrhosis Patients. In Vivo 2019;33:2265-72. [PMID: 31662566 DOI: 10.21873/invivo.11732] [Reference Citation Analysis]
|
| 427 |
Muthiah MD, Huang DQ, Zhou L, Jumat NH, Choolani M, Chan JKY, Wee A, Lim SG, Dan YY. A murine model demonstrating reversal of structural and functional correlates of cirrhosis with progenitor cell transplantation. Sci Rep 2019;9:15446. [PMID: 31659188 DOI: 10.1038/s41598-019-51189-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 428 |
Nithyananthan S, Keerthana P, Umadevi S, Guha S, Mir IH, Behera J, Thirunavukkarasu C. Nutrient mixture from germinated legumes: Enhanced medicinal value with herbs-attenuated liver cirrhosis. J Food Biochem 2020;44:e13085. [PMID: 31646659 DOI: 10.1111/jfbc.13085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 429 |
Li Z, Chen B, Dong W, Kong M, Shao Y, Fan Z, Yu L, Wu D, Lu J, Guo J, Xu Y. The Chromatin Remodeler Brg1 Integrates ROS Production and Endothelial-Mesenchymal Transition to Promote Liver Fibrosis in Mice. Front Cell Dev Biol 2019;7:245. [PMID: 31750301 DOI: 10.3389/fcell.2019.00245] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 430 |
Li C, Meng M, Guo M, Wang M, Ju A, Wang C. The polysaccharides from Grifola frondosa attenuate CCl4-induced hepatic fibrosis in rats via the TGF-β/Smad signaling pathway. RSC Adv 2019;9:33684-92. [PMID: 35528887 DOI: 10.1039/c9ra04679h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 431 |
Lin N, Meng L, Lin J, Chen S, Zhang P, Chen Q, Lin Y. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1. J Cell Biochem 2020;121:1441-51. [PMID: 31609020 DOI: 10.1002/jcb.29380] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 432 |
Lin H, Fan T, Sui J, Wang G, Chen J, Zhuo S, Zhang H. Recent advances in multiphoton microscopy combined with nanomaterials in the field of disease evolution and clinical applications to liver cancer. Nanoscale 2019;11:19619-35. [PMID: 31599299 DOI: 10.1039/c9nr04902a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 433 |
Yoo W, Lee J, Noh KH, Lee S, Jung D, Kabir MH, Park D, Lee C, Kwon KS, Kim JS, Kim S. Progranulin attenuates liver fibrosis by downregulating the inflammatory response. Cell Death Dis 2019;10:758. [PMID: 31591383 DOI: 10.1038/s41419-019-1994-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 434 |
Chen Z, Yao L, Liu Y, Pan Z, Peng S, Wan G, Cheng J, Wang J, Cao W. Astragaloside IV regulates NF-κB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation. Exp Ther Med 2019;18:3741-50. [PMID: 31641375 DOI: 10.3892/etm.2019.8047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 435 |
Ramachandran P, Dobie R, Wilson-kanamori J, Dora E, Henderson B, Taylor R, Matchett K, Portman J, Efremova M, Vento-tormo R, Luu N, Weston C, Newsome P, Harrison E, Mole D, Wigmore S, Iredale J, Tacke F, Pollard J, Ponting C, Marioni J, Teichmann S, Henderson N. Resolving the fibrotic niche of human liver cirrhosis using single-cell transcriptomics.. [DOI: 10.1101/766113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 436 |
Liu Y, Lv W. Research Progress in Astragalus Membranaceus and Its Active Components on Immune Responses in Liver Fibrosis. Chin J Integr Med 2020;26:794-800. [DOI: 10.1007/s11655-019-3039-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 437 |
Chen G, Xia B, Fu Q, Huang X, Wang F, Chen Z, Lv Y. Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis. Int J Biol Sci 2019;15:2509-21. [PMID: 31754325 DOI: 10.7150/ijbs.37500] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 438 |
Adel N, Mantawy EM, El-Sherbiny DA, El-Demerdash E. Iron chelation by deferasirox confers protection against concanavalin A-induced liver fibrosis: A mechanistic approach. Toxicol Appl Pharmacol 2019;382:114748. [PMID: 31499193 DOI: 10.1016/j.taap.2019.114748] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 439 |
Chen X, Li XF, Chen Y, Zhu S, Li HD, Chen SY, Wang JN, Pan XY, Bu FT, Huang C, Li J. Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms. Int Immunopharmacol 2019;76:105838. [PMID: 31473406 DOI: 10.1016/j.intimp.2019.105838] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 440 |
Elias MB, Oliveira FL, Guma FCR, Martucci RB, Borojevic R, Teodoro AJ. Lycopene inhibits hepatic stellate cell activation and modulates cellular lipid storage and signaling. Food Funct 2019;10:1974-84. [PMID: 30889234 DOI: 10.1039/c8fo02369g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 441 |
Han L, Bittner S, Dong D, Cortez Y, Dulay H, Arshad S, Shen WJ, Kraemer FB, Azhar S. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). Mol Cell Endocrinol 2019;498:110538. [PMID: 31415794 DOI: 10.1016/j.mce.2019.110538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 442 |
Niu F, Chong S, Qin M, Li S, Wei R, Zhao Y. Mechanism of Fibrosis Induced by Echinococcus spp. Diseases 2019;7:E51. [PMID: 31409055 DOI: 10.3390/diseases7030051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 443 |
Rashid W, Patel V, Ravat V, Madireddy S, Jaladi PR, Tahir M, Bhimanadham NN, Kuduva Rajan S, Imran S, Patel RS. Problematic Cannabis Use and Risk of Complications in Patients with Chronic Hepatitis C. Cureus 2019;11:e5373. [PMID: 31431849 DOI: 10.7759/cureus.5373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 444 |
Damba T, Zhang M, Buist-Homan M, van Goor H, Faber KN, Moshage H. Hydrogen sulfide stimulates activation of hepatic stellate cells through increased cellular bio-energetics. Nitric Oxide 2019;92:26-33. [PMID: 31401106 DOI: 10.1016/j.niox.2019.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 445 |
Raffaele M, Carota G, Sferrazzo G, Licari M, Barbagallo I, Sorrenti V, Signorelli SS, Vanella L. Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis In Vitro. Antioxidants (Basel) 2019;8:E277. [PMID: 31387260 DOI: 10.3390/antiox8080277] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 446 |
Yamato M, Sakai Y, Mochida H, Kawaguchi K, Takamura M, Usui S, Seki A, Mizukoshi E, Yamashita T, Yamashita T, Ishida K, Nasti A, Tuyen HTB, Komura T, Yoshida K, Wada T, Honda M, Kaneko S. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation. J Gastroenterol Hepatol 2019;34:1432-40. [PMID: 30828861 DOI: 10.1111/jgh.14647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 447 |
Zhang C, An R, Bao Y, Meng X, Wang T, Sun H, Pan F, Zhang C. Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathways. International Immunopharmacology 2019;73:515-26. [DOI: 10.1016/j.intimp.2019.05.055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 448 |
Yuan Q, Zhang Z, Hu X, Liao J, Kuang J. miR-374a/Myc axis modulates iron overload-induced production of ROS and the activation of hepatic stellate cells via TGF-β1 and IL-6. Biochem Biophys Res Commun 2019;515:499-504. [PMID: 31171361 DOI: 10.1016/j.bbrc.2019.05.152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 449 |
Sayed N, Khurana A, Saifi MA, Singh M, Godugu C. Withaferin A reverses bile duct ligation‐induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling. BioFactors 2019;45:959-74. [DOI: 10.1002/biof.1546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 450 |
Feng J, Wang C, Liu T, Li J, Wu L, Yu Q, Li S, Zhou Y, Zhang J, Chen J, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis. J Cell Mol Med 2019;23:6479-93. [PMID: 31328391 DOI: 10.1111/jcmm.14543] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 451 |
He S, Tang J, Diao N, Liao Y, Shi J, Xu X, Xie F, Bai L. Parathyroid hormone-related protein activates HSCs via hedgehog signalling during liver fibrosis development. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:1984-94. [DOI: 10.1080/21691401.2019.1615931] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 452 |
Villar-Lorenzo A, Rada P, Rey E, Marañón P, Arroba AI, Santamaría B, Sáiz J, Rupérez FJ, Barbas C, García-Monzón C, Valverde ÁM, González-Rodríguez Á. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury. Dis Model Mech 2019;12:dmm038810. [PMID: 31262748 DOI: 10.1242/dmm.038810] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 453 |
Gao W, Sun J, Wang F, Lu Y, Wen C, Bian Q, Wu H. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway. Biochem Biophys Res Commun 2019;516:1222-8. [PMID: 31296386 DOI: 10.1016/j.bbrc.2019.07.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 454 |
Nithyananthan S, Thirunavukkarasu C. Arsenic trioxide, a cancer chemo drug hampers fibrotic liver regeneration by interrupting oxidative stress rekindling and stellate cell rejuvenation. J Cell Physiol 2020;235:1222-34. [PMID: 31270803 DOI: 10.1002/jcp.29037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 455 |
Tu Y, Zhu S, Wang J, Burstein E, Jia D. Natural compounds in the chemoprevention of alcoholic liver disease. Phytother Res 2019;33:2192-212. [PMID: 31264302 DOI: 10.1002/ptr.6410] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 456 |
Wu W, Wang T, Sun B, Liu D, Lin Z, Miao Y, Wang C, Geng X, Li B. Xian-Ling-Gu-Bao induced inflammatory stress rat liver injury: Inflammatory and oxidative stress playing important roles. Journal of Ethnopharmacology 2019;239:111910. [DOI: 10.1016/j.jep.2019.111910] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 457 |
Zhao YL, Zhang X, Liu WW, Yang YT, Gao ZK, Liu XL, Liu W, Hayashi T, Yamato M, Fujisaki H, Hattori S, Mizuno K, Atsuzawa Y, Tashiro SI, Onodera S, Ikejima T. Reactive oxygen species are responsible for the cell aggregation and production of pro-inflammatory mediators in phorbol ester (PMA)-treated U937 cells on gelatin-coated dishes through upregulation of autophagy. Connect Tissue Res 2019;60:323-34. [PMID: 30277081 DOI: 10.1080/03008207.2018.1530770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 458 |
Zmorzyński S, Styk W, Filip AA, Krasowska D. The Significance of NOTCH Pathway in the Development of Fibrosis in Systemic Sclerosis. Ann Dermatol 2019;31:365-71. [PMID: 33911613 DOI: 10.5021/ad.2019.31.4.365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 459 |
Xu H, Hong S, Yan Z, Zhao Q, Shi Y, Song N, Xie J, Jiang X. RAP-8 ameliorates liver fibrosis by modulating cell cycle and oxidative stress. Life Sciences 2019;229:200-9. [DOI: 10.1016/j.lfs.2019.04.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 460 |
Li YK, Li YM, Li Y, Wei YR, Zhang J, Li B, You ZR, Chen Y, Huang BY, Miao Q, Wang QX, Peng YS, Gershwin ME, Tang RQ, Bian ZL, Ma X. CTHRC1 expression in primary biliary cholangitis. J Dig Dis 2019;20:371-6. [PMID: 31102333 DOI: 10.1111/1751-2980.12791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 461 |
Zhou R, Fan X, Schnabl B. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Transl Res 2019;209:22-38. [PMID: 30853445 DOI: 10.1016/j.trsl.2019.02.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 462 |
Bae M, Lee Y, Park YK, Shin DG, Joshi P, Hong SH, Alder N, Koo SI, Lee JY. Astaxanthin attenuates the increase in mitochondrial respiration during the activation of hepatic stellate cells. J Nutr Biochem 2019;71:82-9. [PMID: 31302374 DOI: 10.1016/j.jnutbio.2019.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 463 |
Wan Y, Ceci L, Wu N, Zhou T, Chen L, Venter J, Francis H, Bernuzzi F, Invernizzi P, Kyritsi K, Baker P, Huang Q, Wu C, Sybenga A, Alpini G, Meng F, Glaser S. Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes. Lab Invest 2019;99:764-76. [PMID: 30700848 DOI: 10.1038/s41374-018-0178-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 464 |
Bae M, Kim MB, Kang H, Park YK, Lee JY. Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells. Lipids 2019;54:401-10. [PMID: 31140624 DOI: 10.1002/lipd.12157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 465 |
Shipley LC, Axley PD, Singal AK. Liver Fibrosis: A Clinical Update. EMJ Hepatol 2019. [DOI: 10.33590/emjhepatol/10313576] [Reference Citation Analysis]
|
| 466 |
Zhang H, Chen Q, Dahan A, Xue J, Wei L, Tan W, Zhang G. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing. Chem Biol Interact 2019;309:108675. [PMID: 31150632 DOI: 10.1016/j.cbi.2019.05.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 467 |
Attallah AM, Albannan MS, Omran MM, Zayed R, Saif S, Farid A, Hassany M, Yosry A, Omran D. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. Br J Biomed Sci 2019;76:105-10. [PMID: 30924403 DOI: 10.1080/09674845.2019.1600325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 468 |
Barcena-Varela M, Colyn L, Fernandez-Barrena MG. Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis. Int J Mol Sci 2019;20:E2507. [PMID: 31117267 DOI: 10.3390/ijms20102507] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 469 |
Hall KC, Bernier SG, Jacobson S, Liu G, Zhang PY, Sarno R, Catanzano V, Currie MG, Masferrer JL. sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. Proc Natl Acad Sci U S A 2019;116:11057-62. [PMID: 31085647 DOI: 10.1073/pnas.1821045116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 470 |
Peng Y, Li L, Zhang X, Xie M, Yang C, Tu S, Shen H, Hu G, Tao L, Yang H. Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways. Exp Ther Med 2019;18:41-8. [PMID: 31258636 DOI: 10.3892/etm.2019.7548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 471 |
Rafael Rodríguez-aguilera J, Pérez-cabeza de Vaca R, Guerrero-celis N, Velasco-loyden G, Domínguez-lópez M, Recillas-targa F, Chagoya de Sánchez V. Molecular and Cellular Aspects of Cirrhosis and How an Adenosine Derivative Could Revert Fibrosis. Liver Cirrhosis - Debates and Current Challenges 2019. [DOI: 10.5772/intechopen.83481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 472 |
Li X, Zhang H, Pan L, Zou H, Miao X, Cheng J, Wu Y. Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide-induced hepatic fibrosis in rats. Exp Ther Med 2019;18:133-8. [PMID: 31258646 DOI: 10.3892/etm.2019.7534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 473 |
Wei Y, Zhang X, Wen S, Huang S, Huang Q, Lu S, Bai F, Nie J, Wei J, Lu Z, Lin X. Methyl helicterate inhibits hepatic stellate cell activation through downregulating the ERK1/2 signaling pathway. J Cell Biochem 2019;120:14936-45. [DOI: 10.1002/jcb.28756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 474 |
Zhang L, Yao W, Xia J, Wang T, Huang F. Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism. Int J Mol Sci 2019;20:E1885. [PMID: 30995792 DOI: 10.3390/ijms20081885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 475 |
Sircana A, Paschetta E, Saba F, Molinaro F, Musso G. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1745. [PMID: 30970564 DOI: 10.3390/ijms20071745] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 476 |
Jia Y, Zhong F, Jiang S, Guo Q, Jin H, Wang F, Li M, Wang L, Chen A, Zhang F, Shao J, Zheng S. Periostin in chronic liver diseases: Current research and future perspectives. Life Sci 2019;226:91-7. [PMID: 30978348 DOI: 10.1016/j.lfs.2019.04.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 477 |
Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1723. [PMID: 30959975 DOI: 10.3390/ijms20071723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 478 |
Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1723. [PMID: 30959975 DOI: 10.3390/ijms20071723] [Cited by in Crossref: 102] [Cited by in F6Publishing: 115] [Article Influence: 25.5] [Reference Citation Analysis]
|
| 479 |
Ju B, Nie Y, Yang X, Wang X, Li F, Wang M, Wang C, Zhang H. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells. J Cell Mol Med. 2019;23:3824-3832. [PMID: 30945448 DOI: 10.1111/jcmm.14210] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 480 |
Puente A, Fortea JI, Cabezas J, Arias Loste MT, Iruzubieta P, Llerena S, Huelin P, Fábrega E, Crespo J. LOXL2-A New Target in Antifibrogenic Therapy? Int J Mol Sci 2019;20:E1634. [PMID: 30986934 DOI: 10.3390/ijms20071634] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 481 |
Nagórniewicz B, Mardhian DF, Booijink R, Storm G, Prakash J, Bansal R. Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis. Nanomedicine: Nanotechnology, Biology and Medicine 2019;17:106-18. [DOI: 10.1016/j.nano.2018.12.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 482 |
Choi S, Jung HJ, Kim MW, Kang JH, Shin D, Jang YS, Yoon YS, Oh SH. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice. Biochem Biophys Res Commun. 2019;513:49-55. [PMID: 30935693 DOI: 10.1016/j.bbrc.2019.03.156] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 483 |
Wang K, Fang S, Liu Q, Gao J, Wang X, Zhu H, Zhu Z, Ji F, Wu J, Ma Y, Hu L, Shen X, Gao D, Zhu J, Liu P, Zhou H. TGF-β1/p65/MAT2A pathway regulates liver fibrogenesis via intracellular SAM. EBioMedicine 2019;42:458-69. [PMID: 30926424 DOI: 10.1016/j.ebiom.2019.03.058] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 484 |
Jiang R, Zhou Y, Wang S, Pang N, Huang Y, Ye M, Wan T, Qiu Y, Pei L, Jiang X, Huang Y, Yang H, Ling W, Li X, Zhang Z, Yang L. Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway. Life Sci 2019;225:20-8. [PMID: 30928408 DOI: 10.1016/j.lfs.2019.03.064] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 485 |
Chen Z, Jain A, Liu H, Zhao Z, Cheng K. Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis. J Pharmacol Exp Ther 2019;370:695-702. [PMID: 30886124 DOI: 10.1124/jpet.118.256156] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 486 |
Chen L, Zhou T, Wu N, O'Brien A, Venter J, Ceci L, Kyritsi K, Onori P, Gaudio E, Sybenga A, Xie L, Wu C, Fabris L, Invernizzi P, Zawieja D, Liangpunsakul S, Meng F, Francis H, Alpini G, Huang Q, Glaser S. Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis. Biochim Biophys Acta Mol Basis Dis 2019;1865:1525-39. [PMID: 30890428 DOI: 10.1016/j.bbadis.2019.03.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 487 |
Abo El-magd NF, El-karef A, El-shishtawy MM, Eissa LA. Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on Nuclear Factor-kappa B pathway in thioacetamide-induced fibrosis in rats. Egyptian Journal of Basic and Applied Sciences 2019;2:65-74. [DOI: 10.1016/j.ejbas.2014.12.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 488 |
Wu J, Huang J, Kuang S, Chen J, Li X, Chen B, Wang J, Cheng D, Shuai X. Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI-Visible Nanocarrier Targeting Hepatic Stellate Cells. Adv Sci (Weinh) 2019;6:1801809. [PMID: 30886803 DOI: 10.1002/advs.201801809] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 489 |
Tian H, Liu L, Li Z, Liu W, Sun Z, Xu Y, Wang S, Liang C, Hai Y, Feng Q, Zhao Y, Hu Y, Peng J. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. Journal of Ethnopharmacology 2019;232:227-35. [DOI: 10.1016/j.jep.2018.11.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 490 |
Nielsen J, Christensen VB, Borgwardt L, Rasmussen A, Østrup O, Kjær MS. Prognostic molecular markers in pediatric liver disease – Are there any? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019;1865:577-86. [DOI: 10.1016/j.bbadis.2018.12.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 491 |
Liu Z, Chalasani N, Lin J, Gawrieh S, He Y, Tseng YJ, Liu W. Integrative omics analysis identifies macrophage migration inhibitory factor signaling pathways underlying human hepatic fibrogenesis and fibrosis. J BioX Res 2019;2:16-24. [PMID: 32953199 DOI: 10.1097/jbr.0000000000000026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 492 |
Yu Y, Cai J, She Z, Li H. Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. Adv Sci (Weinh) 2019;6:1801585. [PMID: 30828530 DOI: 10.1002/advs.201801585] [Cited by in Crossref: 60] [Cited by in F6Publishing: 72] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 493 |
Zhang H, Sun D, Wang G, Cui S, Field RA, Li J, Zang Y. Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell. Biochem Biophys Res Commun. 2019;511:387-393. [PMID: 30797555 DOI: 10.1016/j.bbrc.2019.02.065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 494 |
Zhao Y, Wang Z, Feng D, Zhao H, Lin M, Hu Y, Zhang N, Lv L, Gao Z, Zhai X, Tian X, Yao J. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species. Theranostics 2019;9:1510-22. [PMID: 30867846 DOI: 10.7150/thno.29620] [Cited by in Crossref: 42] [Cited by in F6Publishing: 53] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 495 |
Ramani K, Biswas PS. Interleukin-17: Friend or foe in organ fibrosis. Cytokine 2019;120:282-8. [PMID: 30772195 DOI: 10.1016/j.cyto.2018.11.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 496 |
Barghi M, Ashrafi M, Aminlari M, Namazi F, Nazifi S. The protective effect of Zataria multiflora Boiss essential oil on CCl4 induced liver fibrosis in rats. Drug Chem Toxicol 2021;44:229-37. [PMID: 30746963 DOI: 10.1080/01480545.2019.1571502] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 497 |
Ren L, Qi K, Zhang L, Bai Z, Ren C, Xu X, Zhang Z, Li X. Glutathione Might Attenuate Cadmium-Induced Liver Oxidative Stress and Hepatic Stellate Cell Activation. Biol Trace Elem Res 2019;191:443-52. [PMID: 30715683 DOI: 10.1007/s12011-019-1641-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 498 |
Zou Y, Li S, Li Z, Song D, Zhang S, Yao Q. MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-β1 mediated epithelial-mesenchymal transition in hepatocytes. Cell Signal 2019;58:1-8. [PMID: 30711634 DOI: 10.1016/j.cellsig.2019.01.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 499 |
Manka P, Coombes JD, Boosman R, Gauthier K, Papa S, Syn WK. Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer Lett 2018;419:175-86. [PMID: 29414304 DOI: 10.1016/j.canlet.2018.01.055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 500 |
Han K, Zhang Y, Yang Z. Cilostazol protects rats against alcohol-induced hepatic fibrosis via suppression of TGF-β1/CTGF activation and the cAMP/Epac1 pathway. Exp Ther Med 2019;17:2381-8. [PMID: 30867723 DOI: 10.3892/etm.2019.7207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 501 |
Yang H, Ni HM, Ding WX. Emerging Players in Autophagy Deficiency-Induced Liver Injury and Tumorigenesis. Gene Expr 2019;19:229-34. [PMID: 30717822 DOI: 10.3727/105221619X15486875608177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 502 |
George J, Tsutsumi M, Tsuchishima M. Alteration of Trace Elements during Pathogenesis of N-Nitrosodimethylamine Induced Hepatic Fibrosis. Sci Rep 2019;9:708. [PMID: 30679730 DOI: 10.1038/s41598-018-37516-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 503 |
Bradding P, Pejler G. The controversial role of mast cells in fibrosis. Immunol Rev 2018;282:198-231. [PMID: 29431218 DOI: 10.1111/imr.12626] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 504 |
Ding Q, Xie XL, Wang MM, Yin J, Tian JM, Jiang XY, Zhang D, Han J, Bai Y, Cui ZJ, Jiang HQ. The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Exp Mol Med 2019;51:1-13. [PMID: 30635551 DOI: 10.1038/s12276-018-0199-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 505 |
Febres-Aldana CA, Alghamdi S, Krishnamurthy K, Poppiti RJ. Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases. J Clin Transl Hepatol 2019;7:21-6. [PMID: 30944815 DOI: 10.14218/JCTH.2018.00053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 506 |
Akdoğan Ö, Atak Yücel A, Gök Sargin Z, Sönmez C, Esendağli Yilmaz G, Özenirler S. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. J Clin Exp Hepatol 2019;9:29-33. [PMID: 30765936 DOI: 10.1016/j.jceh.2018.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 507 |
Yue ZM, Hong DM, Shengdi WM, Peili FM, Zheng LM, Wenjiao ZM, Wenping WM. Histological Reference for Shear Wave Elastography in Liver Fibrosis: Collagen Quantification and Scoring System. Advanced Ultrasound in Diagnosis and Therapy 2019;3:87. [DOI: 10.37015/audt.2019.190815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 508 |
Long T, Wang L, Yang Y, Yuan L, Zhao H, Chang C, Yang G, Ho C, Li S. Protective effects of trans -2,3,5,4′-tetrahydroxystilbene 2- O -β- d -glucopyranoside on liver fibrosis and renal injury induced by CCl 4via down-regulating p-ERK1/2 and p-Smad1/2. Food Funct 2019;10:5115-23. [DOI: 10.1039/c9fo01010f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 509 |
Fan Y, Du Z, Steib CJ, Ding Q, Lu P, Tian D, Liu M. Effect of SEPT6 on the biological behavior of hepatic stellate cells and liver fibrosis in rats and its mechanism. Lab Invest 2019;99:17-36. [PMID: 30315255 DOI: 10.1038/s41374-018-0133-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 510 |
Gürbüz F, Ağın M, Mengen E, Elçi H, Ünal İ, Tümgör G, Yüksel B. Kronik karaciğer hastalığı olan çocukların D vitamini düzeyleri. Cukurova Medical Journal 2018;43:1-1. [DOI: 10.17826/cumj.365057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 511 |
Ma L, Li X, Bai Z, Lin X, Lin K. AdipoRs- a potential therapeutic target for fibrotic disorders. Expert Opin Ther Targets 2019;23:93-106. [PMID: 30569772 DOI: 10.1080/14728222.2019.1559823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 512 |
Shmagel K, Saidakova E. Immune Disorders in HIV-Infected Patients Coinfected with Hepatitis C Virus. Advances in HIV and AIDS Control 2018. [DOI: 10.5772/intechopen.76810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 513 |
Cheng Q, Li C, Yang CF, Zhong YJ, Wu D, Shi L, Chen L, Li YW, Li L. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Chem Biol Interact 2019;299:131-9. [PMID: 30543783 DOI: 10.1016/j.cbi.2018.12.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 514 |
Cops J, Mullens W, Verbrugge FH, Swennen Q, De Moor B, Reynders C, Penders J, Achten R, Driessen A, Dendooven A, Rigo JM, Hansen D. Selective abdominal venous congestion induces adverse renal and hepatic morphological and functional alterations despite a preserved cardiac function. Sci Rep 2018;8:17757. [PMID: 30532057 DOI: 10.1038/s41598-018-36189-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 515 |
Lim BJ, Lee WK, Lee HW, Lee KS, Kim JK, Chang HY, Lee JI. Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice. Cell Commun Signal 2018;16:93. [PMID: 30509307 DOI: 10.1186/s12964-018-0306-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 516 |
Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, Zou GL, Yang J, Cheng ML, Zhao XK. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway. Drug Des Devel Ther 2018;12:4107-15. [PMID: 30584275 DOI: 10.2147/DDDT.S186726] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 517 |
Meng D, Li Z, Wang G, Ling L, Wu Y, Zhang C. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomedicine & Pharmacotherapy 2018;108:1617-27. [DOI: 10.1016/j.biopha.2018.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 518 |
Emara DM, Reda MM, Elwazzan DA. Utility of diffusion weighted imaging (DWI) in assessment of liver fibrosis. Alexandria Journal of Medicine 2018;54:347-352. [DOI: 10.1016/j.ajme.2017.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 519 |
Parvaresh Anbar A, Piran T, Farhadi M, Karimi P. Iranian crack induces hepatic injury through mitogen-activated protein kinase pathway in the liver of Wistar rat. Iran J Basic Med Sci 2018;21:1179-85. [PMID: 30483393 DOI: 10.22038/IJBMS.2018.23543.5930] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 520 |
Wang A, Zhou F, Li D, Lu JJ, Wang Y, Lin L. γ-Mangostin alleviates liver fibrosis through Sirtuin 3-superoxide-high mobility group box 1 signaling axis. Toxicol Appl Pharmacol 2019;363:142-53. [PMID: 30502394 DOI: 10.1016/j.taap.2018.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 521 |
Lestari N, Louisa M, Soetikno V, Suwana AG, Ramadhan PA, Akmal T, Arozal W. Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-β and ERK 1/2 Pathways. J Toxicol 2018;2018:5360496. [PMID: 30538742 DOI: 10.1155/2018/5360496] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 522 |
Wang L, Yang G, Yuan L, Yang Y, Zhao H, Ho C, Li S. Green Tea Catechins Effectively Altered Hepatic Fibrogenesis in Rats by Inhibiting ERK and Smad1/2 Phosphorylation. J Agric Food Chem 2019;67:5437-45. [DOI: 10.1021/acs.jafc.8b05179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 523 |
Wei R, Liu H, Chen R, Sheng Y, Liu T. Astragaloside IV combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway. Exp Ther Med 2019;17:393-7. [PMID: 30651810 DOI: 10.3892/etm.2018.6966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 524 |
Zheng S, Chen Y, Zheng S, He Z, Weng Z. Inhibition of Mastermind-like 1 alleviates liver fibrosis induced by carbon tetrachloride in rats. Exp Biol Med (Maywood) 2018;243:1099-108. [PMID: 30400752 DOI: 10.1177/1535370218810892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 525 |
Zhu J, Wang R, Xu T, Zhang S, Zhao Y, Li Z, Wang C, Zhou J, Gao D, Hu Y, Tian X, Yao J. Salvianolic Acid A Attenuates Endoplasmic Reticulum Stress and Protects Against Cholestasis-Induced Liver Fibrosis via the SIRT1/HSF1 Pathway. Front Pharmacol 2018;9:1277. [PMID: 30455644 DOI: 10.3389/fphar.2018.01277] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 526 |
Mu K, Zhang J, Gu Y, Li H, Han Y, Cheng N, Feng X, Ding G, Zhang R, Zhao Y, Wang H. Cord-derived mesenchymal stem cells therapy for liver cirrhosis in children with refractory Henoch-Schonlein purpura: A case report. Medicine (Baltimore) 2018;97:e13287. [PMID: 30461638 DOI: 10.1097/MD.0000000000013287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 527 |
Saber S, Goda R, El-tanbouly GS, Ezzat D. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis. International Immunopharmacology 2018;64:340-9. [DOI: 10.1016/j.intimp.2018.09.021] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 528 |
Fabre T, Molina MF, Soucy G, Goulet J, Willems B, Villeneuve J, Bilodeau M, Shoukry NH. Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis. Sci Immunol 2018;3:eaar7754. [DOI: 10.1126/sciimmunol.aar7754] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 529 |
Qiu YN, Wang GH, Zhou F, Hao JJ, Tian L, Guan LF, Geng XK, Ding YC, Wu HW, Zhang KZ. PM2.5 induces liver fibrosis via triggering ROS-mediated mitophagy. Ecotoxicol Environ Saf. 2019;167:178-187. [PMID: 30336408 DOI: 10.1016/j.ecoenv.2018.08.050] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 530 |
Yoshioka H, Nonogaki T, Fukaya S, Ichimaru Y, Nagatsu A, Yoshikawa M, Fujii H, Nakao M. Sasa veitchii extract protects against carbon tetrachloride-induced hepatic fibrosis in mice. Environ Health Prev Med 2018;23:49. [PMID: 30322375 DOI: 10.1186/s12199-018-0739-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 531 |
Wang C, Wang B, Xue L, Kang Z, Hou S, Du J, Zhang C. Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton. J Med Chem 2018;61:10573-87. [DOI: 10.1021/acs.jmedchem.8b01165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 532 |
Nascimento M, Piran R, Da Costa RM, Giordani MA, Carneiro FS, Aguiar DH, Dias MC, Sugizaki MM, Luvizotto RA, Nascimento AF, Bomfim GF. Hepatic injury induced by thioacetamide causes aortic endothelial dysfunction by a cyclooxygenase-dependent mechanism. Life Sci 2018;212:168-75. [PMID: 30292829 DOI: 10.1016/j.lfs.2018.09.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 533 |
Jamhiri I, Shahin K, Khodabandeh Z, Kalantar K, Sarvari J, Atapour A, Mina F, Ahmadnejad A, Hosseini SY. Recombinant NS3 Protein Induced Expression of Immune Modulatory Elements in Hepatic Stellate Cells During Its Fibrotic Activity. Viral Immunol 2018;31:575-82. [PMID: 30281404 DOI: 10.1089/vim.2018.0018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 534 |
Chen X, Li WX, Chen Y, Li XF, Li HD, Huang HM, Bu FT, Pan XY, Yang Y, Huang C, Meng XM, Li J. Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis. Cell Death Dis 2018;9:1021. [PMID: 30282980 DOI: 10.1038/s41419-018-1032-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 535 |
Yu F, Geng W, Dong P, Huang Z, Zheng J. LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212. Cell Death Dis 2018;9:1014. [PMID: 30282972 DOI: 10.1038/s41419-018-1068-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 536 |
Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, Horuzsko DD, Arbab AS, Dzutsev A, Sadek R, Trinchieri G, Horuzsko A. The innate immune receptor TREM-1 promotes liver injury and fibrosis. J Clin Invest 2018;128:4870-83. [PMID: 30137027 DOI: 10.1172/JCI98156] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 537 |
Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y, Shimada M. Photobiomodulation with red light-emitting diodes accelerates hepatocyte proliferation through reactive oxygen species/extracellular signal-regulated kinase pathway. Hepatol Res 2018;48:926-36. [PMID: 29710411 DOI: 10.1111/hepr.13182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 538 |
Halpern KB, Shenhav R, Massalha H, Toth B, Egozi A, Massasa EE, Medgalia C, David E, Giladi A, Moor AE, Porat Z, Amit I, Itzkovitz S. Paired-cell sequencing enables spatial gene expression mapping of liver endothelial cells. Nat Biotechnol 2018;36:962-70. [PMID: 30222169 DOI: 10.1038/nbt.4231] [Cited by in Crossref: 193] [Cited by in F6Publishing: 193] [Article Influence: 38.6] [Reference Citation Analysis]
|
| 539 |
Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G, Mathurin P, Urrutia R, Huebert RC, Shah VH. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis. Cell Mol Gastroenterol Hepatol 2019;7:197-209. [PMID: 30539787 DOI: 10.1016/j.jcmgh.2018.09.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 540 |
Yu J, Hu Y, Gao Y, Li Q, Zeng Z, Li Y, Chen H. Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis. Cell Death Discov 2018;4:34. [PMID: 30245857 DOI: 10.1038/s41420-018-0095-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 541 |
Fabregat I, Caballero-Díaz D. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. Front Oncol 2018;8:357. [PMID: 30250825 DOI: 10.3389/fonc.2018.00357] [Cited by in Crossref: 150] [Cited by in F6Publishing: 160] [Article Influence: 30.0] [Reference Citation Analysis]
|
| 542 |
Handayani DS, Ulfa M, Wikanendra GB, Arozal W. Effect of mangiferin on mRNA expression of transforming growth factor beta in rats with liver fibrosis induced by thioacetamide. J Phys : Conf Ser 2018;1073:032076. [DOI: 10.1088/1742-6596/1073/3/032076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 543 |
Petrescu AD, Grant S, Frampton G, McMillin M, Kain J, Kodali M, Shetty AK, DeMorrow S. Gulf war illness-related chemicals increase CD11b/c+ monocyte infiltration into the liver and aggravate hepatic cholestasis in a rodent model. Sci Rep 2018;8:13147. [PMID: 30177688 DOI: 10.1038/s41598-018-31599-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 544 |
He Q, Fu Y, Ding X, Li D, Wang Z, Tian D, Yan W. High-mobility group box 1 induces endoplasmic reticulum stress and activates hepatic stellate cells. Lab Invest 2018;98:1200-10. [PMID: 29959419 DOI: 10.1038/s41374-018-0085-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 545 |
Peng F, Tee JK, Setyawati MI, Ding X, Yeo HLA, Tan YL, Leong DT, Ho HK. Inorganic Nanomaterials as Highly Efficient Inhibitors of Cellular Hepatic Fibrosis. ACS Appl Mater Interfaces 2018;10:31938-46. [DOI: 10.1021/acsami.8b10527] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 546 |
Lao Y, Li Y, Zhang P, Shao Q, Lin W, Qiu B, Lv Y, Tang L, Su S, Zhang H, Tian C, Sun A, Wei H, Zhang P, Wu Y, Jiang Y, He F. Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice. Mol Ther 2018;26:2779-97. [PMID: 30266653 DOI: 10.1016/j.ymthe.2018.08.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 547 |
Allen J, Zhang J, Quickel MD, Kennett M, Patterson AD, Hankey-Giblin PA. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. J Proteome Res 2018;17:3268-80. [PMID: 30091925 DOI: 10.1021/acs.jproteome.8b00379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 548 |
Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91-100. [PMID: 30138605 DOI: 10.1016/j.cbi.2018.08.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 549 |
Rizk FH, Sarhan NI, Soliman NA, Ibrahim MAA, Abd-Elsalam M, Abd-Elsalam S. Heat shock protein 47 as indispensible participant in liver fibrosis: Possible protective effect of lactoferrin. IUBMB Life 2018;70:795-805. [PMID: 30092114 DOI: 10.1002/iub.1884] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 550 |
Zarzour RHA, Alshawsh MA, Asif M, Al-Mansoub MA, Mohamed Z, Ahmad M, Majid AMSA, Asmawi MZ, Kaur G, Al-Dualimi DW, Yam MF. Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease. Nutrients 2018;10:E1057. [PMID: 30096951 DOI: 10.3390/nu10081057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 551 |
Hu JP, Zhang R, Tang M, Li YL, Xun LT, Shi ZZ, An Y, Li T, Song ZJ. Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3p. Cell Mol Biol Lett 2018;23:35. [PMID: 30123297 DOI: 10.1186/s11658-018-0098-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 552 |
Sinkus R, Lambert S, Abd-Elmoniem KZ, Morse C, Heller T, Guenthner C, Ghanem AM, Holm S, Gharib AM. Rheological determinants for simultaneous staging of hepatic fibrosis and inflammation in patients with chronic liver disease. NMR Biomed 2018;31:e3956. [PMID: 30059174 DOI: 10.1002/nbm.3956] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 553 |
Zeng J, Zhu B, Su M. Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway. Biochem Biophys Res Commun 2018;503:1645-50. [PMID: 30055803 DOI: 10.1016/j.bbrc.2018.07.094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 554 |
Peng Y, Yang T, Huang K, Shen L, Tao Y, Liu C. Salvia Miltiorrhiza Ameliorates Liver Fibrosis by Activating Hepatic Natural Killer Cells in Vivo and in Vitro. Front Pharmacol 2018;9:762. [PMID: 30061833 DOI: 10.3389/fphar.2018.00762] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 555 |
Ohara M, Ohnishi S, Hosono H, Yamamoto K, Fu Q, Maehara O, Suda G, Sakamoto N. Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats. Front Pharmacol 2018;9:709. [PMID: 30057547 DOI: 10.3389/fphar.2018.00709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 556 |
Huang SC, Wang PW, Kuo PC, Hung HY, Pan TL. Hepatoprotective Principles and Other Chemical Constituents from the Mycelium of Phellinus linteus. Molecules 2018;23:E1705. [PMID: 30002357 DOI: 10.3390/molecules23071705] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 557 |
Yang Y, Wu XQ, Li WX, Huang HM, Li HD, Pan XY, Li XF, Huang C, Meng XM, Zhang L, Lv XW, Wang H, Li J. PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis. Oncogene. 2018;37:6119-6135. [PMID: 29993036 DOI: 10.1038/s41388-018-0383-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 558 |
Hou B, Zhao Y, Qiang G, Yang X, Xu C, Chen X, Liu C, Wang X, Zhang L, Du G. Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF-β Signaling Pathway Activation in Type 2 Diabetic Rats. Oxid Med Cell Longev 2018;2018:4545321. [PMID: 30057680 DOI: 10.1155/2018/4545321] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 559 |
Wei L, Chen Q, Guo A, Fan J, Wang R, Zhang H. Asiatic acid attenuates CCl 4 -induced liver fibrosis in rats by regulating the PI3K/AKT/mTOR and Bcl-2/Bax signaling pathways. International Immunopharmacology 2018;60:1-8. [DOI: 10.1016/j.intimp.2018.04.016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 560 |
Coll M, Perea L, Boon R, Leite SB, Vallverdú J, Mannaerts I, Smout A, El Taghdouini A, Blaya D, Rodrigo-Torres D, Graupera I, Aguilar-Bravo B, Chesne C, Najimi M, Sokal E, Lozano JJ, van Grunsven LA, Verfaillie CM, Sancho-Bru P. Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis. Cell Stem Cell 2018;23:101-113.e7. [PMID: 30049452 DOI: 10.1016/j.stem.2018.05.027] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 23.2] [Reference Citation Analysis]
|
| 561 |
Fang H, Judd RL. Adiponectin Regulation and Function. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1031-63. [DOI: 10.1002/cphy.c170046] [Cited by in Crossref: 240] [Cited by in F6Publishing: 255] [Article Influence: 48.0] [Reference Citation Analysis]
|
| 562 |
Hardy T, Day CP. Non-Alcoholic Fatty Liver Disease. Sherlock's Diseases of the Liver and Biliary System 2018. [DOI: 10.1002/9781119237662.ch28] [Reference Citation Analysis]
|
| 563 |
Liu Z, Lian B, Dong Q, Sun H, Wei J, Sheng Y, Li W, Li Y, Xie L, Liu L, Qin L. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:2360-8. [DOI: 10.1016/j.bbadis.2018.01.027] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 564 |
Caviglia JM, Yan J, Jang MK, Gwak GY, Affo S, Yu L, Olinga P, Friedman RA, Chen X, Schwabe RF. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology 2018;67:2414-29. [PMID: 29091291 DOI: 10.1002/hep.29627] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 565 |
Shafigullina AK, Mijanovic O, Prottoy RA, Zhuravleva MN, Gomzikova MO, Gumerova AA, Rizvanov AA, Kiyasov AP. Effect of Curcumin and Gliotoxin on Rat Liver Myofibroblast Culture. BioNanoSci 2018;8:522-536. [DOI: 10.1007/s12668-017-0494-z] [Reference Citation Analysis]
|
| 566 |
Pan XY, Yang Y, Meng HW, Li HD, Chen X, Huang HM, Bu FT, Yu HX, Wang Q, Huang C, Meng XM, Li J. DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis. Front Pharmacol 2018;9:553. [PMID: 29892223 DOI: 10.3389/fphar.2018.00553] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 567 |
Xing X, Chen S, Li L, Cao Y, Chen L, Wang X, Zhu Z. The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach. Front Pharmacol 2018;9:525. [PMID: 29881350 DOI: 10.3389/fphar.2018.00525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 568 |
Xia P, He H, Kristine MS, Guan W, Gao J, Wang Z, Hu J, Han L, Li J, Han W, Yu Y. Therapeutic effects of recombinant human S100A6 and soluble receptor for advanced glycation end products(sRAGE) on CCl4-induced liver fibrosis in mice. Eur J Pharmacol 2018;833:86-93. [PMID: 29800549 DOI: 10.1016/j.ejphar.2018.05.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 569 |
Yao W, Wang T, Huang F. p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis. Biomed Res Int 2018;2018:8168791. [PMID: 29862292 DOI: 10.1155/2018/8168791] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 570 |
Wei X, Chen Y, Huang W. Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo. Biofactors 2018. [PMID: 29761840 DOI: 10.1002/biof.1432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 571 |
Qiao H, Zhou Y, Qin X, Cheng J, He Y, Jiang Y. NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation. Stem Cells Int 2018;2018:1239143. [PMID: 29861737 DOI: 10.1155/2018/1239143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 572 |
You K, Li SY, Gong J, Fang JH, Zhang C, Zhang M, Yuan Y, Yang J, Zhuang SM. MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling. Mol Ther Nucleic Acids. 2018;12:57-66. [PMID: 30195793 DOI: 10.1016/j.omtn.2018.04.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 573 |
Huang Y, Fan X, Tao R, Song Q, Wang L, Zhang H, Kong H, Huang J. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway. J Cell Physiol 2018;233:6693-704. [PMID: 29323718 DOI: 10.1002/jcp.26469] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 574 |
Sequera C, Manzano S, Guerrero C, Porras A. How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma. Hepat Oncol 2018;5:HEP05. [PMID: 30302196 DOI: 10.2217/hep-2017-0026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 575 |
Feng X, Zhong GJ, Deng Ba DJ, Yang B, Chen L, Du S. Hepatoprotective effect of Herpetospermum caudigerum Wall. on carbon tetrachloride-induced hepatic fibrosis in rats. J Cell Mol Med 2018;22:3691-7. [PMID: 29654657 DOI: 10.1111/jcmm.13568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 576 |
Fang X, Liu L, Dong J, Zhang J, Song H, Song Y, Huang Y, Cui X, Lin J, Chen C, Liu B, Chen Z, Pan J, Chen X. A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis. J Gastroenterol Hepatol 2018;33:774-80. [PMID: 29293276 DOI: 10.1111/jgh.14081] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 577 |
Ke B, Lee C. Cordyceps cicadae NTTU 868 mycelium prevents CCl 4 -induced hepatic fibrosis in BALB/c mice via inhibiting the expression of pro-inflammatory and pro-fibrotic cytokines. Journal of Functional Foods 2018;43:214-23. [DOI: 10.1016/j.jff.2018.02.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 578 |
Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L. Cellular prognostic markers in hepatitis-related hepatocellular carcinoma. Infect Agent Cancer 2018;13:10. [PMID: 29599818 DOI: 10.1186/s13027-018-0183-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 579 |
Yu JH, Kim JM, Kim JK, Choi SJ, Lee KS, Lee JW, Chang HY, Lee JI. Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis. Oncotarget 2017;8:39534-46. [PMID: 28465473 DOI: 10.18632/oncotarget.17134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 580 |
Sun Q, Miao J, Luo J, Yuan Q, Cao H, Su W, Zhou Y, Jiang L, Fang L, Dai C, Zen K, Yang J. The feedback loop between miR-21, PDCD4 and AP-1 functions as a driving force for renal fibrogenesis. J Cell Sci 2018;131:jcs202317. [PMID: 29361523 DOI: 10.1242/jcs.202317] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 581 |
Inoue T, Ishizaka Y, Sasaki E, Lu J, Mineshige T, Yanase M, Sasaki E, Shimoda M. Thioacetamide-induced hepatic fibrosis in the common marmoset. Exp Anim 2018;67:321-7. [PMID: 29467352 DOI: 10.1538/expanim.17-0156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 582 |
Qin L, Qin J, Zhen X, Yang Q, Huang L. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis：A study in vitro and in vivo. Biomed Pharmacother 2018;101:599-607. [PMID: 29518606 DOI: 10.1016/j.biopha.2018.02.091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 583 |
Zhao XA, Chen G, Liu Y, Wu H, Chen J, Xiong Y, Tian C, Jia B, Wang G, Xia J, Chen Y, Wang J, Yan X, Zhang Z, Huang R, Wu C. Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1hi Monocytes. Evid Based Complement Alternat Med 2018;2018:5738101. [PMID: 29743924 DOI: 10.1155/2018/5738101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 584 |
Li Z, Ji L, Su S, Zhu X, Cheng F, Jia X, Zhou Q, Zhou Y. Leptin up-regulates microRNA-27a/b-3p level in hepatic stellate cells. Exp Cell Res 2018;366:63-70. [PMID: 29548749 DOI: 10.1016/j.yexcr.2018.03.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 585 |
Wang X, Ai L, Xu Q, Wu C, Chen Z, Su D, Jiang X, Fan Z. A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses. Inflammation 2017;40:840-8. [PMID: 28251449 DOI: 10.1007/s10753-017-0528-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 586 |
Cordie A, Salama A, El-Sharkawy M, El-Nahaas SM, Khairy M, Elsharkawy A, Hassany M, Esmat G. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C. J Med Virol 2018;90:1106-11. [PMID: 29476628 DOI: 10.1002/jmv.25064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 587 |
Bu FT, Chen Y, Yu HX, Chen X, Yang Y, Pan XY, Wang Q, Wu YT, Huang C, Meng XM, Li J. SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion. Toxicol Lett 2018;289:86-98. [PMID: 29535048 DOI: 10.1016/j.toxlet.2018.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 588 |
Cao H, Li S, Xie R, Xu N, Qian Y, Chen H, Hu Q, Quan Y, Yu Z, Liu J, Xiang M. Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation. Front Pharmacol 2018;9:187. [PMID: 29556199 DOI: 10.3389/fphar.2018.00187] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 589 |
Zhao L, Shi M, Zhou L, Sun H, Zhang X, He L, Tang Z, Wang C, Wu Y, Chen T, Shang M, Zhou X, Lin Z, Li X, Yu X, Huang Y. Clonorchis sinensis adult-derived proteins elicit Th2 immune responses by regulating dendritic cells via mannose receptor. PLoS Negl Trop Dis 2018;12:e0006251. [PMID: 29505573 DOI: 10.1371/journal.pntd.0006251] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 590 |
Kim KM, Han CY, Kim JY, Cho SS, Kim YS, Koo JH, Lee JM, Lim SC, Kang KW, Kim JS, Hwang SJ, Ki SH, Kim SG. Gα(12) overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol 2018;68:493-504. [PMID: 29080810 DOI: 10.1016/j.jhep.2017.10.011] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 591 |
Li H, Lan J, Han C, Guo K, Wang G, Hu J, Gong J, Luo X, Cao Z. Brg1 promotes liver fibrosis via activation of hepatic stellate cells. Experimental Cell Research 2018;364:191-7. [DOI: 10.1016/j.yexcr.2018.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 592 |
Lee JH, Kim YR, Lee GM, Ryu JH, Cho EY, Lee YH, Yoon KH. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B. Eur J Radiol 2018;102:95-101. [PMID: 29685552 DOI: 10.1016/j.ejrad.2018.02.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 593 |
Saber S, Mahmoud AAA, Helal NS, El-Ahwany E, Abdelghany RH. Renin-angiotensin system inhibition ameliorates CCl4-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B. Can J Physiol Pharmacol. 2018;96:569-576. [PMID: 29425464 DOI: 10.1139/cjpp-2017-0728] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 594 |
Qu K, Liu T, Lin T, Zhang X, Cui R, Liu S, Meng F, Zhang J, Tai M, Wan Y, Liu C. Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis? Oncotarget 2016;7:67650-60. [PMID: 27588502 DOI: 10.18632/oncotarget.11767] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 595 |
Gajendiran P, Vega LI, Itoh K, Sesaki H, Vakili MR, Lavasanifar A, Hong K, Mezey E, Ganapathy-Kanniappan S. Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin. J Cell Mol Med 2018;22:2210-9. [PMID: 29397578 DOI: 10.1111/jcmm.13501] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 596 |
Cao F, Zhang Y, Li W, Shimizu K, Xie H, Zhang C. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways. International Immunopharmacology 2018;55:183-92. [DOI: 10.1016/j.intimp.2017.12.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 597 |
Kuehl T, Lagares D. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts. Matrix Biol 2018;68-69:94-105. [PMID: 29408011 DOI: 10.1016/j.matbio.2018.01.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 598 |
Abu El Makarem MA, El-Sagheer GM, Abu El-Ella MA. The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients. Med Princ Pract 2018;27:115-21. [PMID: 29402841 DOI: 10.1159/000487308] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 599 |
González-Ponce HA, Rincón-Sánchez AR, Jaramillo-Juárez F, Moshage H. Natural Dietary Pigments: Potential Mediators against Hepatic Damage Induced by Over-The-Counter Non-Steroidal Anti-Inflammatory and Analgesic Drugs. Nutrients 2018;10:E117. [PMID: 29364842 DOI: 10.3390/nu10020117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 600 |
Zhang S, Wang Z, Zhu J, Xu T, Zhao Y, Zhao H, Tang F, Li Z, Zhou J, Gao D, Tian X, Yao J. Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats. Front Pharmacol 2017;8:976. [PMID: 29403377 DOI: 10.3389/fphar.2017.00976] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 601 |
Di Carlo SE, Peduto L. The perivascular origin of pathological fibroblasts. J Clin Invest 2018;128:54-63. [PMID: 29293094 DOI: 10.1172/JCI93558] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 18.4] [Reference Citation Analysis]
|
| 602 |
Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver 2018. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 603 |
Gao B, Zakhari S. Epidemiology and Pathogenesis of Alcoholic Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00022-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 604 |
Cheng Y, Zhu X, Cheng F, Ji L, Zhou Y. Delta-like homolog1/GATA binding protein 2 axis mediates leptin inhibition of PPARγ2 expression in hepatic stellate cells in vitro. Life Sciences 2018;192:183-9. [DOI: 10.1016/j.lfs.2017.11.050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 605 |
Hollenbach M, Zipprich A. The Role of Glyoxalase-I in Oxidant Stress of Liver Damage. The Liver 2018. [DOI: 10.1016/b978-0-12-803951-9.00007-0] [Reference Citation Analysis]
|
| 606 |
Pérez-cabeza de Vaca R, Domínguez-lópez M, Guerrero-celis N, Rodríguez-aguilera JR, Chagoya de Sánchez V. Inflammation is regulated by the adenosine derivative molecule, IFC-305, during reversion of cirrhosis in a CCl4 rat model. International Immunopharmacology 2018;54:12-23. [DOI: 10.1016/j.intimp.2017.10.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 607 |
Axley P, Mudumbi S, Sarker S, Kuo YF, Singal AK. Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS One 2018;13:e0197117. [PMID: 29746540 DOI: 10.1371/journal.pone.0197117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 608 |
Demiroren K. Comparing Antioxidants in Liver Disease: l -Carnitine, N -Acetylcysteine, and Genistein. The Liver 2018. [DOI: 10.1016/b978-0-12-803951-9.00022-7] [Reference Citation Analysis]
|
| 609 |
Szabo G, Saha B, Ambade A. The Liver as an Immune Organ. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00004-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 610 |
Li Y, Shang W, Liang X, Zeng C, Liu M, Wang S, Li H, Tian J. The diagnosis of hepatic fibrosis by magnetic resonance and near-infrared imaging using dual-modality nanoparticles. RSC Adv 2018;8:6699-708. [DOI: 10.1039/c7ra10847h] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 611 |
Sud V, van der Windt D, Tsung A. Toll-Like Receptors, PAMPs, and DAMPs in Hepatotoxicity. Comprehensive Toxicology 2018. [DOI: 10.1016/b978-0-12-801238-3.64266-6] [Reference Citation Analysis]
|
| 612 |
Cao Q, Zhu X, Zhai X, Ji L, Cheng F, Zhu Y, Yu P, Zhou Y. Leptin suppresses microRNA-122 promoter activity by phosphorylation of foxO1 in hepatic stellate cell contributing to leptin promotion of mouse liver fibrosis. Toxicology and Applied Pharmacology 2018;339:143-50. [DOI: 10.1016/j.taap.2017.12.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 613 |
Feng J, Chen K, Xia Y, Wu L, Li J, Li S, Wang W, Lu X, Liu T, Guo C. Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways. Drug Des Devel Ther 2018;12:1837-53. [PMID: 29970958 DOI: 10.2147/DDDT.S162950] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 614 |
Yang F, Luo L, Zhu ZD, Zhou X, Wang Y, Xue J, Zhang J, Cai X, Chen ZL, Ma Q, Chen YF, Wang YJ, Luo YY, Liu P, Zhao L. Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo. Front Pharmacol 2017;8:929. [PMID: 29311932 DOI: 10.3389/fphar.2017.00929] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 615 |
Zhao Y, Shi X, Ding C, Feng D, Li Y, Hu Y, Wang L, Gao D, Tian X, Yao J. Carnosic acid prevents COL1A2 transcription through the reduction of Smad3 acetylation via the AMPKα1/SIRT1 pathway. Toxicol Appl Pharmacol 2018;339:172-80. [PMID: 29253500 DOI: 10.1016/j.taap.2017.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 616 |
Namsen R, Rojanasthien N, Sireeratawong S, Rojsanga P, Nimlamool W, Potikanond S. Thunbergia laurifolia Exhibits Antifibrotic Effects in Human Hepatic Stellate Cells. Evid Based Complement Alternat Med 2017;2017:3508569. [PMID: 29410686 DOI: 10.1155/2017/3508569] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 617 |
Li J, Hu R, Xu S, Li Y, Qin Y, Wu Q, Xiao Z. Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats. Biomedicine & Pharmacotherapy 2017;96:847-53. [DOI: 10.1016/j.biopha.2017.10.065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 618 |
Atallah MAA, Elaidy SM, Tawfik MK. Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats: Oxidative stress/TGF-β1-induced HSCs activation pathway. Pharmacol Rep 2018;70:509-18. [PMID: 29660654 DOI: 10.1016/j.pharep.2017.11.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 619 |
Wang B, Yang H, Fan Y, Yang Y, Cao W, Jia Y, Cao Y, Sun K, Pang Z, Du H. 3-Methyladenine ameliorates liver fibrosis through autophagy regulated by the NF-κB signaling pathways on hepatic stellate cell. Oncotarget 2017;8:107603-11. [PMID: 29296191 DOI: 10.18632/oncotarget.22539] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 620 |
Bae M, Park YK, Lee JY. Food components with antifibrotic activity and implications in prevention of liver disease. J Nutr Biochem 2018;55:1-11. [PMID: 29268106 DOI: 10.1016/j.jnutbio.2017.11.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 621 |
Delire B, Lebrun V, Selvais C, Henriet P, Bertrand A, Horsmans Y, Leclercq IA. Aging enhances liver fibrotic response in mice through hampering extracellular matrix remodeling. Aging (Albany NY). 2016;9:98-113. [PMID: 27941216 DOI: 10.18632/aging.101124] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 622 |
Wan Y, McDaniel K, Wu N, Ramos-Lorenzo S, Glaser T, Venter J, Francis H, Kennedy L, Sato K, Zhou T. Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. Am J Pathol. 2017;187:2788-2798. [PMID: 29128099 DOI: 10.1016/j.ajpath.2017.08.027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 623 |
Guo L, Zhang P, Chen Z, Xia H, Li S, Zhang Y, Kobberup S, Zou W, Lin JD. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. J Clin Invest 2017;127:4449-61. [PMID: 29106384 DOI: 10.1172/JCI96324] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 624 |
Theron AJ, Anderson R, Rossouw TM, Steel HC. The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders. Front Immunol 2017;8:1461. [PMID: 29163528 DOI: 10.3389/fimmu.2017.01461] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 625 |
Yazdani S, Bansal R, Prakash J. Drug targeting to myofibroblasts: Implications for fibrosis and cancer. Adv Drug Deliv Rev 2017;121:101-16. [PMID: 28720422 DOI: 10.1016/j.addr.2017.07.010] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 626 |
Böttcher K, Pinzani M. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv Drug Deliv Rev 2017;121:3-8. [PMID: 28600202 DOI: 10.1016/j.addr.2017.05.016] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 627 |
Mazza G, Al-Akkad W, Rombouts K. Engineering in vitro models of hepatofibrogenesis. Adv Drug Deliv Rev 2017;121:147-57. [PMID: 28578016 DOI: 10.1016/j.addr.2017.05.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 628 |
Karsdal MA, Nielsen SH, Leeming DJ, Langholm LL, Nielsen MJ, Manon-Jensen T, Siebuhr A, Gudmann NS, Rønnow S, Sand JM, Daniels SJ, Mortensen JH, Schuppan D. The good and the bad collagens of fibrosis - Their role in signaling and organ function. Adv Drug Deliv Rev 2017;121:43-56. [PMID: 28736303 DOI: 10.1016/j.addr.2017.07.014] [Cited by in Crossref: 227] [Cited by in F6Publishing: 235] [Article Influence: 37.8] [Reference Citation Analysis]
|
| 629 |
Auguet T, Aragonès G, Berlanga A, Martínez S, Sabench F, Binetti J, Aguilar C, Porras JA, Molina A, Del Castillo D, Richart C. Hepcidin in morbidly obese women with non-alcoholic fatty liver disease. PLoS One 2017;12:e0187065. [PMID: 29065180 DOI: 10.1371/journal.pone.0187065] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 630 |
Zhai X, Cheng F, Ji L, Zhu X, Cao Q, Zhang Y, Jia X, Zhou Q, Guan W, Zhou Y. Leptin reduces microRNA-122 level in hepatic stellate cells in vitro and in vivo. Mol Immunol 2017;92:68-75. [PMID: 29054053 DOI: 10.1016/j.molimm.2017.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 631 |
He J, Bai K, Hong B, Zhang F, Zheng S. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats. Int Immunopharmacol 2017;53:56-62. [PMID: 29035816 DOI: 10.1016/j.intimp.2017.09.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 632 |
Xuanfei L, Hao C, Zhujun Y, Yanming L, Jianping G. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway. Oncotarget 2017;8:21015-30. [PMID: 28423499 DOI: 10.18632/oncotarget.15472] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 633 |
Bangen JM, Hammerich L, Sonntag R, Baues M, Haas U, Lambertz D, Longerich T, Lammers T, Tacke F, Trautwein C, Liedtke C. Targeting CCl(4) -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice. Hepatology 2017;66:1242-57. [PMID: 28520165 DOI: 10.1002/hep.29275] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 634 |
Paquissi FC. Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis. Front Immunol. 2017;8:1195. [PMID: 29033929 DOI: 10.3389/fimmu.2017.01195] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 635 |
Xuan J, Chen Y, Zhu L, Guo Y, Deng L, Zheng Y, Wang Z, Wang Z, Ao M. Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model. Oncotarget 2017;8:108676-91. [PMID: 29312560 DOI: 10.18632/oncotarget.21358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 636 |
Attallah AM, Omran D, Omran MM, Albannan MS, Zayed RA, Saif S, Farid A, Hassany M, Yosry A. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci 2018;75:19-23. [PMID: 28945150 DOI: 10.1080/09674845.2017.1362950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 637 |
Özerkan D, Özsoy N, Akbulut KG, Güney Ş, Öztürk G. The protective effect of vitamin D against carbon tetrachloride damage to the rat liver. Biotech Histochem 2017;92:513-23. [PMID: 28910170 DOI: 10.1080/10520295.2017.1361549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 638 |
Gong J, Han J, He J, Liu J, Han P, Wang Y, Li M, Li D, Ding X, Du Z, Liao J, Tian D. Paired related homeobox protein 1 regulates PDGF-induced chemotaxis of hepatic stellate cells in liver fibrosis. Lab Invest 2017;97:1020-32. [PMID: 28737764 DOI: 10.1038/labinvest.2017.65] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 639 |
Xie SR, An JY, Zheng LB, Huo XX, Guo J, Shih D, Zhang XL. Effects and mechanism of adenovirus-mediated phosphatase and tension homologue deleted on chromosome ten gene on collagen deposition in rat liver fibrosis. World J Gastroenterol 2017; 23(32): 5904-5912 [PMID: 28932082 DOI: 10.3748/wjg.v23.i32.5904] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 640 |
Koh EK, Kim JE, Song SH, Sung JE, Lee HA, Kim KS, Hong JT, Hwang DY. Ethanol extracts collected from the Styela clava tunic alleviate hepatic injury induced by carbon tetrachloride (CCl4) through inhibition of hepatic apoptosis, inflammation, and fibrosis. J Toxicol Pathol 2017;30:291-306. [PMID: 29097839 DOI: 10.1293/tox.2017-0021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 641 |
Yan Y, Guan C, Du S, Zhu W, Ji Y, Su N, Mei X, He D, Lu Y, Zhang C, Xing XH. Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl4-Induced Liver Fibrosis. Front Pharmacol. 2017;8:514. [PMID: 28871223 DOI: 10.3389/fphar.2017.00514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 642 |
Kimura K, Ikoma A, Shibakawa M, Shimoda S, Harada K, Saio M, Imamura J, Osawa Y, Kimura M, Nishikawa K, Okusaka T, Morita S, Inoue K, Kanto T, Todaka K, Nakanishi Y, Kohara M, Mizokami M. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial. EBioMedicine 2017;23:79-87. [PMID: 28844410 DOI: 10.1016/j.ebiom.2017.08.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 643 |
Lu C, Xu W, Zheng S. Nrf2 activation is required for curcumin to induce lipocyte phenotype in hepatic stellate cells. Biomed Pharmacother 2017;95:1-10. [PMID: 28826090 DOI: 10.1016/j.biopha.2017.08.037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 644 |
Liu H, Pan X, Cao H, Shu X, Sun H, Lu J, Liang J, Zhang K, Zhu F, Li G, Zhang Q. IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs. Exp Ther Med 2017;14:3880-6. [PMID: 29042996 DOI: 10.3892/etm.2017.4956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 645 |
Hu Q, Hu Z, Chen Q, Huang Y, Mao Z, Xu F, Zhou X. BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats. Prostaglandins Other Lipid Mediat 2017;131:75-82. [PMID: 28822808 DOI: 10.1016/j.prostaglandins.2017.08.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 646 |
Debes JD, de Knegt RJ, Boonstra A. The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals. Transplantation. 2017;101:910-915. [PMID: 28045877 DOI: 10.1097/tp.0000000000001623] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 647 |
Liu Y, Li L, Liu J, She WM, Shi JM, Li J, Wang JY, Jiang W. Activated hepatic stellate cells directly induce pathogenic Th17 cells in chronic hepatitis B virus infection. Exp Cell Res. 2017;359:129-137. [PMID: 28780305 DOI: 10.1016/j.yexcr.2017.08.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 648 |
Lu C, Xu W, Shao J, Zhang F, Chen A, Zheng S. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells. International Immunopharmacology 2017;49:203-11. [DOI: 10.1016/j.intimp.2017.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 649 |
Guo Y, Ding Q, Chen L, Ji C, Hao H, Wang J, Qi W, Xie X, Ma J, Li A, Jiang X, Li X, Jiang H. Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Mediates Liver Fibrosis in Transgenic Mice. The American Journal of the Medical Sciences 2017;354:199-210. [DOI: 10.1016/j.amjms.2017.04.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 650 |
Kim G, Kim KJ, Rhee Y, Lim SK. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. PLoS One 2017;12:e0182202. [PMID: 28759632 DOI: 10.1371/journal.pone.0182202] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 651 |
Stokkeland K, Lageborn CT, Ekbom A, Höijer J, Bottai M, Stål P, Söderberg-löfdal K. Statins and Angiotensin-Converting Enzyme Inhibitors are Associated with Reduced Mortality and Morbidity in Chronic Liver Disease. Basic Clin Pharmacol Toxicol 2018;122:104-10. [DOI: 10.1111/bcpt.12844] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 652 |
Chen Q, Zhang H, Cao Y, Li Y, Sun S, Zhang J, Zhang G. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways. Drug Des Devel Ther 2017;11:2179-91. [PMID: 28794616 DOI: 10.2147/DDDT.S137507] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 653 |
Teran-Hinojosa E, Sobral H, Sánchez-Pérez C, Pérez-García A, Alemán-García N, Hernández-Ruiz J. Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy. Biomed Opt Express 2017;8:3816-27. [PMID: 28856052 DOI: 10.1364/BOE.8.003816] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 654 |
Bao S, Zheng J, Shi G. The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review). Mol Med Rep 2017;16:3713-9. [PMID: 28731149 DOI: 10.3892/mmr.2017.7044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 655 |
de Oliveira da Silva B, Ramos LF, Moraes KCM. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int 2017;41:946-59. [PMID: 28498509 DOI: 10.1002/cbin.10790] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 656 |
Liang Z, Li T, Jiang S, Xu J, Di W, Yang Z, Hu W, Yang Y. AMPK: a novel target for treating hepatic fibrosis. Oncotarget 2017;8:62780-92. [PMID: 28977988 DOI: 10.18632/oncotarget.19376] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 657 |
de Azevedo LA, Matte U, da Silveira TR, Álvares-da-Silva MR. Genetic variants underlying vitamin D metabolism and VDR-TGFβ-1-SMAD3 interaction may impact on HCV progression: a study based on dbGaP data from the HALT-C study. J Hum Genet 2017;62:969-77. [PMID: 28703134 DOI: 10.1038/jhg.2017.75] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 658 |
Li G, Peng Y, Zhao T, Lin J, Duan X, Wei Y, Ma J. Plumbagin Alleviates Capillarization of Hepatic Sinusoids In Vitro by Downregulating ET-1, VEGF, LN, and Type IV Collagen. Biomed Res Int 2017;2017:5603216. [PMID: 28770223 DOI: 10.1155/2017/5603216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 659 |
Takahashi Y. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. Int J Mol Sci. 2017;18. [PMID: 28678199 DOI: 10.3390/ijms18071447] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 660 |
Kang J, Lee M. Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease. Liver Cirrhosis - Update and Current Challenges 2017. [DOI: 10.5772/intechopen.68317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 661 |
Rodríguez‐aguilera JR, Guerrero‐hernández C, Pérez‐molina R, Cadena‐del‐castillo CE, Pérez‐cabeza de Vaca R, Guerrero‐celis N, Domínguez‐lópez M, Murillo‐de‐ozores AR, Arzate‐mejía R, Recillas‐targa F, Chagoya de Sánchez V. Epigenetic Effects of an Adenosine Derivative in a Wistar Rat Model of Liver Cirrhosis. J Cell Biochem 2018;119:401-13. [DOI: 10.1002/jcb.26192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 662 |
Cheng JC, Tseng CP, Liao MH, Peng CY, Yu JS, Chuang PH, Huang JT, Chen JJW. Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes. Sci Rep 2017;7:4448. [PMID: 28667290 DOI: 10.1038/s41598-017-04259-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 663 |
Fausther M, Lavoie EG, Goree JR, Dranoff JA. An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts. Purinergic Signal 2017;13:417-28. [PMID: 28667437 DOI: 10.1007/s11302-017-9570-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 664 |
Cohen C, Leal MF, Belangero PS, Figueiredo EA, Smith MC, Andreoli CV, de Castro Pochini A, Cohen M, Ejnisman B, Faloppa F. The roles of Tenascin C and Fibronectin 1 in adhesive capsulitis: a pilot gene expression study. Clinics (Sao Paulo) 2016;71:325-31. [PMID: 27438566 DOI: 10.6061/clinics/2016(06)07] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 665 |
Ibba-Manneschi L, Rosa I, Manetti M. Telocytes in Chronic Inflammatory and Fibrotic Diseases. Adv Exp Med Biol 2016;913:51-76. [PMID: 27796880 DOI: 10.1007/978-981-10-1061-3_4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 666 |
Kerola A, Lampela H, Lohi J, Heikkilä P, Mutanen A, Jalanko H, Pakarinen MP. Molecular signature of active fibrogenesis prevails in biliary atresia after successful portoenterostomy. Surgery 2017;162:548-56. [PMID: 28655415 DOI: 10.1016/j.surg.2017.04.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 667 |
Omar R, Yang J, Liu H, Davies NM, Gong Y. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Rev Physiol Biochem Pharmacol 2016;172:1-37. [PMID: 27534415 DOI: 10.1007/112_2016_6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 668 |
Zhou L, Shi M, Zhao L, Lin Z, Tang Z, Sun H, Chen T, Lv Z, Xu J, Huang Y, Yu X. Clonorchis sinensis lysophospholipase A upregulates IL-25 expression in macrophages as a potential pathway to liver fibrosis. Parasit Vectors. 2017;10:295. [PMID: 28623940 DOI: 10.1186/s13071-017-2228-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 669 |
Manchanda M, Das P, Gahlot GPS, Singh R, Roeb E, Roderfeld M, Datta Gupta S, Saraya A, Pandey RM, Chauhan SS. Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models. Clin Transl Gastroenterol 2017;8:e99. [PMID: 28617446 DOI: 10.1038/ctg.2017.25] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 670 |
Ma T, Cai X, Wang Z, Huang L, Wang C, Jiang S, Hua Y, Liu Q. miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway. Biomed Res Int. 2017;2017:2670658. [PMID: 28691020 DOI: 10.1155/2017/2670658] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 671 |
Liu H, Chen Z, Jin W, Barve A, Wan YY, Cheng K. Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells. Liver Res 2017;1:70-9. [PMID: 28966795 DOI: 10.1016/j.livres.2017.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 672 |
Mihaylov R, Pencheva B, Stoeva D, Ruseva A. Non-invasive Diagnostics of Liver Fibrosis. Acta Medica Bulgarica 2017;44:50-6. [DOI: 10.1515/amb-2017-0009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 673 |
Li L, Duan M, Chen W, Jiang A, Li X, Yang J, Li Z. The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J Transl Med 2017;15:111. [PMID: 28535799 DOI: 10.1186/s12967-017-1214-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 674 |
Gong J, Wang ZX, Liu ZY. miRNA‑1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1. Mol Med Rep 2017;16:143-50. [PMID: 28535003 DOI: 10.3892/mmr.2017.6610] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 675 |
Ma Y, Yang M, He Z, Wei Q, Li J. The Biological Function of Kupffer Cells in Liver Disease. In: Ghosh A, editor. Biology of Myelomonocytic Cells. InTech; 2017. [DOI: 10.5772/67673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 676 |
Zhang Y, Zhao H, Li H, Cao W, Wang F, Zhang T, Wang SW. Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice. Molecules 2017;22:E754. [PMID: 28481234 DOI: 10.3390/molecules22050754] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 677 |
Tanikawa AA, Grotto RM, Silva GF, Ferrasi AC, Sarnighausen VC, Pardini MI. Platelet-derived growth factor A mRNA in platelets is associated with the degree of hepatic fibrosis in chronic hepatitis C. Rev Soc Bras Med Trop 2017;50:113-6. [PMID: 28327812 DOI: 10.1590/0037-8682-0302-2016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 678 |
Sokar SS, El-sayad ME, Ghoneim ME, Shebl AM. Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats. Biomedicine & Pharmacotherapy 2017;89:98-107. [DOI: 10.1016/j.biopha.2017.02.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 679 |
El-sisi AEE, Sokar SS, Shebl AM, Mohamed DZ. Antifibrotic effect of diethylcarbamazine combined with hesperidin against ethanol induced liver fibrosis in rats. Biomedicine & Pharmacotherapy 2017;89:1196-206. [DOI: 10.1016/j.biopha.2017.03.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 680 |
Elmahdy NA, Sokar SS, Salem ML, Sarhan NI, Abou-Elela SH. Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl(4)- induced liver fibrosis in mice. Biomed Pharmacother 2017;89:1378-86. [PMID: 28320105 DOI: 10.1016/j.biopha.2017.03.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 681 |
Zhou L, Dong X, Wang L, Shan L, Li T, Xu W, Ding Y, Lai M, Lin X, Dai M, Bai X, Jia C, Zheng H. Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway. Oncotarget 2017;8:56267-80. [PMID: 28915589 DOI: 10.18632/oncotarget.17453] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 682 |
Kim SM, Choi JE, Hur W, Kim JH, Hong SW, Lee EB, Lee JH, Li TZ, Sung PS, Yoon SK. RAR-Related Orphan Receptor Gamma (ROR-γ) Mediates Epithelial-Mesenchymal Transition Of Hepatocytes During Hepatic Fibrosis. J Cell Biochem 2017;118:2026-36. [PMID: 27791279 DOI: 10.1002/jcb.25776] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 683 |
Sutherland JJ, Webster YW, Willy JA, Searfoss GH, Goldstein KM, Irizarry AR, Hall DG, Stevens JL. Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity. Pharmacogenomics J 2018;18:377-90. [DOI: 10.1038/tpj.2017.17] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 684 |
Wang Y, Shen RW, Han B, Li Z, Xiong L, Zhang FY, Cong BB, Zhang B. Notch signaling mediated by TGF-β/Smad pathway in concanavalin A-induced liver fibrosis in rats. World J Gastroenterol 2017; 23(13): 2330-2336 [PMID: 28428712 DOI: 10.3748/wjg.v23.i13.2330] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 685 |
Hong JS, Lee DH, Yook YW, Na D, Jang YJ, Kim JH, Lee YS. MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice. Biosci Biotechnol Biochem 2017;81:1348-55. [PMID: 28372490 DOI: 10.1080/09168451.2017.1308242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 686 |
Ceni E, Mello T, Polvani S, Vasseur-Cognet M, Tarocchi M, Tempesti S, Cavalieri D, Beltrame L, Marroncini G, Pinzani M, Milani S, Galli A. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells. J Hepatol 2017;66:754-64. [PMID: 27866920 DOI: 10.1016/j.jhep.2016.11.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 687 |
Li W, Chen X, Yang Y, Huang H, Li H, Huang C, Meng X, Li J. Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway. Toxicology 2017;381:75-86. [DOI: 10.1016/j.tox.2016.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 688 |
Zhao ZM, Liu HL, Sun X, Guo T, Shen L, Tao YY, Liu CH. Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway. Exp Biol Med (Maywood) 2017;242:974-85. [PMID: 28440736 DOI: 10.1177/1535370217701005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 689 |
Ni YH, Huo LJ, Li TT. Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22. World J Gastroenterol 2017; 23(11): 2002-2011 [PMID: 28373766 DOI: 10.3748/wjg.v23.i11.2002] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 690 |
Chen JY, Newcomb B, Zhou C, Pondick JV, Ghoshal S, York SR, Motola DL, Coant N, Yi JK, Mao C, Tanabe KK, Bronova I, Berdyshev EV, Fuchs BC, Hannun Y, Chung RT, Mullen AC. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells. Sci Rep 2017;7:44867. [PMID: 28322247 DOI: 10.1038/srep44867] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 691 |
Carotti S, Perrone G, Amato M, Vespasiani Gentilucci U, Righi D, Francesconi M, Pellegrini C, Zalfa F, Zingariello M, Picardi A, Onetti Muda A, Morini S. Reelin expression in human liver of patients with chronic hepatitis C infection. Eur J Histochem 2017;61:2745. [PMID: 28348420 DOI: 10.4081/ejh.2017.2745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 692 |
Shi J, Zhao J, Zhang X, Cheng Y, Hu J, Li Y, Zhao X, Shang Q, Sun Y, Tu B, Shi L, Gao B, Wang FS, Zhang Z. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients. Sci Rep 2017;7:44544. [PMID: 28291251 DOI: 10.1038/srep44544] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 693 |
Han M, Liu X, Liu S, Su G, Fan X, Chen J, Yuan Q, Xu G. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic stellate cell (HSC) activation and liver fibrosis in C57BL6 mouse via activating Akt and NF-κB signaling pathways. Toxicol Lett 2017;273:10-9. [PMID: 28302560 DOI: 10.1016/j.toxlet.2017.03.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 694 |
Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L, Yu D, Han Y, Zhang D, Chen P, Zhang X, Yuan Z, Huang J, Zhang X. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep 2017;7:43446. [PMID: 28262670 DOI: 10.1038/srep43446] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 695 |
Xiang H, Han Y, Zhang Y, Yan W, Xu B, Chu F, Xie T, Jia M, Yan M, Zhao R, Wang P, Lei H. A New Oleanolic Acid Derivative against CCl₄-Induced Hepatic Fibrosis in Rats. Int J Mol Sci 2017;18:E553. [PMID: 28272302 DOI: 10.3390/ijms18030553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 696 |
Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells. J Virol. 2017;91. [PMID: 28077652 DOI: 10.1128/jvi.02225-16] [Cited by in Crossref: 74] [Cited by in F6Publishing: 96] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 697 |
Attallah AM, El-far M, Ghaly MF, Omran MM, Albannan MS, Attallah AA, Shoghey TM, Atrees MM, Elbendary MS, Farid K. Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus. British Journal of Biomedical Science 2017;74:95-100. [DOI: 10.1080/09674845.2017.1278888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 698 |
Zhang X, Lou J, Bai L, Chen Y, Zheng S, Duan Z. Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice. Med Sci Monit 2017;23:1009-16. [PMID: 28235976 DOI: 10.12659/msm.899725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 699 |
Li JY, Cao HY, Sun L, Sun RF, Wu C, Bian YQ, Dong S, Liu P, Sun MY. Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases. World J Gastroenterol 2017; 23(7): 1125-1138 [PMID: 28275293 DOI: 10.3748/wjg.v23.i7.1125] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 700 |
Griffin CT, Gao S. Building discontinuous liver sinusoidal vessels. J Clin Invest 2017;127:790-2. [PMID: 28218626 DOI: 10.1172/JCI92823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 701 |
Natarajan V, Harris EN, Kidambi S. SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis. Biomed Res Int. 2017;2017:4097205. [PMID: 28293634 DOI: 10.1155/2017/4097205] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 702 |
Polanec SH, Bickel H, Baltzer PA, Thurner P, Gittler F, Hodge JC, Bashir MR, Ba-ssalamah A. Respiratory motion artifacts during arterial phase imaging with gadoxetic acid: Can the injection protocol minimize this drawback?: How to Minimize Gadoxetic Acid Artifacts. J Magn Reson Imaging 2017;46:1107-14. [DOI: 10.1002/jmri.25657] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 703 |
Lv PY, Feng H, Huang WH, Tian YY, Wang YQ, Qin YH, Li XH, Hu K, Zhou HH, Ouyang DS. Aucubin and its hydrolytic derivative attenuate activation of hepatic stellate cells via modulation of TGF-β stimulation. Environ Toxicol Pharmacol 2017;50:234-9. [PMID: 28199906 DOI: 10.1016/j.etap.2017.02.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 704 |
Tang SH, Gao JH, Wen SL, Tong H, Yan ZP, Liu R, Tang CW. Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride. Mol Med Rep 2017;15:1507-12. [PMID: 28259935 DOI: 10.3892/mmr.2017.6161] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 705 |
Wang H, Sit W, Tipoe GL, Liu Z, Wan JM. Comparative proteomic analysis of fibrotic liver of rats fed high fat diet contained lard versus corn oil. Clinical Nutrition 2017;36:198-208. [DOI: 10.1016/j.clnu.2015.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 706 |
Zhang F, Hao M, Jin H, Yao Z, Lian N, Wu L, Shao J, Chen A, Zheng S. Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis. Br J Pharmacol 2017;174:409-23. [PMID: 28052321 DOI: 10.1111/bph.13701] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 707 |
Wang Y, Yang F, Xue J, Zhou X, Luo L, Ma Q, Chen YF, Zhang J, Zhang SL, Zhao L. Antischistosomiasis Liver Fibrosis Effects of Chlorogenic Acid through IL-13/miR-21/Smad7 Signaling Interactions In Vivo and In Vitro. Antimicrob Agents Chemother 2017;61:e01347-16. [PMID: 27872076 DOI: 10.1128/AAC.01347-16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 708 |
Cheng Y, Tian Y, Xia J, Wu X, Yang Y, Li X, Huang C, Meng X, Ma T, Li J. The role of PTEN in regulation of hepatic macrophages activation and function in progression and reversal of liver fibrosis. Toxicol Appl Pharmacol. 2017;317:51-62. [PMID: 28095306 DOI: 10.1016/j.taap.2017.01.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 709 |
Kim LB, Shkurupy VA, Putyatina AN. Altered Liver Proteoglycan/Glycosaminoglycan Structure as a Manifestation of Extracellular Matrix Remodeling upon BCG-induced Granulomatosis in Mice. Bull Exp Biol Med 2017;162:331-5. [PMID: 28091914 DOI: 10.1007/s10517-017-3608-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 710 |
Wu X, Wang Y, Wang S, Xu R, Lv X. Purinergic P2X7 receptor mediates acetaldehyde-induced hepatic stellate cells activation via PKC-dependent GSK3β pathway. Int Immunopharmacol 2017;43:164-71. [PMID: 28061416 DOI: 10.1016/j.intimp.2016.12.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 711 |
Vorobioff J, Groszmann R. Portal Hypertension—Molecular Mechanisms. Liver Pathophysiology. Elsevier; 2017. pp. 435-49. [DOI: 10.1016/b978-0-12-804274-8.00034-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 712 |
Parvin-nejad FP, Friedman SL. Cell Death and Autophagy in Hepatic Stellate Cell Activation and Function. Molecules, Systems and Signaling in Liver Injury 2017. [DOI: 10.1007/978-3-319-58106-4_3] [Reference Citation Analysis]
|
| 713 |
Hung W, Yang G, Wang Y, Chiou Y, Tung Y, Yang M, Wang B, Ho C, Wang Y, Pan M. Protective effects of theasinensin A against carbon tetrachloride-induced liver injury in mice. Food Funct 2017;8:3276-87. [DOI: 10.1039/c7fo00700k] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 714 |
Xia F, Zeng L, Yao X, Zhou B. Hepatic Apoptosis and Necrosis. Liver Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804274-8.00003-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 715 |
Ganai AA, Husain M. Genistein attenuates D-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways. Chemico-Biological Interactions 2017;261:80-5. [DOI: 10.1016/j.cbi.2016.11.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 716 |
Pinto S, Hoek M, Huang Y, Costet P, Ma L, Imbriglio J. Drug Discovery in Tissue Fibrosis. Comprehensive Medicinal Chemistry III 2017. [DOI: 10.1016/b978-0-12-409547-2.12432-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 717 |
Alhomrani M, Lim R, Sievert W. Cell Therapy in Chronic Liver Disease. Stem Cells in Clinical Applications 2017. [DOI: 10.1007/978-3-319-46693-4_2] [Reference Citation Analysis]
|
| 718 |
Huang Y, Jeffrey GP, Adams LA. Hepascore and Its Application to Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_29] [Reference Citation Analysis]
|
| 719 |
Vetter D, Friedman SL. Liver fibrogenesis. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00007-8] [Reference Citation Analysis]
|
| 720 |
Brunt EM, Carpenter DH. Cirrhosis and portal hypertension. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00076-5] [Reference Citation Analysis]
|
| 721 |
Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Glycosides Based Standardized Fenugreek Seed Extract Ameliorates Bleomycin-induced Liver Fibrosis in Rats Via Modulation of Endogenous Enzymes. J Pharm Bioallied Sci 2017;9:185-94. [PMID: 28979073 DOI: 10.4103/0975-7406.214688] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 722 |
Marfà S, Jimenez W. Fibrinogen α-Chain as a Serum Marker of Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 723 |
Brown DL. Immunopathology of the Hepatobiliary System. Immunopathology in Toxicology and Drug Development 2017. [DOI: 10.1007/978-3-319-47385-7_7] [Reference Citation Analysis]
|
| 724 |
Bian F, Jiang H, Man M, Mai K, Zhou H, Xu W, He G. Dietary gossypol suppressed postprandial TOR signaling and elevated ER stress pathways in turbot (Scophthalmus maximus L.). Am J Physiol Endocrinol Metab 2017;312:E37-47. [PMID: 27894064 DOI: 10.1152/ajpendo.00285.2016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 725 |
Han CY, Koo JH, Kim SH, Gardenghi S, Rivella S, Strnad P, Hwang SJ, Kim SG. Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt. Nat Commun. 2016;7:13817. [PMID: 28004654 DOI: 10.1038/ncomms13817] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 726 |
Lua I, Asahina K. The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration. Gut Liver. 2016;10:166-176. [PMID: 26934883 DOI: 10.5009/gnl15226] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 727 |
Zhang F, Zhang M, Wang A, Xu M, Wang C, Xu G, Zhang B, Zou X, Zhuge Y. TWEAK increases SIRT1 expression and promotes p53 deacetylation affecting human hepatic stellate cell senescence. Cell Biol Int. 2017;41:147-154. [PMID: 27888541 DOI: 10.1002/cbin.10706] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 728 |
Hsu DC, Sereti I. Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection. Drugs 2016;76:533-49. [PMID: 26915027 DOI: 10.1007/s40265-016-0546-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 729 |
Lee J, Choi B, No da Y, Lee G, Lee SR, Oh H, Lee SH. A 3D alcoholic liver disease model on a chip. Integr Biol (Camb) 2016;8:302-8. [PMID: 26857817 DOI: 10.1039/c5ib00298b] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 730 |
Wu Y, Bu F, Yu H, Li W, Huang C, Meng X, Zhang L, Ma T, Li J. Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis. Toxicol Appl Pharmacol 2017;315:35-49. [PMID: 27939986 DOI: 10.1016/j.taap.2016.12.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 731 |
Terzioglu D, Uslu L, Simsek G, Atukeren P, Erman H, Gelisgen R, Ayvaz S, Aksu B, Uzun H. The Effects of Hyperbaric Oxygen Treatment on Total Antioxidant Capacity and Prolidase Activity after Bile Duct Ligation in Rats. Journal of Investigative Surgery 2016;30:376-82. [DOI: 10.1080/08941939.2016.1257666] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 732 |
Affo S, Yu LX, Schwabe RF. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annu Rev Pathol 2017;12:153-86. [PMID: 27959632 DOI: 10.1146/annurev-pathol-052016-100322] [Cited by in Crossref: 263] [Cited by in F6Publishing: 291] [Article Influence: 37.6] [Reference Citation Analysis]
|
| 733 |
Cheng CF, Pan TM. Ankaflavin and Monascin Induce Apoptosis in Activated Hepatic Stellate Cells through Suppression of the Akt/NF-κB/p38 Signaling Pathway. J Agric Food Chem 2016;64:9326-34. [PMID: 27960292 DOI: 10.1021/acs.jafc.6b03700] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 734 |
Salloum S, Holmes JA, Jindal R, Bale SS, Brisac C, Alatrakchi N, Lidofsky A, Kruger AJ, Fusco DN, Luther J, Schaefer EA, Lin W, Yarmush ML, Chung RT. Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types. Hepatology 2016;64:1951-68. [PMID: 27531241 DOI: 10.1002/hep.28766] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 735 |
Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. Lancet Gastroenterol Hepatol 2016;1:328-40. [PMID: 28404203 DOI: 10.1016/S2468-1253(16)30110-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 736 |
Meissner EG, McLaughlin M, Matthews L, Gharib AM, Wood BJ, Levy E, Sinkus R, Virtaneva K, Sturdevant D, Martens C, Porcella SF, Goodman ZD, Kanwar B, Myers RP, Subramanian M, Hadigan C, Masur H, Kleiner DE, Heller T, Kottilil S, Kovacs JA, Morse CG. Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial. Liver Int 2016;36:1783-92. [PMID: 27232579 DOI: 10.1111/liv.13177] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 737 |
Xu M, Zhang F, Wang A, Wang C, Cao Y, Zhang M, Zhang M, Su M, Zou X, Xu G, Zhuge Y. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Promotes Hepatic Stellate Cells Migration via Canonical NF-κB/MMP9 Pathway. PLoS One 2016;11:e0167658. [PMID: 27907201 DOI: 10.1371/journal.pone.0167658] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 738 |
Mohammadalipour A, Karimi J, Khodadadi I, Solgi G, Hashemnia M, Sheikh N, Bahabadi M. Dasatinib prevent hepatic fibrosis induced by carbon tetrachloride (CCl 4 ) via anti-inflammatory and antioxidant mechanism. Immunopharmacology and Immunotoxicology 2017;39:19-27. [DOI: 10.1080/08923973.2016.1263860] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 739 |
Tang M, Zhou Y, Li Y, Zou J, Yang B, Cai L, Zhang X, Liu Q. Hydrogen donors and acceptors and basic amino acids jointly contribute to carcinogenesis. Med Hypotheses 2017;98:42-4. [PMID: 28012602 DOI: 10.1016/j.mehy.2016.11.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 740 |
He P, Yu ZJ, Sun CY, Jiao SJ, Jiang HQ. Knockdown of HIPK2 attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1. Biomed Pharmacother 2017;85:575-81. [PMID: 27890429 DOI: 10.1016/j.biopha.2016.11.066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 741 |
Gong J, Tu W, Han J, He J, Liu J, Han P, Wang Y, Li M, Liu M, Liao J, Tian D. Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx. Sci Rep 2016;6:37717. [PMID: 27883059 DOI: 10.1038/srep37717] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 742 |
Yin R, Guo D, Zhang S, Zhang X. miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis. Sci Rep 2016;6:37509. [PMID: 27876854 DOI: 10.1038/srep37509] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 743 |
Debes JD, Bohjanen PR, Boonstra A. Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection. J Clin Transl Hepatol. 2016;4:328-335. [PMID: 28097102 DOI: 10.14218/jcth.2016.00034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 744 |
Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. World J Hepatol 2016;8:1354-69. [PMID: 27917262 DOI: 10.4254/wjh.v8.i32.1354] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 745 |
Xu Z, Lin JZ, Lin GL, Wei FF, Liu J, Zhao ZX, Zhang Y, Ke WM, Zhang XH. Hepatitis C virus load in parenchyma cells correlates with hepatic injury in infected patients. Exp Ther Med 2017;13:155-9. [PMID: 28123484 DOI: 10.3892/etm.2016.3915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 746 |
van den Berg PJ, Bansal R, Daoudi K, Steenbergen W, Prakash J. Preclinical detection of liver fibrosis using dual-modality photoacoustic/ultrasound system. Biomed Opt Express 2016;7:5081-91. [PMID: 28018726 DOI: 10.1364/BOE.7.005081] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 747 |
Yang Y, Bae M, Park YK, Lee Y, Pham TX, Rudraiah S, Manautou J, Koo SI, Lee JY. Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells. J Nutr Biochem 2017;40:172-7. [PMID: 27915160 DOI: 10.1016/j.jnutbio.2016.11.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 748 |
Sferra R, Vetuschi A, Pompili S, Gaudio E, Speca S, Latella G. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis. Pathol Res Pract 2017;213:58-65. [PMID: 27894619 DOI: 10.1016/j.prp.2016.11.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [ |
